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The developing mammalian embryo is subjected to low O2 tensions, which owing to the 
short diffusion distance of O2 may form a gradient within the early embryo, and thus may 
function as a developmental morphogen. It was observed that culture of mouse 
embryonic stem cells (mESCs) in 1% O2, compared to atmospheric [O2], acted to skew 
differentiation. The cause of this effect was studied with respect to alterations in 
chromatin structure, via regulation of epigenetic modifications. The ten-eleven 
translocation (Tet) demethylase enzymes, Tet1/2/3, oxidise methylated DNA to form 5-
hydroxymethylcytosine (5-hmC); a stable epigenetic mark that is implicated in 
developmental events. The mechanism(s) which underlie the regulation of their 
function(s) are unknown. However, intriguingly the catalytic activity of these enzymes is 
mediated via a conserved O2-dependent hydroxylase domain. Therefore, it was 
hypothesised that the Tet enzymes may be differentially regulated by [O2] to influence 
cellular specification and thus contribute to asymmetry within the developing embryo. 
Here it was identified that Tet1 is the most likely isoform to be inhibited by O2 tensions 
deemed physiologically relevant during embryogenesis. Further, differentiating mESCs 
displayed a transient, Tet1-mediated, O2-dependent burst of hydroxylation. This 
hydroxylation was predominantly targeted to a CG rich region of a Tet3 promoter, driving 
expression of a truncated protein isoform that lacks a CXXC DNA binding domain. This 
promoter region was shown to associate with Tet1, and also both the repressive 
(H3K27me3) and activating (H3K4me3) histone marks, characteristic of a bivalent 
promoter. Here it was also confirmed that 2 distinct Tet3 protein isoforms are expressed 
in differentiated mESCs, which were found to have differential transcriptional regulation 
and are thus likely to serve distinct cellular functions. It is suggested that Tet1 activity, in 
part determined by [O2] within the early embryo, may regulate Tet3 expression spatially 














2-HG: 2-hydroxyglutarate  
2-OG: 2-oxoglutarate  
2-OGDO: 2-oxoglutarate dependent dioxygenases 
3'UTR: 3’-untranslated regions  
5-hmC: 5-hydroxymethylcytosine 
5-mC: 5-methylcytosine 
5'RACE: 5’Rapid Amplfication of cDNA ends 
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ADCRs: ATP-dependent remodelling complexes 
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ATP: Adenosine triphosphate  
BER: Base-excision repair  
bp: Base pairs  
BSO: Buthionine sulfoxime  
C: Cytosine 
ChIP: Chromatin immunoprecipitation  
CMML: Chronic myleomonocytic leukemia  
CpG: CG dinucleotides 
DFO: Desferrioxamine  
Dgcr8: DiGeorge syndrome critical region 8  
DHA: Dehydroascorbic acid  
DMOG: Dimethyloxalyglycine  
DMSO: Dimethyl sulfoxide  
Dnmt: DNA methyltransferase 
DSBH: Distorted double stranded -helix 
E: Embryonic day 
EBs: Embryoid bodies 
EMT: Epithelial to mesenchymal transition 
Epi: Epiblast 
EPO: Erythropoietin 
ExE: Extraembryonic ectoderm 
FBS: Fetal bovine serum  
FGF: Fibroblast growth factor  
FH: Fumarate hydratase  
FIH: Factor inhibiting HIF 
GlcNAc: β-N-acetylglucosamine  
GSH: Glutathione 
GSK: Glycogen synthase kinase-3  
Gulo: L-gulonolactone--oxidase  
H3K27me2: Histone H3 lysine 27 dimethylation  
H3K27me3: Histone H3 lysine 27 trimethylation  
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H3K4me3: Histone H3 lysine 4 trimethylation  
HCF1: Host cell factor 1  
HEK cells: Human embryonic kidney cells 293 
hESCs: human embryonic stem cells 
HIF: Hypoxic inducible factors 
HMT: histone methyltransferases 
hMedip-seq/PCR: 5-hmC-DNA immunoprecipitation-
sequencing/PCR 
HPLC: High pressure liquid chromatography 
HRE: Hypoxic response elements 
HSPC: Hematopoietic stem/progenitor cells  
ICM: Inner cell mass 
IDH: Isocitrate dehydrogenase  
IP: Immunoprecipitation  
iPSCs: induced pluripotent stem cells 
JmjC: Jumonji C 
K: Lysine  
KD: Knockdown  
KDM: Histone demethylases  
KO: KnockOut (Serum replacement) 
L-gulonolactone--oxidase: Gulo 
LB: Lysogeny broth  
LIF: Leukemia inhibitory factor 
lncRNA: long ncRNAs 
LSD: Lysine specific demethylase  
MAPK: Mitogen-activated protein kinase  
MBD: Methyl-CpG-binding domain  
MEFs: Mouse embryonic fibroblasts 
mESCs: mouse embryonic stem cells 
miRNAs: microRNAs 
MPN: Myeloproliferative neoplasms  
mRNA: messenger RNA  
ncRNA: non-coding RNAs 
NPCs: Neural progenitor cells  
O-GlcNac: O-linked -N-acetylglucosamine  
OGT: O-GlcNac transferase  
OxPhos: Oxidative phosphorylation 
PBS/T: Phosphate buffered saline/ containing 0.1% tween-20  
PcGs: Polycomb group of proteins 
PCR: Polymerase chain reaction  
PGCs: Primordial germ cells  
PHD: Prolyl hydroxylase domain 
piRNAs: piwi-interacting RNAs 
Prc1: Polycomb repressor complex 1 
Prc2: Polycomb repressor 2  
PrE: Primitive endoderm 
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Precursor-miRNAs: pre-miRNAs 
PS: Primitive streak 
pVHL: von Hippel-Lindau 
QPCR: Quantitative polymerase chain reaction 
RA: Retinoic acid  
RISC: RNA induced silencing complex  
RNAse: ribonuclease III  
RPE: Retinal pigment epithelial 
SAH: S-adenosylhomocysteine 
SAM: S-adensylmethionine 
SDG: Succinate dehydrogenase  
SEM: Standard error of the mean  
shRNA: short hairpin RNA 
siRNA: short interfering RNAs 
T: Thymine  
TBS/T: Tris-buffered salt solution/ containing 0.1% tween-20  
TCA: Tricarboxylic acid cycle  
TDG: Thymine DNA glycosylase 
TE: Trophectoderm 
Tet: Ten-eleven translocation enzymes 
TFs: Transcription factors  
TKO: Triple Tet silenced  
TLC: Thin layer chromatography  
U: Uracil  
VE: Visceral endoderm 



























































 Regenerative Medicine: Stem cell therapies  
 
Advancements in medicine have enabled effective treatments against a plethora of 
pathological conditions enabling a better quality of life and prolonged survival for much 
of the first world population. However, many of these treatments either slow progression 
or relieve symptoms of a disease rather than acting directing to repair the damaged 
tissue or organ. Thus, in this new age of modern medicine there is a paradigm shift away 
from the development of molecular pharmaceutical agents towards methods of 
regeneration. Regenerative medicine encompasses any method to replace or 
regenerate cells, tissues or organs to restore normal biological function1. A major arm of 
regenerative medicine is cell-based therapies. Cell therapy involves the introduction of 
live cells either alone, or in combination with a scaffold (tissue engineering), directly to 
the patient, to repair the target tissue or organ2. The concept of cell therapy dates back 
to the first successful blood transfusions in the 19th century3, and has now evolved to be 
the focus of many research laboratories and the pharmaceutical industry worldwide.  
 
Cell therapy has the potential to be applied to a variety of medical conditions, including 
heart failure, neurodegenerative diseases and spinal cord injury. For example, heart 
failure, which can result from myocardial infarction, culminates in the loss of 
cardiomyocytes and hence heart hemodynamic function. This loss of contractile 
machinery results in an inability to pump blood sufficiently to sustain physiological 
function and can often prove fatal. This is in part due to the fact that the mammalian 
heart, compared to amphibians and zebrafish, has a limited regenerative capacity, and 
thus is unable to effectively facilitate de novo generation of a functional myocardium4. 
Therefore, the replacement of cells, with the aim of restoring biological function, provides 
an exciting avenue of scientific exploration. Significant advances in this field have led to 
some, albeit limited, success in clinical studies5,6, however perhaps the most profound 
and convincing proof-of-concept studies for cellular therapy in cardiac regeneration was 
conducted by Chong, J et al (2014)7. Here it was shown human embryonic stem cell 
(hESC) derived cardiomyocytes could substantially engraft and remuscularise the non-
human primate heart in a model of myocardial ischemia7.  
 
Mesenchymal stem cells, a type of adult stem cell, obtained initially from bone marrow, 
but also found in adipose tissue and umbilical cord blood8, offer a cell source for 
therapeutic applications. Specifically, these multipotent cells can differentiate into 
osteoblasts and chondrocytes and have thus been assessed for their ability to treat 
conditions such as osteoarthritis9. However, ESCs have been at forefront of much 
research owing to their unique pluripotency properties, allowing them to differentiate into 
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cells of all 3 embryonic germ layers10. 3 methods are commonly used to promote ESC 
differentiation: the formation of 3-dimensional cell aggregates named embryoid bodies 
(EBs), the culture of cells as monolayers on extracellular matrix proteins and culture of 
cells directly on a stroma-cell supportive layer11. This differentiation can be directed to 
form for instance cardiomyocytes and neurons12,13,14,15,16,17, with the aim to exogenously 
transplant such cells to the target site for therapeutic use (see Figure 1:1 for current cell 




























The use of ESCs are regarded as a powerful tool for regeneration strategies, however 
the development of cell therapies has been impeded by ethical constraints and immuno-
incompatibility18. However, the development of reprogramming technology, which is the 
ability to restore pluripotency to somatic cells through ectopic expression of 4 key 
Figure 1:1 Clinical applications for human pluripotent stem cells in 
regenerative medicine. The use of human pluripotent stem cell derived 
therapeutics undergoing clinical testing include neurons (Parkinson’s disease), 
retinal pigment epithelial cells (retinal degenerative diseases), cardiomyocytes 
(heart disease), oligodendrocytes progenitor cells (OPCs) (spinal cord injury) and -
islet cells ( cells) (type 1 diabetes). Image taken from Thies, R and Murry, C. 
Development. 2015; 142:3077-30846.  
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transcription factors (TFs) (Oct4, Sox2, Klf4 and c-Myc), may have overcome these 
issues19. The generation of these patient-specific induced pluripotent stem cells (iPSCs) 
can be used in cell therapy and disease modelling. This type of cell therapy enables 
autologous generation of terminally differentiated cells for transplantation back into the 
patient, thereby reducing the requirement of immune suppression20. An example of how 
such a treatment has been used clinically is in the treatment of age-related macular 
degeneration. An iPSC-derived transplantation of retinal pigment epithelial cells 
revealed, albeit in a single patient, functional integration of these autologous cells, which 
halted visual deterioration21. However, in a contrasting report intravitreal injections of 
autologous adipose-tissue derived stem cells in 3 AMD patients resulted in loss of 
vision22. Thus collectively knowledge regarding how stem cells can be properly 
differentiated into desired cell types is paramount to ensure safe and efficacious 
therapies23. In addition to cell based therapies, such cells can be used for disease 
modelling, enabling the recapitulation of a cellular phenotype that occurs in a specific 
patient, which for example may have a genetic defect. These cells can subsequently be 
used for drug screening and toxicology studies with the aim of treating similar patients 
and thus paving the way for personalised medicine. Currently, various tissue-specific 
iPSC derived models have been generated, including neurological24, and 
cardiovascular25, which can provide a useful tool to investigate pathophysiology26.  
 
Despite the huge applicability of cell-based regenerative therapies there are concerns 
that are hindering their therapeutic use. Aside from the requirement to generate 
adequate numbers of cells for the clinic, one of the most fundamental residing challenges 
is the ability to generate homogenous fully differentiated cell populations, which 
eliminates the risk of teratoma formation, a characteristic pluripotent trait that occurs in 
both ESCs and iPSCs upon transplantation27. Teratomas are characterised by a 
disorganised arrangement of differentiated tissues originating from a pluripotent cell, and 
are histologically classified as ‘’mature and benign’’ or ‘’immature and malignant’’ 
(referred to as teratocarcinomas)28,29. Teratoma formation has been previously reported 
upon the transplantation of mouse ESC (mESC) derived cardiomyocytes30, neurons31 
and -islet cells32 into immunosuppressed mice, but the initiation and pathogenesis of 
teratomas are not fully understood29. Furthermore, despite the potential elimination of 
immunogenic concerns associated with allogeneic stem cell sources, additional safety 
concerns surround the clinical use of iPSCs due to the use of integrating viruses for gene 
delivery, and the oncogenic properties of the reprogramming factors33.  
 
Overall, the huge economic burden and high mortality rates imposed by such conditions 
as heart failure and degenerative diseases requires a new era of therapeutic strategy, 
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of which regenerative cell therapies show much promise. However, despite global 
research effort and much advancement in the field there remains a distinct lack of FDA-
approved treatments. To date, only one approved stem-cell based product for the 
treatment of hematopoietic disorders exists (https://www.fda.gov). To prevent this field 
becoming no more than a pipeline dream for routine treatment a greater understanding 
of the basic mechanisms of embryogenesis is required. Specifically addressing the 
molecular pathways governing how ESCs become specialised will inform strategies to 
efficiently generate homogenous functional cell populations, which upon transplantation 
will successfully engraft and survive in the host.   
 
 Early Embryogenesis: formation of the three germ layers  
 
1.2.1 Fertilisation to blastocyst implantation  
 
The process of mammalian embryogenesis begins from the fertilised egg, which must 
subsequently proliferate, differentiate to form multiple cell types and generate polarity to 
enable formation of the body axis34. An overview of early embryogenic events describing 
the processes of how cells undergo fate decisions are given below.   
 
Upon fertilisation the resulting zygote undergoes cleavage events to firstly form 2 
identical cells (or blastomeres), which after 3 rounds of this division marks the start of 
compaction. Compaction is the process whereby bastomeres become attached to each 
other, interconnected by gap junctions35, forming a tightly packed spherical structure 
named the morula (see Figure 1:2). Here, each cell acquires apical-basal polarity and 
as a result the next cell division can be symmetric (the outside positioned cells give rise 
to additional outside positioned cells), or asymmetric (the outside cells divide along an 
in/out axis giving rise to one outside and one inside cell)36. Thus, the defining difference 
between these 2 cell types is that the outside cells has its apical surface exposed, 
whereas the inside cells has cell-cell contact on all sides. Following 2 major rounds (or 
waves) of asymmetric cell division (from 8 to 16 cells and 16 to 32 cells) outside cells 
differentiate to form the trophectoderm (TE) (the precursor to placenta formation)34. This 
arises in part through differential activation of Hippo signalling, a regulator of cell contact-
mediated inhibition of proliferation37, which is activated only in inner positioned cells 
(surrounded by other cells)38. In outside cells Hippo signalling is down regulated, 
preventing the phosphorylation of the transcriptional co-activator Yes-associated 
protein, enabling its translocation to the nucleus where it binds TEA domain family 
transcription factor 4, leading to activation of TE-specific genes such as caudal-related 
homeobox 2 (Cdx2)34. The inner cells form the pluripotent inner cell mass (ICM) and are 
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associated with the markers Oct439, Sox240 and Nanog41. The expression of TFs are 
restricted to their respective cells, such that the TE (also marked with Eomes42 and 
Gata343) and ICM are incompatible (Cdx2 and Oct4 inhibit each other44). Here, the 
morula transitions to form the early blastocyst, which sees the TE form the fluid-filled 
blastocyst cavity in a process called cavitation (see Figure 1:2)45. This process is 
associated with epigenetic changes and will become the focus of later sections (see 1.4 
and 1.5).  
 
The second cell fate decision sees the cells of the ICM segregated into the 
extraembryonic primitive endoderm (PrE) (cells become positioned to be in contact with 
the blastocyst cavity46) and the epiblast (Epi)34. While Epi cells retain expression of 
pluripotency genes, the PrE activates the Gata447, Gata648, Sox1749 and Sox750 TFs. 
The separation of these lineages is regulated by fibroblast growth factor (Fgf) signalling. 
Fgf4 is secreted from Epi progenitor cells and interacts with the Fgf receptor 2 on PrE 
progenitors to activate mitogen-activated protein kinase (MAPK) pathway to induce 
Gata6 expression51,52. 
 
At this stage the blastocyst has migrated towards the uterus where it hatches out from 
the zona pellucida, a glycoprotein rich structure that originally surrounded the oocyte, 
invades maternal tissues and implants in the uterine wall53. Once hatched, the blastocyst 
adheres to the luminal epithelium, facilitated by integrins and cadherins54,55, where it 
invades the stroma at the antimesometrial site of the uterus, proliferates, and  
subsequently transforms into the egg cylinder53. The surrounding stroma cells 
differentiate to decidual cells (forming the endometrium layer)56 enabling nutrients and 
gas exchange and ensuring fetomaternal immune tolerance53,57. The TE then proliferates 
and differentiates into the extraembryonic ectoderm (ExE) to form the proximal half of 
the egg cylinder and subsequently the placenta53,58 (See Figure 1:2). Note, the PrE gives 
rise to the visceral endoderm (VE) which covers both the Epi and ExE compartments 
elongating the egg cylinder53 (See Figure 1:2). This provides a foundation for germ layer 





























Figure 1:2 Murine Embryogenesis: Fertilisation to Implantation. After 3 rounds 
of symmetrical cellular division the fertilised egg reaches the 8-cell developmental 
stage, the point of compaction. Here cells gain apical-basal polarity where they can 
divide asymmetrically over 2 waves of division to form cell populations of the 
trophectoderm (TE) and the epiblast (Epi), marking the formation of the early 
blastocyst. Upon implantation to the uterine wall, the primitive endoderm (PrE) 
segregates from the Epi and the blastocyst then transitions into the egg cylinder, 
facilitated by TE differentiation into the extraembryonic ectoderm (ExE). The start of 
gastrulation is marked by the formation of the primitive streak (PS) from the posterior 
side of the Epi.  
ExE: extraembryonic ectoderm, AVE: anterior visceral endoderm, DVE: distal 
visceral endoderm. ‘A’ and ‘P’ refer to anterior and posterior. Image taken from 
Takaoka, K and Hamada, H. Development. 2012; 139(1):3-1434.  
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1.2.2 Gastrulation  
 
The next major phase of development is gastrulation, a morphogenetic process resulting 
in the formation of the 3 primary germ layers: ectoderm (outer layer), mesoderm (middle 
layer) and endoderm (inner layer). These layers form the basis of all tissues types of the 
body, the ectoderm derives cells of the central nervous system, eye and the skin; the 
mesoderm forms cells of the heart, blood and kidney; and the endoderm produces cells  
of the lung, liver and digestive system59.  
 
In the mouse the start of gastrulation is marked by the formation of the primitive streak 
(PS) at the posterior side of the Epi. The PS forms from an epithelial to mesenchymal 
transition (EMT)60 and provides a gateway for emboly (internalisation) of mesodermal 
and endodermal cells via ingression61. The maintenance signals required for PS 
formation come from reciprocal interactions between the Epi and ExE via Nodal and 
Bone morphogenetic protein 4 signalling respectively62, thereby ensuring proper 
elongation of the PS to form the tip or primitive node63. Prospective mesodermal cells 
invade the space between the Epi and the VE at the posterior side of the PS where they 
become distributed to 4 compartments: axial mesoderm, paraxial mesoderm, lateral 
plate mesoderm and extraembryonic mesoderm62. In comparison, the definitive 
endoderm arises from the anterior distal region of the PS, in proximity to the node, and 
intercalates with the VE64. It can be noted that from clonal analysis Epi cells are not 
restricted in their lineage prior to ingression65, suggesting it likely represents a transient 
cell population, named the mesoendoderm (which has the potential to form either the 
mesoderm or the definitive endoderm)62. Although such a population has not been found 
in the mouse embryo, evidence for this bipotential cell has been shown in ESCs66. The 
cells remaining in the Epi, which do not give rise to the PS (found at the anterior side) 
form the ectoderm.  
 
Gastrulation is marked with specific gene expression patterns that subsequently directs 
further development of germ layers. For example, Brachyury and Mixl1 are expressed 
throughout the PS; Foxa2 and Goosecoid are restricted to anterior regions; and HoxB1 
and Evx1 are found at posterior locations67,68. However, the mechanisms regulating the 
precise control of spacio-temporal gene expression patterns that results in segregation 





 O2 and embryogenesis  
 
1.3.1 O2 availability in embryogenesis  
 
Ambient air has an O2 concentration of 21%, which equates to an O2 exposure for 
embryonic and adult cells in the range of 2-9%, termed physiological normoxia69. More 
specifically, within the uterine environment, concentrations are typically lower than this 
and have been reported between 1-5% O270,71. Hence prior to formation of the 
uteroplacental circulation (occurring at the end of the first trimester of pregnancy)72, it 
can be conceived that embryogenesis transpires at a low [O2]70. This low O2 tension was 
confirmed in the developing mouse embryo with 2-nitromidazole compounds, which bind 
to protein and DNA at ≤ 2% O273,74,75,76. Therefore, delivery of O2 to the embryo at this 
stage is mediated through diffusion alone. Owing to the short diffusion distance of O2, 
approximately 150 m from a blood vessel77,78,79, as demonstrated through an ability to 
halt tumour development beyond a diameter of 2 mm (without vascularisation)80, 
gradients of O2 across the developing embryo are likely to form81. Thus, cells towards 
the centre of the developing embryo are exposed to a lower [O2] than those in outer 
positions, which are closer to the O2 source. Intriguingly, even after perfusion of maternal 
blood from spiral arteries, fetal pO2 is approximately 50% of maternal levels70. This is 
consistent with detection of isolated low O2 regions within the mouse embryo, including 
the developing heart, lung and midbrain, likely attributed to the lack of developing 
vasculature to meet the rapid growth rate76.  
 
The concept of O2 gradients in embryogenesis may in part underlie the basis of 
morphogenesis: a system of signalling molecules that emanate and diffuse away from 
the source to form a gradient82,83. The idea of a morphogen in development emerged 
from a collection of studies dating back to the early 20th century84, and may go some way 
as to explain asymmetry in the developing embryo. In this regard, the concentration of a 
morphogenic signal at an exact position within the embryo may function to induce a 
transcriptional response to determine cell fate. Examples of morphogenic signals are 
apparent in vertebrate development, for instance: Hedgehog85, Wingless86, 
Decapentaplegic87, Squint88 and Fgf83. Therefore, it may seem plausible to consider O2 
as a developmental morphogen69. However, the precise mechanisms behind how O2 





1.3.2 O2 sensing within the developing embryo   
 
Adaptive mechanisms have evolved to maintain O2 homeostasis in multicellular 
organisms and therefore minimise the potential deleterious effects of O2 deficiency. Initial 
or acute responses aim to maximise O2 delivery to the most critical organs such as the 
heart or brain via increasing cardiac output, hyperventilation and arterial vasodilation89. 
In comparison, chronic adaptive responses refer to alterations in gene expression for 
instance activation of glucose metabolism, erythropoiesis, angiogenesis89. To facilitate 
such adaptive responses, changes in [O2] must be sensed. Candidates for potential O2 
sensors include NADPH oxidases90, the mitochondria91 and specific ion channels92,93. 
However, central to the role of O2 sensing are the hypoxic inducible factors (HIFs), and 
evidence for their role in developmental processes are discussed below.  
 
HIFs are heterodimeric TFs consisting of a constitutively expressed HIF-1 subunit and 
an O2-sensing HIF- subunit (HIF-1-3)94. In environments of an [O2] greater than 5%95, 
the HIF- protein becomes hydroxylated at 2 proline residues by a prolyl hydroxylase 
domain (PHD)96. The 3 isoforms of PHDs (PHD1, 2, 3) belong to the 2-oxoglutarate 
dependent dioxygenase (2-OGDO) family (discussed below) and crucially require 
molecular O2 as a cofactor97. Hydroxylation acts as a recognition signal for the binding 
of the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex, which functions to induce 
HIF- polyubiquitination resulting in subsequent proteosomal degradation94. 
Furthermore an additional hydroxylation event occurs at asparagine residues by factor 
inhibiting HIF (FIH) (also a member of the 2-OGDO family), which prevents the binding 
of the HIF- transcriptional coactivator CBP/p300 thereby repressing HIF- 
transcriptional activity98. Upon a reduction in [O2] the rate of prolyl and asparaginyl 
hydroxylation is reduced, consequently stabilising HIF- and thus enabling its 
translocation to the nucleus and subsequent dimerisation with HIF-1 subunit96. This 
HIF-/ dimer binds to hypoxic response elements (HRE), characterised by the core 
DNA motif G/ACGTG, to induce gene transcription96. Over 60 HIF target genes have 
been identified, and were found to be involved in processes including, angiogenesis, 
vasodilation, and glycolytic metabolism activation99,100.  
 
The impact of HIF-signalling upon development can be best understood from genetic 
ablation studies. Loss of the HIF-1 in vivo results in embryonic lethality by embryonic 
day (E) 10.5, attributed to defective angiogenesis99,100. Similarly, silencing of the HIF- 
subunit in vivo is also lethal by E 11, manifested by neural tube defects and 
cardiovascular malformations101,102. In addition, silencing of Cited2, a negative regulator 
of HIF-1 via competitive binding to CBP/p300, also has lethal effects through 
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enhancement of HIF response genes103. Collectively, these studies demonstrate that 
HIF-mediated O2-sensing plays a critical role in embryogenesis. 
 
Specifically, a fundamental role of HIF is in the development of the placenta76, which 
forms in the mouse at E 10.5-11.5 and is required for O2 and nutrient delivery to sustain 
embryo growth. Placental defects arising from the loss of HIF include reduced 
chorioallantoic interaction (an interaction between the embryo and forming placenta)104, 
limited vascularisation of the placenta105 and reduced development of the labyrinthine 
layer (site at which fetal blood vessels and maternal blood sinuses are bought in 
proximity)106. As embryogenesis progresses the Exe expands to form the chorion and 
ectoplacental cone, which contain trophoblast progenitor cells. Trophoblast cells 
proliferation and differentiate into distinct cell subtypes to support placental 
development. HIF activity, demonstrated through ablation of HIF-1, HIF-1 or HIF-2, 
was shown to be required to drive spongiotrophoblast specification (required for 
structural support to the labyrinthine) through regulation of the Mash2 TF104. Therefore, 
this not only suggests there are potential overlapping roles of the HIF family members, 
but also directly demonstrated that HIF can regulate cell fate decisions. Related to this, 
[O2] has shown to be a direct regulator of placental development. An [O2] mimicking the 
uterine environment before and after connections are developed with the maternal 
vasculature (2.5% vs 8.6% O2)69 was shown to control cytotrophoblast (single cell inner 
later for the trophoblast) differentiation into an invasive phenotype, which is required to 
aid the establishment of maternal-fetal circulation at the placental bed107. Importantly, 
this highlights the impact of O2 gradients on cellular differentiation. 
 
An additional system in which HIF is intrinsic to is the formation of the cardiovascular 
system.  Silencing of HIF-1 resulted in decreased vascular endothelial growth factor 
(VEGF) messenger RNA (mRNA) and protein expression, which resided in vascular 
defects99,100. Furthermore, HIF-1-deficient embryos showed arrested cardiac 
morphogenesis, recorded at various stages of development108,109. Unlike HIF-1 or HIF-
1, HIF-2 deficient embryos survive until mid-to-late gestation, and have independently 
been shown to present with catecholamine dysregulation110, cardiac hypertrophy111 and 
a lung maturation defect112. These experiments therefore demonstrate that HIF-1 and 
HIF-2 perform separate developmental functions.  
 
HIF-signalling, exclusively via HIF-2, has been shown to regulate stem cell function by 
regulation of Oct4 and additional pluripotency markers such as Sox2 and Nanog113,114,115. 
In support of this notion, HIF-2-silenced embryos showed a loss of primordial germ 
cells (PGCs), which require Oct4 for survival113. In addition Cited2 has been shown to 
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control expression of the pluripotency genes Nanog, Tbx3, Klf4 and interesting its 
ablation induced spontaneous ESC differentiation, suggestive of a role in stem cell 
maintenance116. In comparison, HIF-1 has been implicated in the maintenance of 
neural stem cells in vivo117 and is linked to the commitment of ESCs to the neural lineage 
via direct activation of Sox1118. In agreement with the in vivo role for HIF-1 in 
cardiogenesis as described above, exogenous expression of HIF-1 in mESCs 
promoted cardiac differentiation, demonstrated by lineage marker specific expression 
and an enhanced beating phenotype of EBs119. Overall, this suggests O2, and hence its 
downstream signalling pathways, are required for the regulation of stem cell function. 
Note, HIF-3 is the least studied of the HIF protein subunits and is subject to extensive 
splicing, displaying different O2 sensitivities and abilities to dimerise HIF-1120. The 
precise biological functions of HIF-3 are unknown, but it has previously been proposed 
in a hESC study to regulate the long-term response to low [O2], after the initial transient 
response from HIF-1 has elapsed114.  
 
1.3.3 2-oxoglutarate dependent dioxygenases 
 
The 2-OGDO domain containing proteins (PHDs and FIH) are responsible for the O2 
sensing capabilities of HIFs, as mentioned above, and are highly conserved within many 
other proteins. The 2-OGDO family are comprised of over 60 members in humans 
alone121, and can catalyse oxidative transformations in a diverse array of biological 
processes within mammalian cells including: post-translational modification of collagen, 
fatty acid metabolism and epigenetic regulation122.  
 
2-OGDO’s are soluble, non-heme, Fe2+ containing proteins123. Activation of these 
enzymes begins with binding of 2-oxoglutarate (2-OG) (also known as -ketoglutarate) 
and Fe2+ in the catalytic domain124. Next, O2 binds to Fe2+ to induce oxidative 
decarboxylation of 2-OG to succinate and CO2, which results in the formation of an 
oxidised ferryl intermediate (Fe3+/4+)124 (illustrated in Figure 1:3). During this catalysis an 
O atom becomes incorporated into the alcohol group (-OH) of the oxidised prime 
substrate and into succinate96. Enzymatic activity is restored by recycling Fe3+/4+ back to 
Fe2+ by the reducing agents ascorbic acid (AA)125 and glutathione (GSH)126. Fe2+ is 
ligated by 2 histidine residues and a carboxylate (named the facial triad96) at the catalytic 
site, which is positioned within a distorted double stranded -helix (DSBH) fold consisting 
of 8 strands (referred to as a jelly roll) that supports the binding of Fe2+ and 2-OG122. 
Owing to the varying number of residues between the 4th and 5th strands of the -helix, 
the jelly roll structure can distinguish 2-OG subfamilies. FIH has a long insert (thought to 
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be involved in substrate recognition) and is part of the Jumonji C (JmjC) family of histone 
modifying enzymes, which have a characteristic squashed DSBH barrel structure (JmjC 
fold)127,128. PHD2 has no insert and comes from the same structural subfamily as the 
collagen prolyl hydroxylases (the first identified pathway involving 2-OGDO), which have 
a cupin barrel formation127,128. 
 
Due to the co-substrate requirements to sustain the activity of 2-OGDOs, these enzymes 
are considered cellular sensors for changes in metabolites, O2 availability and Fe2+ redox 
status124. Given the low O2 tensions present during early embryogenesis and the large 
number of enzymes that share the 2-OGDO domain, it is reasonable to believe that aside 
from HIF regulation other proteins may be involved in developmental events. One 
emerging novel area is the role 2-OGDOs have in the regulation of epigenetic function 





































Figure 1:3 The catalytic 2-oxoglutarate dependent dioxygenase reaction. 2-
oxoglutarate and O2 are required as co-substrates for the hydroxylation of target 
molecules by 2-oxoglutarate dependent dioxygenase domain containing proteins. 
This reaction yields succinate and CO2 while also generating oxidised ferryl 
intermediates. Fe2+/3+ is recycled back to Fe2+ by ascorbic acid (AA) and glutathione 
(GSH) to restore enzymatic activity. 
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1.3.4 The effects of O2 on embryonic stem cell function  
 
Historically, cell culture was focussed upon the exact requirement of nutrients and 
growth factors to maintain cell growth. However, in an in vivo environment, cells are 
exposed to a much lower partial pressure (pO2) than that found in a humidified cell 
incubator, which consists of an atmosphere of 95% air/5% CO2 (equating to 20% O2). 
Therefore, to better resemble more physiological conditions such as those representing 
the stem niche, manipulation of O2 concentrations has been the focus of much research.  
 
Measurements of O2 tensions in cellular compartments have defined physiological 
normoxia in a range of 2-9% O269. However, concentrations have been recorded to be 
as low as 1% or less among stem cell niches81. Exposure of hESCs to 21% O2 (ambient 
air) promoted spontaneous differentiation, whereas if maintained under low O2 
conditions (3% or 1% O2) cells maintained pluripotency129. A similar study demonstrated 
culture of hESCs in 5% O2 (in contrast to 21% O2) acted to maintain long-term self-
renewal of cells through elevated Nanog expression130. In addition, culture of hESCs in 
5% O2 was shown to prevent X chromosome inactivation, the process of transcriptionally 
silencing one of the X chromosome copies in female mammals, enabling ESCs to be 
maintain in a developmentally more immature state131. Further to enhanced 
chromosomal stability and clonality when cultured under physiological normoxic [O2], 
microarray profiling revealed hESCs to have minimal activation of developmental 
pathways when cultured in 2% O2, compared to ambient air132.  However, these findings 
are controversial as it has been shown in separate studies in hESCs that exposure to 
5% O2133 and 4% O2134 had no effect on stemness marker expression, compared to 
culture in 21% O2.  
 
Furthermore, culture of mouse preimplantation embryos in 5% O2 demonstrated fewer 
gene expression perturbations, compared to control embryos exposed to atmospheric 
O2135. This O2 tension has independently been shown to enhance embryo development, 
suggesting low O2 tensions may enhance proliferation136. Despite this, 1% O2 has been 
shown to reduce self-renewal and induce differentiation of mESCs via downregulation of 
the LIF-Stat pathway via HIF-1137. Spontaneous differentiation of mESCs towards the 
endodermal lineage was observed in 1% O2 (but not in 3% and atmospheric O2 
conditions)138, which was in agreement with the effect of 5% O2 under a directed 
differentiation protocol139.  
 
Discrepancies in the literature over the exact function of O2 in pluripotency regulation are 
apparent, likely due to the source of ESCs, culture conditions and the time exposed to 
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low [O2]. However, collectively it is accepted that a more ‘hypoxic environment’ promotes 
the undifferentiated state in stem and precursor cell populations, but the mechanisms 
underpinning this process are still largely not understood69. Therefore, O2 is likely to be 
an intrinsic signalling molecule in early differentiation events.  
 
 Epigenetics  
 
The process of embryogenesis requires ESCs to lose pluripotency and differentiate 
towards specific cell lineages. During this process transcriptional programmes, which 
can be controlled through epigenetic modifications, define cellular identity140. The term 
epigenetics refers to heritable and reversible changes to gene expression (and hence 
cell function), which do not involve alterations to the DNA sequence141. Hence, despite 
most cells within multicellular organisms sharing an identical genotype, epigenetics 
enables the generation of diverse array of cell types with distinct functions during 
development141. Epigenetics can control gene transcription through regulation of 
chromatin compaction, which consequently controls the levels of TF accessibility to the 
DNA. The cellular ‘epigenetic landscape’ or signature is inherited across cell divisions, 
imparting an epigenetic memory, functioning to maintain the cellular transcriptional 
profile and thus specificity142.  
 
1.4.1 Epigenetic modifications  
 
In the nucleus 147 bps of DNA is wrapped around an octamer of histones, consisting of 
2 H3-H4 histone dimers that are surrounded by 2 H2A-H2B dimers, to form the 
nucleosome, the basic subunit of chromatin143. The spacing of nucleosomes, which are 
separated by linker DNA, determines the chromatin structure143. Regions that are tightly 
packaged are referred to as heterochromatin, while the loosely packaged areas are 
named euchromatin, and are thus associated with transcriptional silencing and activation 
respectively144. The level of chromatin compaction can be controlled by 4 main types of 
epigenetic modification: adenosine triphosphate- (ATP) dependent remodelling 
complexes (ADCRs), non-coding RNAs (ncRNA), histone modifications and DNA 
methylation141. These chromatin remodelling complexes often function in combination 
with each other to enable precise and diverse transcriptional control to obtain specified 
cell types141,145. 
 
ADCRs utilise energy from ATP hydrolysis to destabilise the nucleosome by altering its 
position, changing the conformation of nucleosomal DNA and the composition of the 
histone octamer146. This nucleosome remodelling can thus lead to transcriptional 
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activation or repression, depending upon TF accessibility to DNA147. These complexes 
can be characterised into 4 groups based upon their core ATPase subunits, and are 
essential for aspects of embryonic development  (reviewed by Hargreaves, D and 
Crabtree G (2011)148). ncRNAs, which make up greater than 80% of transcribed genes, 
are also implicated in the control of gene expression149. ncRNAs are divided into 2 
groups based on size: small ncRNAs (<200 nucleotides) encompassing microRNAs 
(miRNAs), piwi-interacting RNAs (piRNAs) and short interfering RNAs (siRNAs); and 
long ncRNAs (lncRNAs) (>200 nucleotides)150.  ncRNAs regulate gene expression post-
transcriptionally and have also been found to be associated with chromatin remodelling 
complexes to facilitate the alteration of DNA methylation and histone status151 (reviewed 
by Wahlesedt, C and Peschansky, V (2014)152).  
 
Histones can be post-translationally modified covalently at their protruding tails (Figure 
1:4) predominantly by acetylation, phosphorylation and methylation. These dynamically 
expressed marks can be found in combination on the same histone tail, encompassing 
what is described as the ‘histone code’153. Acetylation, controlled via 2 opposing enzyme 
families: histone acetyltransferases (HATs) (addition) and histone deacetylases (HDAC) 
(removal), occurs on lysine residues and is associated with euchromatin154. 
Phosphorylation of serine, threonine and tyrosine residues also functions to control 
chromatin compaction, regulated through the action of kinases and phosphatases that 
add and remove this modification respectively155. The methylation of histones occurs at 
lysine (K) residues on histones H3 and H4, and can be presented in either a mono, di or 
trimethylated (me2/3) form (arginine residues can also be modified by 1 or 2 methyl 
groups)156. This array of modifications results in a huge potential for the regulation of 
gene function, and have subsequently been shown to be associated with gene activation 
and repression. For example, methylation at H3K4, H4K36 or H3K79 is linked with 
transcriptional activation, whereas at H3K27, H3K9 or H3K20 is associated with 
transcriptional repression149. Histone methylation is also controlled by the function of 2 
enzymatic processes; histone methyltransferases (HMTs) and histone demethylases 
(KDMs), to add and remove methyl marks respectively149.  
 
Perhaps the most well studied of the epigenetic modifications is DNA methylation. DNA 
methyltransferase (Dnmts) catalyse the covalent addition of a methyl to the 5th carbon 
residue of cytosine (Figure 1:4)157. These enzymes incorporate the methyl from the 
donor S-adensylmethionine (SAM), at CG dinucleotides (CpG) within the genome, 
forming the 5-mC mark and S-adenosylhomocysteine (SAH)157. Clusters of CpG 
dinucleotides are typically found at CpG islands within gene regulatory elements, for 
example approximately 70% of gene promoters in the human genome were found to 
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have a high CpG content158. De novo methylation conducted by Dnmt3A and Dnmt3B 
(maintenance of methylation performed by Dnmt1)159 functions to repress gene 
transcription through blocking recognition sites for TF binding143. Alternatively, the 5-mC 
mark can recruit methyl-CpG-binding domain (MBD) proteins, which subsequently 
function to assign histone deacetylases to facilitate gene repression160.  
 
Unlike the previously stated epigenetic modifications, the ability to adjust levels of the 5-
mC through a demethylation pathway is less well characterised. Formerly, the removal 
of the 5-mC mark was believed to occur passively during replication in the absence of 
Dnmt1161. However, due to evidence for rapidly changing methylation events occurring 
during embryonic development (mentioned above) and in somatic cells, an active 
demethylation process was proposed161. Multiple candidate mechanisms have been 
proposed: cytidine deaminases162, DNA glycosylase-mediated base excision repair 
(BER) pathway163, nucleotide excision DNA repair164 and even Dnmt enzymes 
themselves165. However, the lack of a unifying active DNA demethylation pathway 
questions the significance of these mechanisms, suggesting each pathway may be 
specific to an individual biological system166. But, recent advancements in this field have 
now led to the identification of a novel direct oxidative DNA demethylation pathway. 
 
1.4.2 DNA demethylation: formation of a novel epigenetic mark  
 
 
In 1972 an additional modified form of cytosine was discovered in mammalian DNA, 
named 5-hydroxymethylcytosine (5-hmC)167. Originally perceived as an oxidative-
damage product of DNA, 5-hmC was largely ignored until 2 independent pioneering 
publications in 2009 demonstrated 5-hmC was readily detected in mESCs and in 
terminally differentiated neuronal cells168,169. Levels of 5-hmC in mammalian tissues have 
subsequently been reported to be prevalent in typically 0.1% of cytosine (C) residues, 
with the largest levels of up to 0.7% recorded in brain169,170.  
 
The 5-hmC mark is generated from oxidation of the 5-mC via ten-eleven translocation 
(Tet) enzymes (Figure 1:4). Tet1, the founding member of this enzymatic family, was 
initially discovered in acute myeloid leukaemia as a fusion partner of the histone 
methyltransferase (MLL) gene171. However, it was the pioneering work by Rao, A et al 
(2009)168,172 that identified the potential 5-mC modification capabilities of Tet proteins, 
due to their identification as homologs to the trypanosome J-binding proteins, which 
function to oxidise thymine to hydroxymethyluracil166. Currently, this Tet enzymatic family 
consists of 3 members (Tet1, Tet2 and Tet3), which all share a core catalytic domain at 
their C-terminus (Figure 1:5A)173. This domain features a cysteine-rich insert and a larger 
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DSBH fold, which exhibits 2-OGDO activity, and thus for catalytic function has an 
absolute requirement for molecular O2 (Figure 1:5B)173. In addition, at the N-terminus, 
Tet1 and Tet3 contain a CXXC zinc-finger binding domain (Figure 1:5A)166. The precise 
function of this domain is elusive, although has been suggested to facilitate binding to 
CpG regions and thus targeting to specific gene loci174,175,176. Tet2 lost its CXXC domain 
during evolution due to a chromosomal inversion172. However, this separated region 
encodes for the CXXC-containing gene product Idax, which binds to CpGs and interacts 
with the catalytic domain of Tet2177.  
 
The Tet-mediated erasure of the 5-mC mark occurs as a result of 2-OGDO activity to 
yield 5-hmC. Investigations into the stability of 5-hmC suggested this mark is not a 
transient intermediate of demethylation, and in fact may itself regulate chromatin 
structure and transcription178,179, leading to suggestions that it may be considered the 6th 
base of the genome (whereby the 5th base is 5-mC)180. 5-hmC has been shown to be 
positioned within gene regulatory regions181 and in some cases has been shown to 
positively correlate with gene transcription182,183,184. This may be due to remodelling of 
the chromatin structure into a euchromatic form (Figure 1:4)185,186, potentially through 
influencing the thermodynamic properties of the DNA helix187. Alternatively, 5-hmC has 
been shown to prevent the recruitment of MBD proteins and thereby relieving their 
transcriptional repressive effects188. Tet proteins may also induce transcriptional 
activation by facilitating the generation of the H3K4me3 mark via a physical association 
with O-GlcNAc transferase (Ogt)189,190. Ogt is required for the activation of Host cell factor 
1 (Hcf1), a component of the Set protein methyltransferase complex191,192,193 (see further 
details in Chapter 4: Results 2 Introduction). Nonetheless, Tet proteins have also been 
reported to have potential transcriptional repressive effects. Genetic ablation of Tet1 in 
mESCs was found to upregulate a significant fraction of genes that are normally silenced 
by Polycomb Repressor 2 (Prc2) mediated H3K27me3 generation194 (see further details 
in Chapter 4: Results 2 Introduction). Furthermore, transcriptional repression may be 
achieved through association of Tet1 with the Sin3A corepressor complex to mediate 
histone deacetylation195,196. Collectively, this fundamentally highlights the multiple 
transcriptional regulatory roles surrounding this novel Tet/5-hmC pathway. 
 
To restore the unmodified C base 5-hmC can be removed in a replication-dependent 
manner, or subjected to further successive oxidation reactions by Tet enzymes to form 
5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC) (Figure 1:5A)166,197,198,199. These 
intermediates can be subjected to active removal by a DNA repair pathway, specifically 
involving the use of the DNA repair protein thymine DNA glycosylase (TDG)166. TDG 
recognises and excises 5-fC and 5-caC (but not 5-mC or 5-hmC) at the glycosidic bond, 
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generating an abasic site that is subsequently repaired by BER200 to restore C166. This 
mechanism is consistent with the low abundance of these intermediates in the genome, 
whereby it has been reported in mESCs, that 5-hmC is approximately 10-100-fold more 
prevalent than 5-fC and 5-caC201. In line with this, genetic ablation of TDG in mESCs 
resulted in a 5-10-fold elevation in both 5-fC and 5-caC marks202,203,204,204,205, suggesting 
that these are short-lived intermediate epigenetic marks. Furthermore, despite all 
oxidative substrates having similar Tet binding affinities, Tet enzymes display different 
substrate preferences, such that Tet enzymes are less active on 5-hmC and 5-fC 
substrates198,206. This may be attributable to the adoption of a more restrained 
conformation in the active site, which prevents hydrogen bond abstraction and thus 
reduces catalytic efficiency206. This therefore further suggesting 5-hmC is the most stable 
and abundant oxidative mark. Alternatively, the presence of oxidative marks can prevent 
de novo methylation. Following DNA replication, hemi-methylated CpGs are transiently 
formed, with only the parental strand containing the 5-mC mark207. Recruitment of Dnmt1 
is required to restore original methylation patterns in the newly synthesised DNA 
strands207. The presence of oxidative marks prevents the ability of Dnmt1 to methylate 











































Figure 1:4 Chromatin and DNA methylation. The chromosome is made up of DNA 
packaged in chromatin, which is formed from nucleosomes, separated by linker 
DNA. The level of chromatin compaction, affecting transcription factor accessibility, 
can be dynamically adjusted through epigenetic modifications. For example, histone 
tails can be modified by acetylation, methylation and phosphorylation, or the DNA 
itself can undergo methylation. Specifically, the addition of a methyl group to the 5 th 
carbon residue of cytosine (C), via DNA methyltransferases (Dnmts), is associated 
with a condensed (or heterochromatic) chromatin structure, and is representative of 
transcriptional repression. Demethylation (oxidation) of the methylated cytosine 
mark (5-mC) by ten eleven translocation (Tet) enzymes form 5-
hydroxymethylcytosine (5-hmC), which relaxes the chromatin structure into its 
euchromatic form, permitting gene transcription. The 5-hmC mark can undergo 
successive oxidation reactions via Tet enzymes, to form 5-formylcytosine (5-fC) and 
5-carboxylcytosine (5-caC). These oxidative intermediates can subsequently 
undergo DNA repair to regenerate unmodified C. Note the coloured circles represent 
histone marks, which can also influence chromatin structure, see main text for 
specific details. Adapted from: Rajender, S et al. Mutat Res. 2011; 727:62-71144 and 







































Figure 1:5 The structure and mechanism of Tet enzymes. (A) Schematic 
structural representation of the 3 ten eleven translocation (Tet) enzymes. All 
enzymes contain a C-terminal catalytic domain containing a cysteine rich region and 
a double stranded -helix harbouring 2-oxoglutarate dependent dioxygenase 
activity. Tet1 and Tet3 additionally contain a CXXC DNA binding domain at their N-
terminal region. Due to a chromosomal inversion event during evolution, Tet2 lost its 
CXXC domain. This separated region encodes for the CXXC-containing protein Idax 
and can functionally associate with Tet2. (B) Tet1/2/3 mediate the successive 
oxidation of methylated cytosine (5-mC) into 5-hydroxymethylcytosine (5-hmC), 5-
formylcytosine (5-fC) and 5-carboxylcytosine (5-caC). This catalytic reaction, via the 
2-oxoglutarate dependent dioxygenase domain, requires 2-oxoglutarate (2-OG) and 
O2, which in the presence of Fe2+ are used to oxidise the substrate, yielding 
succinate and CO2. Note ATP is required for further oxidation of 5-hmC. (A) Adapted 
and (B) taken from Tan, S and Shi, Y. Development. 2012; 139:1895-1902173. 
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 Epigenetics in early mammalian development  
 
A fundamental question of developmental biology surrounds the signalling mechanisms 
that instruct cell fate decisions during embryogenesis. Such cell specification events 
have been linked to chromatin regulation, resulting in a hypothesis that epigenetic 
asymmetry functions as a driver for cell lineage allocation211.  
 
Perhaps one of the most significant developmental epigenetic events occurs in the 
process of X-inactivation. Both X-chromosomes express Xist, a large untranslated RNA, 
which coats the X-chromosome from which it is expressed and triggers genetic 
silencing212. DNA methylation silences one of the Xist genes213, and it is this 
chromosome from which genes will be expressed in future progeny cells. Changes in 
global methylation levels also occur during early embryogenesis. After fertilisation a 
global loss in DNA methylation occurs in the zygote214. Methylation patterns become re-
established de novo in the developing embryo in all but CpG islands214. Hypomethylation 
of these CpG islands remains until later developmental stages when cellular 
specification arises. Here, methylation is acquired and functions to silence germline-
specific genes (including pluripotency genes), correlating with induction of 
differentiation215,216. Furthermore, developmental genes Pax and Hox, have reported to 
show cell type specific DNA methylation at CpGs217, leading to the hypothesis that 
differential methylation may serve to regulate gene expression during differentiation218. 
In fact, throughout development, the oscillating levels of methylation have recently been 
recognised to contribute to the left-right asymmetric body plan during vertebrate 
embryogenesis219. A second wave of DNA demethylation occurs during germ line 
formation. PGCs, which arise from the extraembryonic mesoderm cells of the Epi, 
undergo a reprogramming event for erasure of genomic imprints for formation of mature 
sperm and oocytes220,221. The importance of DNA methylation in development was made 
apparent through genetic ablation of Dnmts in mice, whereby Dnmt1 silencing resulted 
in embryonic lethality at E 8.5-9222. In comparison, Dnmt3A-null embryos appeared 
normal at birth, but died at approximately 1 month of age, whereas Dnmt3B ablated 
embryos resulted in no viable mice at birth, attributed to growth impairment and defects 
in neural tube formation223. Furthermore, in the embryos of patients suffering from early 
pregnancy loss, Dnmt1 expression and DNA global methylation levels were 
downregulated, which was associated with abnormal embryo implantation and 
development224.  
 
Epigenetic events also control genomic imprinting, the process of enabling a small 
proportion of genes (150 in mouse, 75 in human225) to be expressed in a parent-of-origin-
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specific manner (compared to the vast majority of genes, which are expressed from both 
alleles simultaneously)221. Differential DNA methylation between the 2 parental 
chromosomes is the main mark defining imprinted genes and remain present during 
global DNA demethylation events after zygote fertilisation221. Interestingly, a 
trimethylated-histone mark signature (H3K4me3, H3K9me3 and H4K20me3) has also 
been identified in imprinting control regions226, suggesting potential cross-talk between 
epigenetic modifications. The presence of H3K4me3 and H3K27me3 marks at specific 
chromatin regions (bivalent domains) (see Chapter 4: Results 2 Introduction) were also 
detected on the same allele in imprinted genes226. These bivalent domains are also 
present within the TE and to a greater extent in the ICM of mouse blastocysts of 
developmental and differentiation-related genes227. This is attributable to a greater 
abundance of H3K27me3 mark in the ICM, which was determined to be a fundamental 
epigenetic component for inducing the segregation between the ICM and TE, and 
therefore demonstrates epigenetic asymmetry in the embryo221,228. Furthermore, the 
H3K9me3 mark was identified as a repressive mark for TE development, whereby 
H3K9me3 expression was inversely proportional to expression of TE-related genes as 
they undergo differentiation229. In support of this evidence for the presence of lineage-
specific histone marks during embryogenesis, a gradient of the H3R26me2 mark across 
the 4-cell blastomere stage was reported, whereby high levels of this mark were found 
to form the pluripotent cells of the ICM, compared to low expression that formed the 
TE228,230.   
 
1.5.1 The functional role of Tets in early mammalian development  
 
To examine the relevance of Tet enzymes as potential O2 sensors during embryogenesis 
their ability to have functional roles in developmental processes must be considered.  
 
The importance of Tet enzymes in physiology was first discovered from myeloid 
malignancies, whereby mutations of Tet2 were reported in acute myeloid leukemia 
(AML), myeloproliferative neoplasms (MPN) and chronic myleomonocytic leukemia 
(CMML)207. The majority of mutations are inactivating, disrupting catalytic function and 
thus inducing aberrant DNA methylation patterns207. Interestingly, hematopoietic 
stem/progenitor (HSPC) cells bearing Tet2 mutations from MPN231, and HSPCs 
genetically ablated of Tet2, demonstrated a skewed differentiation towards myeloid 
lineages232. These events have also been recapitulated in various mouse models207, 
which highlights the influence Tets can have upon cell differentiation. Furthermore, in 
AML and MPN further inhibition of the Tet-mediated active DNA demethylation process 
can transpire due to mutations in isocitrate dehydrogenase (IDH) enzymes233,234. IDH 
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enzymes produce 2-OG, a co-substrate of the 2-OGDOs, in the tricarboxylic acid cycle 
(TCA), however mutations in IDH result in the synthesis of the oncometabolite 2-
hydroxyglutarate (2-HG)235. 2-HG functions as a competitive inhibitor of Tet enzymes 
(and JmjC-KDMs) culminating in the loss of 5-hmC levels (and histone methylation)236. 
This loss of 5-hmC is also associated with other cancer types including melanoma, 
colorectal, gastric and glioblastoma, and is therefore considered a hallmark of 
cancer237,238,239. 
 
The first instance of Tet involvement in embryogenesis was reported during the global 
loss of DNA methylation in the zygote. Here, 5-mC becomes oxidised to 5-hmC 
predominantly in the paternal genome, while the maternal genome is protected from this 
oxidation stage via an interaction between H3K9me2 and the oocyte derived factor 
Pgc7173,240. Paternal oxidation is catalysed by maternal Tet3, owing to its high expression 
(prior to cleavage events where expression is lost) relative to Tet1 and Tet2 in the 
fertilised zygote241,242. This increase in 5-hmC was abrogated by silencing of Tet3 in 
mouse oocytes243. Furthermore, Tet3-deficient zygotes showed reduced expression of 
the Oct4 pluripotency marker during the morula developmental stage, which in some 
animals resulted in abnormalities in E 11.5 and failed to develop242. However, it has since 
been suggested that Tet3 haplo-insufficiency may be the cause of these aberrant 
phenotypes induced by the maternal loss of Tet3, rather than defective 5-mC oxidation, 
suggesting Tet3 is required for neonatal growth244. This study further demonstrated that 
the paternal genome can become hypomethylated independent of maternal Tet3, 
suggesting existence of compensatory mechanisms244.  
 
A second developmental transition involving the loss of 5-mC occurs in PGCs, which 
can be divided into 2 waves. In mouse (but also conserved in human) between days E 
7.25 and E 9.5 global levels of 5-mC are lost through passive dilution, but then in addition 
acquire active removal via Tet1-mediated oxidation up to E 13.5236. Immunostaining 
showed 5-hmC was induced after E 9.5, which in combination with the presence of BER 
machinery is suggestive of Tet involvement to restore unmodified C245,246. mRNA 
expression analysis in PGCs (from E 9.5) revealed that Tet1 was most abundant 
paralogue246 and from Tet1-deficient mice it was shown that this hydroxylation is required 
for imprinting erasure in germline cells (new sex-specific epigenetic modifications are 
established as development progresses)247. It should be noted that global methylation in 
germ cells is largely unaffected by the loss of Tet1 alone247 or in combination with 
silencing of Tet2248, indicative of Tet-mediated oxidation having a locus specific effect 
and/or that passive demethylation is accountable for the global 5-mC loss236.  
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Staining for 5-hmC in the pre-implantation mouse embryo revealed detectable levels in 
all stages (2-cell to blastocyst), but maximal signal intensity was reported in the ICM of 
the blastocyst, which appear matched to Tet1 and Tet2 mRNA expression173,249. This 
detection of 5-hmC within ESCs has been further confirmed separately by thin layer 
chromatography (TLC)168 and immunofluorescence186 techniques. Suggestions of Tet 
involvement in development was first realised via in vivo teratoma formation assays, a 
method of determining cell pluripotency via assessing the ability of cells, upon injection 
into immunosuppressed mice, to form tumours (teratomas) comprising tissues 
representative of all 3 germ layers250. ESCs ablated of Tet1, and in combination with 
Tet2 loss248, formed large haemorrhagic teratomas containing trophoblast cells251 and 
increased endodermal and loss of neuroectodermal differentiation makers252. 
Expression analysis confirmed the induction of TE markers Cdx2, Eomes and Elf5, 
indicative of Tet protein involvement in supressing TE formation252. However, in vivo the 
functional loss of either Tet1 or Tet2 in mice is compatible with development and animals 
appear healthy throughout adulthood, suggesting deficiency in either Tet does not 
compromise developmental potential251,253 232. Combined loss of Tet1 and Tet2 negates 
5-hmC (to greater extent than when either Tet alone is silenced)252, which despite 
retaining pluripotency in ESCs does reside in a fraction of mice displaying midgestation 
abnormalities and perinatal lethality248. 
 
More recent studies sought to elucidate the developmental potential of mESCs 
displaying complete loss of Tet activity. Triple Tet silenced (TKO) mESCs were 
completely depleted of 5-hmC and showed restricted developmental potential, attributed 
by a lack of endodermal and mesodermal markers as well as immature ectodermal 
structures254. The differentiation potential was clarified in vivo, whereby GFP targeted 
TKO and Tet1/2/3 heterozygote (Thet) mESCs were transplanted into foster mice and 
their ability to contribute to chimeras was determined. Embryos were dissected at E13.5 
and revealed that approximately 60% of Thet cells contributed to chimeras, compared to 
15% for TKO cells254. Interestingly, ectopic expression of Tet1 in TKO mESCs rescued 
the differentiation capacity and restored contribution to chimeras254. Consistent with this 
developmental impairment, mouse embryonic fibroblasts (MEFs) deleted in all 3 Tet 
paralogues could not be reprogrammed into iPSCs, inferring that oxidative DNA 
demethylation is required for pluripotent transition255. However, implementation of a 
CRISPR/Cas9 genetic deletion strategy to generate TKO mESCs, did not appear to 
affect pluripotency256. Consistently, TDG deficiency in mESCs also did not appear to 
disrupt pluripotency, suggesting active DNA demethylation is not required for ESC 
maintenance204,203. This is potentially supported by the observed embryonic lethality in 
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TDG-ablated mice at the E 11.5 developmental stage, which may therefore support a 
role of active demethylation in cellular differentiation257.  
 
Transcriptional analysis of TKO ESCs was associated gene activation and repression, 
attributable to hypermethylation at both enhancers and promoter regions256. Intriguingly, 
silenced genes upregulated in TKO cells were found to be primarily expressed in the 
early preimplantation embryo, indicative of stringent control of Tet activity in early 
embryogenesis256. Furthermore, inactivating all known Tet family members resulted in 
gastrulation defects, proposing the control of DNA methylation is fundamental for proper 
functioning of key signalling pathways to enable early body plan formation258. Further 
research is required to determine the exact functional role(s) of each Tet in development. 
However, owing to the murine neonatal lethality effects of a homozygous mutation in 
Tet3242 it may be speculated, in agreement with the elevated mRNA expression profile 
during differentiation252, that this paralogue is necessary for embryo development. 
 
Staining of mouse embryos at the post-implantation stage signified the restriction of 5-
hmC to multi-potent progenitor cells, and as development progressed further levels were 
found to decrease249. 5-hmC becomes restricted to terminally differentiated cell types, 
predominantly neuronal tissue and the bone marrow249. 5-hmC enrichment in the brain 
was established in 2009 through pioneering experiments in Purkinje neurons by TLC, 
high pressure liquid chromatography (HPLC) and mass-spectrometry techniques259. 
This has since been confirmed in multiple studies182,260, and therefore suggests a role 
for this epigenetic mark in neuronal differentiation and neural plasticity261. Therefore, 
based on the literature evidence described thus far it can be alluded Tets/5-hmC are 
intrinsically linked to early developmental events. However, despite characterisation of 
the enzymatic function of Tet enzymes, investigations into the regulation of their activity, 
which may provide mechanistic insights underlying potential role(s) in cell specification 
events, remains largely unexplored.  
 
 Chromatin dynamics are sensitive to [O2]  
 
It has been recorded that 12% of the human population experience sustained ‘hypoxia’ 
as a consequence of low barometric pressure at high altitude262. This subsequently 
initiates as series of physiological adaptations that are regulated at the transcriptional 
level to maintain O2 homeostasis, such as increased erythropoiesis, neovascularisation 
and metabolic reprogramming263. As stated previously, epigenetic modifications can 
regulate chromatin dynamics to enable TF accessibility to the DNA and thus may play a 
crucial role in the cellular response to changes in [O2]. Hence, considering gradients of 
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O2 form across the developing embryo, it is conceivable that O2-dependent, 2-OGDO 
domain containing epigenetic modifiers influence chromatin structure and thus gene 
transcription.  
 
Mechanisms that can facilitate alterations to the chromatin structure in response to 
changes to [O2] include HMT and KDMs. Exposure of human embryonic kidney 293 cells 
(HEK cells) and human lung carcinoma A549 cells to 0.5% O2 increased global levels of 
H3K9me2, which was attributed to elevated activity of the methyltransferase G9a264. G9a 
is essential for early embryogenesis via repression of developmental genes265, and thus 
it can potentially be inferred that [O2] in the embryo may define this HMT activity to 
ensure precise transcriptional regulation. Histone methylation marks can be removed by 
2 different classes of KDMs, the lysine specific demethylase (LSD) and the JmjC domain 
containing demethylase266. The JmjC-KDMs, as alluded to previously, contain the 2-
OGDO domain and are thus poised to respond to gradients of O2. These demethylases 
are classified into 7 KDM subfamilies (KDM2-8) and can exhibit different histone 
substrate specificities, for examples KDM5 and KDM6 are specific for methylated H3K4 
and H3K27 respectively267. Numerous studies on an array of cell types have directly 
demonstrated alterations to the histone methylation status in a variety of cells lines 
subjected to low O2 tensions267. For example, a global increase in H3K4me2/3, 
H3K79me3, H3K9me2 and H3K27me3, was detected in Hepa1-6 cells after 48 hrs 
exposure to 0.2% O2268. This result may be attributable to changes in JmjC-KDM activity 
and/or adaptions to their mRNA expression. For instance, a selection of JmjC-KDMs, 
such as KDM3A, KDM4C/D269 and KDM6A270, have been established as direct targets 
of HIF-signalling, and thus induction of their expression in response to low O2 tensions 
may function as a compensatory effect for reduced KDM activity271.  
 
The absolute requirement of JmjC-KDMs for O2 suggests these proteins may be O2 
sensors, and thus gives rise to the notion that [O2] can be a determinant of chromatin 
structure272. Currently, biochemical data validating the sensitivities of JmjC-KDM to [O2] 
are limited. Although Km data is available for the KDM4 family, calculated for KDM4A, 
KDM4C and KDM4E as 57, 157 and 197 M respectively273,274 (further details of O2 
sensors are provided in Chapter 3: Results 1 Introduction). These differential O2 
sensitivities, which fall within the physiological [O2] range, suggests O2-signalling may 
differentially regulate KDMs in a spatial manner. This potentially may have 
consequences for gene regulation and therefore contribute to asymmetry in the 
developing embryo.  
 
 47 
HIFs drive gene expression for an array targets when presented with a low [O2] 
environment, which are in part dependent upon binding to its HAT domain containing 
CBP/p300 transcriptional coactivator275. O2 has been shown to recruit p300 to 
erythropoietin (EPO) and VEGF genes to drive histone acetylation and thus gene 
transcription276,277. In fact, approximately 40% of HIF target genes are dependent upon 
this association with the HAT p300 or CBP275,272. Furthermore, HDAC activity and 
expression is also increased by low [O2], which functionally has been shown to promote 
tumorigenesis by enhancing angiogenesis through suppression of hypoxia-responsive 
tumour suppressive genes278. This was further emphasised through inhibition of HDAC 
activity that blocked VEGF synthesis and resulted in decreased angiogenesis279. HDACs 
are also described to interact with HIF-170, for example HDAC7 was found to form a 
complex with HIF-1 to mediate nuclear translocation and thus transcriptional activity280. 
Overall, the influence of [O2] on HATs and HDACs suggests that chromatin structure is 
tightly controlled, which is likely to function to enable precise transcriptional regulation. 
However, an additional layer of O2-dependent transcriptional complexity was shown by 
the convergence of histone modifications to drive hypoxia-induced EMT. Here, HIF-1-
mediated activation of HDAC3 was shown to recruit H3K4-specific HMT activity to induce 
mesenchymal gene expression281.  
 
Similarly, Tet enzymes also contain the 2-OGDO domain, and thus it can be speculated 
that DNA methylation dynamics (and thus chromatin organisation) may also be regulated 
through [O2]. However, at present investigation of Tet proteins in this context remain in 
its infancy and have not been considered in a developmental setting (more details are 
given in Chapter 3: Results 1). Although, independent of catalytic activity, Tet1 has been 
shown to function as a transcriptional co-activator, interacting with HIF-2 to regulate 
hypoxia-responsive gene expression and EMT282. By contrast, from cancer studies, DNA 
methylation has shown to be sensitive to changes in [O2]283. Exposure of human 
colorectal and melanoma cell lines to low [O2] displayed a reduction in 5-mC284. Similarly, 
in a human hepatoma cell line, a low O2 tension decreased the level of the methyl donor 
SAM, which culminated in DNA hypomethylation285. This tumour associated reduction in 
5-mC has been shown to facilitate the binding of HIF-1 to the HRE and thus augment 
the HIF-mediated effects on malignant cell growth286. Although, prolonged exposure (14 
weeks) to low O2 tensions was shown to increase 5-mC levels in a PwR-1E cells, a 
prostate epithelial line287. It was further demonstrated that this hypermethylation was not 
a result of increased Dnmt activity, but instead may be due to a specific increase in 
Dnmt3b mRNA expression287. In addition, the mRNA expression of Dnmt enzymes were 
confirmed to be regulated by [O2], but were reported to be increased in cardiac fibroblasts 
and downregulated in colorectal cancer cells288,289. Collectively, owing to the sensitivity 
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to 5-mC by O2, it is reasonable to believe that demethylation may be integrated into 
regulating these methylation changes.  
 
 Hypothesis  
 
Tet enzymes are O2 sensors at concentrations deemed physiologically relevant in 
embryogenesis. The catalytic activity of Tet1, Tet2 and Tet3 is differentially regulated by 
[O2] to influence gene transcription and thus cell fate decisions, thereby determining 
embryonic asymmetry. 
 
This hypothesis will be tested over 3 independent results chapters, which each contain 



































































 Reagents   
 
All reagents used in these studies were purchased from Sigma unless otherwise stated. 
Primers were purchased from Sigma or Integrated DNA Technologies. 
 
 Cell Culture  
 
All cell cultures, unless stated, were conducted in a humidified 37 C incubator exposed 
to a gas mixture of 5% CO2 and 95% air.  
 
2.2.1 Murine P19 embryonal carcinoma cells  
 
Mouse P19 embryonal carcinoma cells (a kind gift from Mona Nema) were cultured in -
Minimum Essential Medium Eagle (Sigma, M8042) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) and 1% L-glutamine-penicillin-streptomycin 
solution. Cells were cryopreserved in FBS containing 10% DMSO in a Coolcell freezing 
container (Biocision) at -80 C overnight, this ensured a cool rate of -1 C/minute. 
Cryovials were transferred to liquid nitrogen for long-term storage. 
 
P19 cells were induced to differentiate into EB-like aggregates through culture onto 100 
mm2 non-adherent petri dishes at a density of 1x106 cells/dish. Differentiation was 
directed towards a cardiac and neural-like fate in the presence of 1 M retinoic acid (RA) 
and 1% dimethyl sulfoxide (DMSO) respectively. Medium was changed every 3 days by 
pelleting EB-like aggregates under gentle centrifugation (800 G, 3 mins). 
 
2.2.2 Mouse embryonic stem cells  
 
R1 mESCs (ATCC), provided by Shukry Habib (Centre for Stem Cell & Regenerative 
Medicine, King’s College London), were maintained undifferentiated on 0.1% gelatin 
coated flasks in Advanced DMEM/F12 (Invitrogen, 12634) containing 8 µM 2-
mercaptomethanol (Invitrogen), 2 mM GlutaMAX-I™ (Invitrogen), 100 U/ml penicillin and 
100 µg/ml streptomycin (Invitrogen). Medium was further supplemented with 10% 
EmbryoMax FBS (Millipore), 20 ng/ml leukemia inhibitory factor (LIF) (Millipore), 3 µM 
CHIR-99021, 1 µM PD0325901 and 5 µg/ml plasmocin prophylactic (InvivoGen). Cell 
medium was changed daily and cells passaged with StemPro Accutase (Invitrogen) 
every 2 days in a 1:4 ratio. Cells were cryopreserved in EmbryoMax FBS containing 
10% DMSO, as described above.  
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mESCs were induced to differentiate unbiasedly into EBs by plating cells onto 100 mm2 
non-adherent petri dishes, at a density of 1x106 cells/dish. Cells were differentiated in 
KnockOut DMEM (Invitrogen, 10829) containing 15% KnockOut (KO) serum 
replacement (Invitrogen), 0.1 mM MEM amino acid solution (Invitrogen) and 2 mM 
GlutaMAX-I™. Media was changed every other day by pelleting EBs by gentle 
centrifugation (800 G, 3 mins).  
 
2.2.3 Human embryonic kidney cells, rat cardiomyoblasts and human 
neuroblastoma cells 
 
HEK-293T (ATCC), rat cardiomyoblasts (H9c2) (ATCC) and human neuroblastoma 
(SH-SY5Y) (provided by John Pizzey, Guy’s Campus, King’s College London) cells were 
cultured in Dulbecco’s Modified Eagle’s medium (high glucose) (Sigma, D6546) 
complemented with 10% heat-inactivated FBS and 1% L-glutamine-penicillin-
streptomycin solution. Cells were cryopreserved in FBS containing 10% DMSO as 
described above.  
 
 Low O2 culture  
 
Cells were exposed to low O2 tensions using a ProOx C21 regulated C-chamber 
(BioSpherix) positioned inside a humidified 37 C incubator. Desired O2 tensions were 
achieved by the control of N2 balance in 5% CO2. For low O2 cellular differentiation 
experiments, fresh medium was equilibrated to the desired O2 tension overnight prior to 
medium changes. To determine the ability of the O2 chamber to activate hypoxic 
signalling pathways, mESCs were plated onto 6-well plates at a density of 250,000 
cells/well and 24 hrs later exposed to 3% O2 for 4 and 24 hrs. Protein was harvested and 
probed for HIF-1 levels, as described in section 2.10.  
 
 Tet overexpression  
 
Bacteria containing Tet overexpression plasmids, were kindly provided by Anjana Rao 
(Addgene plasmids: Tet1; 49792168,290,291,292,293, Tet2; 41710, Tet3; 49446). These were 
streaked onto agar plates from the bacterial stabs provided. Single colonies were 
isolated, inoculated into lysogeny broth (LB), and cultures grown overnight at 37 C 
under agitation. Plasmid DNA was purified using a HiSpeed plasmid maxi kit (Qiagen) 
and stored at -20 C.  
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To optimise transfection conditions for Tet overexpression in mESCs, an array of 
transfection reagents were tested for their transfection efficiency using a GFP expression 
plasmid (Invitrogen). According to their manufacturer’s instructions: Viafect™ 
(Promega), Lipofectamine® 2000 (Invitrogen), TurboFect™ (Thermo Scientifc), 
FuGENE® HD (Promega) and Xfect™(Clontech) were used to transfect 1 g of GFP 
plasmid into 24-well plates pre-seeded with 100,000 mESCs/well 24 hrs before. In 
addition, nucleofection was also used as alternative transfection technique to further 
assess the transfectability of mESCs. A 4D-nucleofector™ system (Lonza), using the P3 
primary cell kit was used to optimise the transfection of a pmaxGFP™ plasmid (Lonza), 
in accordance with manufacturer’s instructions. 2 g pmaxGFP™ plasmid was combined 
with 3x106 mESCs suspended in Nucleofector™ solution containing Nucleofector™ 
supplement, in a total volume of 100 l. The reaction mix was transferred into 
Nucleocuvette™ vessels and exposed to either one of 4 pulse programs: CG-104, CA-
137, CB-150, CD-118 within the 4D-nucleofector™ system. Following re-suspension in 
500 l of fresh medium, cells were plated into 24-well plates at 100,000 cells/well. GFP 
expression was analysed 24 hr post-transfection on a Leica fluorescent microscope and 
cell images acquired with a Q-imaging® camera and Openlab™ software (PerkinElmer).  
 
Despite success with GFP transfection, Tet proteins were not expressed under the same 
transfection conditions. Therefore, HEK cells were used as an overexpression model for 
future studies. HEK cells were plated onto 6-well plates at 400,000 cells/well in 3 ml of 
medium, 24-hrs prior to transfection. Transfection mixes for overexpression of each Tet, 
and pcDNA™ 3.1 (Invitrogen) transfection control, was conducted in triplicate as follows: 
6 g of plasmid DNA was added to 300 l Opti-MEM (Invitrogen) and mixed with 300 
l Opti-MEM containing 12 l of Lipofectamine® 2000. Following a 10 min incubation 
at room temperature, 200 l of transfection mix was added to each well and cells 
harvested for downstream applications after 48 hrs. For low O2 experiments, HEK cells 
were exposed to the desired O2 tension directly after transfection mixes were added to 
the cells.  
 
Tet proteins were also overexpressed in P19 cells for a microarray study (see section 
2.15). P19 cells were plated onto T25 culture flasks at 500,000 cells/flask in 5 ml of 
medium, 24 hrs prior to transfection. For a single transfection, 15 g of either Tet 
overexpression construct (or pcDNA™ 3.1 control) was mixed with 45 l of Fugene HD 
transfection reagent in a total of 500 l of Opti-MEM. Following a 15 min incubation at 
room temperature, DNA and transfection reagent complexes were added to respective 
culture flasks. 
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 Cell treatments  
 
2.5.1 Dimethyloxalyglycine and colbalt chloride 
 
The ability to activate HIF-dependent signalling in P19 cells chemically by 
Dimethyloxalylglycine (DMOG) was assessed.  P19 cells were plated onto 6-well culture 
plates at 250,000 cells/well in 3 ml of medium and 24 hrs later treated with 0.5 mM and 
1 mM DMOG for 16 hrs. Cells were harvested and protein levels of HIF-1 determined, 
as described in section 2.10. mESCs were treated with 100 M cobalt chloride (a less 
toxic alternative to DMOG) for 24 hrs as a positive control for the induction of HIF-1 
protein for assessing the function of the O2-controlled chamber, see section 2.3.   
 
To understand whether chemical activation of O2-dependent signalling could influence 
cellular differentiation, P19 cells were differentiated into EB-like aggregates in the 
presence of 1 mM DMOG for 4 days and expression of lineage markers determined by 
QPCR analysis, see section 2.7. In a separate preconditioning experiment, P19 cells 
were differentiated in the presence of 1 mM DMOG for 4 days, before being allowed to 
differentiate further till days 7 and 11. The effect of this initial hypoxic-mimetic stimulus 
upon lineage marker expression at later differentiation time points was assessed by 
QPCR.  
 
2.5.2 Ascorbic Acid and inhibitors   
 
mESCs were plated onto 6-well culture plates at a density of 250,000 cells/well in 3 ml 
of medium, 24 hrs prior to the addition of AA (vitamin C) at increasing doses (0.01 mM, 
0.1 mM, 1 mM, 5 mM and 10 mM) (AA solution was made up in water and neutralised 
to pH 7.2 using 5 M sodium hydroxide). Cells were harvested 24 hrs after treatment and 
5-hmC levels detected by a dot-blot, as described in 2.8. Differentiating mESCs were 
also treated with 1 mM AA and differentiated for 3 days. Cells were subsequently 
harvested and 5-hmC levels detected as described in 2.8.  
 
To investigate whether 5-hmC levels were affected by a reduction in intracellular AA, the 
use of phloretin and buthionine sulfoximine (BSO), inhibitors of AA uptake transporters 
and dehydroascorbic acid (DHA) reduction, respectively, were studied. mESCs were 
plated onto 6-well plates at 250,000 cells/well in 3 ml of medium and 24 hrs later treated 
with 1 mM BSO (made up in water) or 200 M phloretin (made up in DMSO). In addition, 
cells were pre-treated with 1 mM BSO or 200 M phloretin for 3 hrs, before addition of 1 
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mM AA. Cells were harvested for 5-hmC analysis after 24 hrs as described in section 
2.8. Furthermore, the effect of these inhibitors upon 5-hmC levels during mESC 
differentiation was also examined. mESCs were differentiated in the presence of 
increasing doses of BSO (100 M, 500 M and 1 mM) and phloretin (100 M and 200 
M) for 3 days before cells were harvested for 5-hmC analysis, as described in section 
2.8. For phloretin treatments, a DMSO vehicle control was included at an equivalent 
DMSO level to that contained in the 200 M dose.   
 
Owing to the different AA concentrations within mESC maintenance and differentiation 
medium, both cell mediums were tested to ensure the 5-hmC profile of differentiating 
mESCs was not a result of changes in AA levels. Firstly, undifferentiated mESCs were 
plated at 250,000 cells/well into 6-well culture dishes and cultured in either fresh 
maintenance medium or maintenance medium containing 15% KO serum (used in 
differentiation studies) in replace of EmbryoMax FBS. As a control, 1 mM AA treatment 
was included in this study. Cells were harvested 24 hrs later for 5-hmC analysis, see 
section 2.8. In an independent investigation, mESCs were plated into T25 culture flasks 
at 625,000 cells/well and pre-treated with different serum-containing maintenance 
medium for 24 hrs, as described above, before being induced to differentiate in full 
differentiating medium (containing 15% KO serum) for 3 days (described in 2.2.2). 5-
hmC levels were then quantified as described in section 2.8.  
 
 Generation of stable Tet ablated mESC lines  
 
Genetic ablation of each Tet in mESCs was conducted using MISSION® short hairpin 
RNA (shRNA) lentiviral transduction particles. Lentiviruses are capable of infecting 
dividing and non-dividing cells and stably integrating into the host genome resulting in 
long term transgene expression. The shRNA is transcribed by the pol III promoter U6 
from the pLKO.1-puro vector into 2 complementary 19-22 base pair (bp) RNA 
sequences, linked by a short loop of 4-11 nucleotides294. This shRNA molecule is 
exported to the cytosol where it is recognised by Dicer and processed into siRNA 
duplexes. These siRNA duplexes are incorporated into the RNA-induced silencing 
complex (RISC) and subsequently targeted to specific mRNA molecules initiating their 





2.6.1 Puromycin dose response curve   
 
To select for positively transduced cells, the sensitivity of mESCs to puromycin (a 
resistance gene is contained within the lentiviral vectors) was determined by a dose 
response curve. mESCs were seeded onto 0.1% gelatin coated 24-well tissue culture 
plates at 50,000 cells/well, 24 hrs prior to the addition of increasing concentration of 
puromycin (0.5-10 g/ml) (Invitrogen). Puromycin containing media was changed daily. 
1 g/ml, the lowest concentration to induce cell death after 72 hrs, was used to select 
for positive lentiviral transduced mESCs.  
 
2.6.2 Lentiviral transduction  
 
mESCs were seeded onto 0.1% gelatin-coated 24-well tissue culture plates at 20,000 
cells/well in 1 ml of medium, 24 hrs prior to lentiviral transduction. Lentiviral transduction 
particles were thawed on ice and the volume of particles to give a multiplicity of infection 
(MOI) of 15 (see equations in Figure 2:1) were added to culture medium, containing 10 
g/ml hexadimethrine bromide, to give a total volume of 250 l. For each transduction, 
mESC medium was replaced with 250 l lentiviral containing medium.  2 clones for each 
Tet paralogue were available: Tet1 (TRCN0000341849 and TRCN0000341850), Tet2 
(TRCN0000192770 and TRCN0000201087) and Tet3 (TRCN0000376843 and 
TRCN0000375340). A non-targeted shRNA (MISSION®, pLKO.1, (SHC016V-1)) control 
cell line was also generated to control for Tet silencing studies. Virus containing medium 
was incubated on cells overnight and subsequently replaced with 500 l fresh medium. 
72 hrs post-infection transduced mESCs were cultured in medium containing 1 g/ml 
puromycin. Selected cells were expanded and subsequently cryopreserved as described 
in 2.2.2. Successful ablation of the Tet enzymes, compared to shRNA control, was 










MOI x cell number = TU 
 
TU/TU per ml = ml of lentiviral particles required  
 
 
Figure 2:1 Equations required for calculating the volume of lenti-viral shRNA 
particles for a desired multiplicity of infection for mESC transduction  
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 Quantification of mRNA expression   
 
2.7.1 RNA isolation   
 
RNA was extracted from cell and tissue using ReliaPrep RNA tissue miniprep system 
(Promega), according to manufacturer’s instructions, but modified by the addition of 1 l 
RQ1 DNase (Promega) per sample during the DNase incubation step. RNA was 
quantified and assessed for purity using a NanoDrop spectrophotometer (ND-1000, 
Labtech international). RNA was stored at -80 C. Note, for overexpression studies an 
additional in-solution DNase step, to ensure all plasmid DNA was removed, was 
performed on purified RNA, as described for the gene profiler arrays in section 2.7.2.  
 
Differentiating P19 and mESCs were harvested by pelleting cell aggregates under gentle 
centrifugation (800 G, 3 mins), washed in ice cold phosphate buffered saline (PBS), 
pelleted and lysed in 500 l RNA lysis buffer (LBA) containing 1-Thioglyerol (Promega). 
Adherent cells were harvested from tissue-culture plates, after washing with ice cold 
PBS, by scraping into LBA (volume varied depending on the size of the culture dish, but 
did not exceed 500 l). If required, cell lysates were centrifuged through Qiashredder 
columns (Qiagen) (13000 G, 1 min).  
 
Tissue samples (20 mg) were lysed in 500 l of LBA and homogenised using FastPrep® 
lysing beads D (MP biomedicals) on a Precellys 24 machine (Bertin) at program 3 for 20 
sec bursts (usually performed twice).  
 
2.7.2 cDNA synthesis  
 
cDNA synthesis from a single stranded RNA template occurs via a process called 
reverse transcription. Here the polyadenylated 3’ end of the mRNA becomes hybridised 
to a oligodeoxythymine primer (Oligo dT18), and extended with a reverse transcriptase 
enzyme in the presence of dNTPS to yield a single stranded cDNA copy.  
 
For each RNA sample, 1 g was diluted in RNase/DNase-free water to a total volume of 
13 l, and mixed with 1 l oligo-dt18 primers (1 g/ml) and 1 l dNTPs (10 mM) 
(Promega). Samples were initially heated at 70 C for 3 mins to disrupt any secondary 
structures that may be present within the RNA and  incubated at 4 C. 4 l of 5X reverse 
transcriptase buffer (Promega), 0.5 l RNase inhibitor (Promega) and 0.5 l reverse 
transcriptase (Moloney murine leukaemia virus) (Promega) were then added, giving a 
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total reaction volume of 20 l. Negative controls comprising all reaction components, 
except the reverse transcriptase enzyme (substituted with 0.5 l RNase/DNase-free 
water) were used to assess for genomic DNA contamination within the sample. All 
samples were incubated at 42 C for 90 mins and heated to 70 C for 10 mins. cDNA 
was diluted in 80 l of RNase/DNase-free water and stored at -20 C.  
 
For mouse cell lineage gene profiler PCR arrays (RT2 profiler PCR array, 384-well format 
(Qiagen)), RNA samples were treated with an additional in-solution DNase step as 
recommended by the manufacturer’s instructions prior to reverse transcription. Each 
DNase reaction contained the RNA sample (1-2 g), 1 l RQ1 10X reaction buffer 
(Promega) and 1.5 l RQ1 DNase (Promega) made up to a total volume of 10 l in 
RNase/DNase-free water. Samples were heated at 37 C for 30 mins. The reaction was 
terminated by the addition of 1 l RQ1 DNase stop solution (Promega) and a 65 C heat 
step (for 10 mins), to inactivate the DNase. Triplicate RNA samples were equally pooled, 
and a total of 400 ng of RNA was reversed transcribed, as conducted above, and diluted 
with 91 l RNase/DNase-free water (giving a total volume of 111 l). 
 
2.7.3 Quantitative PCR (QPCR) 
 
Quantitative PCR (QPCR) was used to determine the relative mRNA expression of 
specific genes. This analysis method relies on fluorescence detection. For experiments 
described here, SYBR green, a nucleic acid stain, emits a fluorescent signal when bound 
to double stranded DNA by intercalating with DNA bases. Therefore, the fluorescent 
signal increases proportionally to the amount of double-stranded DNA product amplified 
after each PCR cycle, enabling quantitation of the gene of interest’s expression across 
sample sets.  
 
Each QPCR reaction was performed in a 20 l reaction volume, made up as follows: 2 
l cDNA, 2 l of 3 M gene-specific primers (see primer list in Table 3) 6 l 
RNase/DNase-free water and 10 l 2X qPCRbio Sygreen mix Hi-ROX (PCR 
Biosystems). QPCR reactions were conducted on a StepOnePlus QPCR machine 
(Applied Biosystems). Samples were initially denatured (95 C, 10 mins) and amplified 
for 40 cycles at the following conditions: denatured at 95 C, for 15 secs, annealed at 60 
C for 30 secs and extended at 72 C for 20 secs. Melt curve analysis was performed 
for all reactions in order to determine primer specificity, see section 2.7.4.  
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For the gene profiler PCR arrays, QPCR reagents were prepared as follows: 102 l of 
cDNA, 650 l 2X qPCRbio Sygreen mix Hi-ROX and 548 l of RNase/DNase-free water. 
10 l of QPCR mix was dispensed by a Bravo automated liquid handling platform 
(Agilent) to each well. QPCR reactions were conducted on a Viia 7 system (Applied 
Biosystems), under the following conditions: initial denaturation step (95 C, 10 mins) 
and 40 cycles of denaturation (95 C, for 15 secs) and annealing (60 C for 1 min). Melt 
curve analysis was performed for all reactions in order to determine primer specificity. 
 
Quantification of mRNA expression was determined from the amplification plot of natural 
log fluorescence against cycle number. A cycle threshold (Ct) was determined from the 
linear phase of the exponential amplification curve for each tested gene. Hence, the Ct 
of each sample was determined as the cycle number at which fluorescence reached this 
threshold. Relative mRNA expression was quantified using the comparative Ct (∆∆Ct) 
method. The target gene of interest was normalised to a control gene (see 2.7.4) and 
subsequently normalised to a control sample, as shown from the equation below (Figure 
2:2). The expression of the target gene for each sample relative to control is then 







2.7.4 QPCR primer design 
 
Gene specific primers were designed to bridge exon-exon junctions using the NCBI 
primer design tool (www.ncbi.nlm.nih.gov/tools/primer-blast/). Primers were designed to 
have a minimal and maximal amplicon size of 70 and 200 bp respectively, with an optimal 
melting temperature of 60 C. The specificity of primers was assessed for their ability to 
produce a solo melting peak and further confirmed through the detection of a single PCR 
product on a DNA gel by electrophoresis (visualised by Nancy-520 nucleic acid stain), 
an example is shown in Figure 2:3. A table of validated QPCR primer sets are displayed 
in Table 3. 
∆∆Ct = (Ct target (sample) - Ct normalisation control (sample)) - (Ct target (control sample) - Ct normalisation control (control sample)) 
Figure 2:2 Comparative Ct method for relative quantification of mRNA 
expression. Relative mRNA expression for each sample against the tested target 




























A normalisation control gene was selected from the geNorm™ reference selection kit 
(Primerdesign) in accordance with manufacturer’s instructions. The mRNA expression 
of an array of normalisation genes were assessed against mESCs samples at their 
undifferentiated and day 3-, day 7- and day 11-differentiated state. Expression data was 
analysed using geNorm qbase software to determine the most stably expressed genes 
among the tested sample sets. Canx was selected as a normalisation control gene for 





Figure 2:3 QPCR Primer validation. (A) Melt curve analysis performed after each 
QPCR run to confirm amplification of a single product (depicted by a single melt 
peak). (B) Primer sets were further verified to produce a single gene product by gel 
electrophoresis after QPCR amplification. Primer pairs producing multiple bands 
were discarded from future studies, denoted by the cross, and redesigned.  
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 Dot-blotting  
 
The dot-blot technique was used to immobilise DNA onto nylon membranes in a series 
of spots, which is amenable for densitometry analysis to assess global changes in 5-mC 
and 5-hmC levels.  
 
2.8.1 DNA isolation  
 
EBs were harvested by gentle centrifugation (800 G, 3 mins), washed in ice cold PBS, 
pelleted and stored at -20 °C. Adherent cells were washed and scraped into ice cold 
PBS, transferred to a microcentrifuge tube, centrifuged (800 G, 5 min) and cell pellets 
stored at -20 °C.  
 
Genomic DNA was prepared from cell pellets by 350 µg/ml proteinase K (Sigma) 
digestion in 15 mM NaCl, 1% Sodium dodecyl sulfate (SDS), 100 mM 
Ethylenediaminetetraacetic acid (EDTA), 50 mM Tris-HCl pH 8 in a total volume of 700 
µl, at 55 °C for 4 hrs for cells and overnight for tissue (samples up to 40 mg). Samples 
were sonicated (Branson 150 sonfier, setting 2) twice for 10 secs to obtain 200-1000 bp 
fragments, before undergoing RNaseA (140 µg/ml) (Qiagen) treatment for 30 mins at 55 
°C. DNA was phenol/chloroform extracted using 5 prime phase lock gel tubes (Scientific 
Laboratory Supplies) and ethanol precipitated. DNA pellets were re-suspended in up to 
200 µl of RNase/DNase-free water and quantified using a NanoDrop spectrophotometer.  
 
2.8.2 Immunoblotting  
 
2 µg of DNA was applied to a Hybond™-N membrane (GE Healthcare) using a dot-blot 
hybridisation manifold (Cleaver Scientific), as described by Brown, T (2001)295. DNA was 
prepared in a total volume of 105 µl containing 45 µl 20X SSC (3 M NaCl and 300 mM 
trisodium citrate, adjusted to pH 7) and made up to volume in RNase/DNase-free water. 
Known DNA standards for 5-mC (10 ng) (Actif Motif) and 5-hmC (5 ng) (Actif Motif) were 
included in initial optimisation experiments as separate samples to control for antibody 
specificity. DNA was denatured at 100 °C for 10 mins and placed on ice. In parallel, 
membranes were soaked 6X SSC and incubated for 10 mins. The dot-blot manifold was 
assembled with an initial filter paper layer, pre-soaked in 6X SSC, with the membrane 
placed on top, secured firmly and 0.8 bar pressure applied. An initial 150 µl of 6X SSC 
was applied to each well prior to addition of the 150 µl of the DNA sample. Once samples 
had passed through, the manifold was dismantled and the membrane submerged in 
denaturation solution (1.5 M NaCl, 0.5 M NaOH) for 10 mins followed by neutralisation 
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solution (1M NaCl, 0.5 M Tris-HCl) for 5 mins. Membranes were dried and exposed to 
UV irradiation on a UVP GelDoc-it imager (5 mins) to covalently bind DNA to the nylon 
membrane. Next, membranes were blocked in 10% milk (Marvel) in PBS with 0.1% 
Tween-20 (PBS/T) for 5-hmC blots or with Odyssey® blocking buffer (PBS) (LiCor) for 
5-mC blots, for a minimum of 1 hr at room temperature. Membranes were probed with 
5-hmC and 5-mC antibodies diluted in their respective blocking conditions (see Table 2 
for antibody information) overnight, under agitation, at 4 °C. Subsequently, blots were 
washed 3 times for a minimum of 10 mins in PBS/T, and incubated with IRDye® 800CW 
secondary antibodies (LiCor) (diluted 1:15000) (5-mC (LiCor, 926-32210) and 5-hmC 
(LiCor 926-32213)) in respective blocking conditions, shielded from light, for 1 hr under 
agitation at room temperature. Membranes were then washed 3 times for a minimum of 
10 mins in PBS/T, with an additional final PBS-only wash for 5 mins prior to signal 
detection on an Odyssey® Clx imaging system (LiCor). Blots were quantified using 
Image Studio™ software (LiCor), enabling the ratio of 5-hmC to 5-mC to be calculated 
for each sample.  
 
 Mass spectrometry analysis  
 
Mass spectrometry was utilised as a sensitive and accurate method to quantify and 
distinguish between 3 nucleotide bases of interest; C, 5-mC and 5-hmC, within the same 
sample.  
 
Genomic DNA was prepared for mass-spectrometry analysis in accordance with Le, T 
et al (2011)296. DNA was broken down to individual nucleoside components as follows: 
1 µg DNA was mixed with 2.5 µl 10X DNA Degradase™ reaction buffer (Zymo Research) 
and 1 µl DNA Degradase Plus™ (Zymo Research) made up to a total volume of 25 µl 
with RNase/DNase-free water. Samples were incubated at 37 °C for 4 hrs and the 
reaction inactivated by the addition 175 µl of 0.1% formic acid to yield a final 
concentration of 5 ng/µl of DNA.  
 
DNA samples were diluted 4 times in 25 µl DNA Degradase™ reaction buffer and 175 
µl of 0.1% formic acid before injection into an LC column (Zorbax Eclipse plus C18 RR 
HT 100 x 2.1mm, 1.8µ particle size) integrated to an Agilent 1100 LC system, which was 
set to a flow rate of 0.1 ml/min of water/methanol/formic acid (95%/ 5%/ 0.1%). The 
effluent of the column was directed to electrospray ion source interfaced with Waters 
Quattro LC triple quadrupole mass spectrometer. The intensity of specific MH+ > 
fragment ion transitions were recorded (C m/z 228.1→112.1, 5-mC m/z 242.1→126.1 
and 5-hmC 258.1→142.1). The multiple reaction monitoring (MRM) peak area was 
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identified for C, 5-mC and 5-hmC, shown in Figure 2:4A/B. A series of DNA standards 
of C, 5-mC and 5-hmC (Actif Motif) were prepared for calibration at a concentration of 1 
µg/ml in MeOH, mixed and diluted to 1.5 ng/µl in 25 µl DNA Degradase™ reaction buffer 
and 175 µl of 0.1% formic acid (Figure 2:4A). Amounts of 5-mC and 5-hmC were 








Figure 2:4 Mass-spectrometry chromatograms for C, 5-mC and 5-hmC 
detection. (A) Chromatograms showing the detection of 1.5 ng/l of C, 5-mC and 
5-hmC DNA standards. (B) An example of a set of chromatograms for C, 5-mC and 
5-hmC detection in an undifferentiated mESC sample.  
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 Western blotting  
 
Western blotting is a technique used to analyse the expression of specific proteins within 
a sample by polyacrylamide gel electrophoresis, which relies on the separation of 
proteins according to their molecular weight.  
 
2.10.1 Sample preparation  
 
Cells were washed and scraped into ice cold PBS, transferred into a microcentrifuge 
tube and pelleted by gentle centrifugation (800 G, 3 mins). Cell pellets were either stored 
at -80 °C or lysed, dependent on pellet size in up to 300 µl of protein lysis buffer (150 
mM NaCl, 2 mM EGTA, 5 mM EDTA, 30 mM sodium fluoride, 40 mM β- 
glycerophosphate, 20 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM 
phyenylmethylsulfonyl-fluroide, 0.5% Nonidet P-40, in 25 mM Tris-HCl at pH 7.4, 
supplemented with 5 µl/ml protease inhibitor cocktail). In some instance, where lysates 
appeared insoluble, samples were briefly sonicated for 10 secs (Branson 150 sonfier, 
setting 1).  
 
Protein concentration was determined by a Bradford colorimetric protein assay, which 
utilises the spectral properties of Coomassie Brilliant Blue G-250 upon protein binding. 
A standard curve, performed in triplicate, was made with increasing concentrations of 
bovine serum albumen (BSA) (0-50 µg/ml) supplemented with 2 µl of protein lysis buffer 
(since Bradford reagent is sensitive to detergents in lysis buffer) made up to a total 
volume of 200 µl with Bradford reagent. 2 µl of each protein lysate was added to 198 µl 
of Bradford reagent in triplicate and after a short incubation absorbance measured at a 
wavelength of 595 nm (Tecan, GENios pro). Sample protein content was determined 
from the standard curve and added to 5X loading buffer (0.5 M DTT, 0.02% Bromophenol 
blue, 30% glycerol, 10% SDS in 250 mM Tris-base, pH 6.8), heated at 95 °C for 10 mins 
(to denature proteins) and stored at -20 °C.  
  
2.10.2 Immunoblotting  
 
Polyacrylamide gels were cast (see Table 1 for volume and reagents) and 30 µg of 
protein sample was loaded to each well alongside a molecular weight marker (Bio-rad). 
Gels were electrophoresed in running buffer (25 mM Tris-base, 192 mM Glycine, 0.1% 
SDS) at 100 V through the stacking gel, before increasing to 150 V through the resolving 
gel. Proteins were transferred onto nitrocellulose membranes at 100 V for 70 mins in 
transfer buffer (25 mM Tris-base, 192 mM Glycine, 10% methanol). Membranes were 
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either stained with Ponceau S red to confirm efficient transfer, or alternatively total 
protein/lane was quantified using Revert total protein stain kit (LiCor), according to 
manufacturer’s instructions.  
 
Membranes were blocked in either 10% milk Tris-buffered salt solution containing 0.1% 
tween-20 (TBS/T) or 10% milk PBS/T for a minimum of 1 hr at room temperature. Blots 
were probed with primary antibodies overnight at 4 °C under agitation (see Table 2 for 
primary antibodies used, complete with conditions). Membranes were washed in TBS/T 
or PBS/T 3 times for a minimum of 10 mins and incubated with the appropriate IRDye® 
800CW (926-32213/926-32212) or IRDye® 680RD (926-68072) secondary antibodies 
(1:15000) for 1 hr at room temperature, under agitation. Following 3 washes for a 
minimum of 10 mins in TBS/T/PBS/T and a final wash in either TBS/PBS alone, blots 
were visualised on an Odyssey® Clx imaging system.  
 
Blots were quantified using Image Studio™ software. Signal from the protein of interest 
was normalised to the signal of a loading control gene or the total protein signal/lane.  
 
 1H-NMR metabolite assessment  
 
HEK cells were plated onto 150 mm2 tissue culture dishes at a density of 4x106 cells/dish 
for atmospheric O2 and 6.5 x106 cells/dish for low O2 studies. After 24 hrs, cells were 
exposed to 3% and 1% O2 (or kept under atmospheric conditions) for 24 hrs. Cells were 
washed in ice cold PBS twice and incubated on dry ice to quench metabolites for 3 mins. 
Next, cells were scraped into 1.7 ml of methanol (a 10 µl aliquot was taken for protein 
quantification), mixed with 1.7 ml chloroform and incubated under agitation at 4 °C for 
10 mins. 1.7 ml of water (Milli-Q) was added to the metabolite extraction buffer and 
centrifuged (800 G, 45 mins, 4 °C). The top (polar) fraction was collected and the 
methanol and water evaporated using a SpeedVac™ concentrator (Thermo Scientific) 
at 30 °C. Dried extracts were reconstituted in a 100 mM sodium monophosphate buffer 
(pH 7.0) containing 500 μM sodium 3-(trimethylsilyl)propionate-2,2,3,3-d4 (TMSP), 1.5 
mM sodium azide , 0.5 mM EDTA and 100% deuterium oxide (D2O). 
 
A 700 MHz Bruker spectrometer equipped with a cryogenic probe was used for 1D 1H 
NMR data acquisition with supressed water resonance. 1H NMR spectra were acquired 
using 9.3 kHz spectral width and 32 K data points with acquisition time of 1.67 secs, 
relaxation delay of 5 secs and 128 scans. The resulting spectra were processed to 65536 
data point and corrected for phasing and zero referencing using NMRLab297. Resonance 
assignments and quantification were made with reference to Chenomx NMR Suite 7.1 
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(Chenomx). Data was normalised to total protein, determined by a Bradford assay, as 
described 2.10.1. 
 
 5-hmC-DNA immunoprecipitation-sequencing/PCR  
 
The 5-hmC-DNA immunoprecipitation (hMeDIP) (Active Motif) assay was used to enrich 
for the 5-hmC mark on genomic DNA using a 5-hmC antibody. These enriched DNA 
fractions were analysed by a non-targeted genome wide sequencing approach (hMeDIP-
seq) and a more targeted PCR approach (hMeDIP-PCR).  
 
Genomic DNA was isolated from day 3-differentiated mESCs, exposed to atmospheric 
and 1% O2, as described in section 2.8.1. Triplicate samples were pooled equally and a 
total of 1 μg of fragmented DNA (Figure 2:5) was used for the hMeDIP protocol in 
accordance with manufacturer’s instructions. In brief, fragmented DNA was incubated in 
a reaction mix containing 4 µl 5-hmC antibody (or IgG control) in a total volume of 100 
µl, overnight at 4 °C with rotation. An aliquot of fragmented DNA was set aside as an 
input control for downstream applications. Protein G magnetic beads were added to each 
immunoprecipitation (IP) and a further incubation of 2 hrs at 4 °C with rotation was 
conducted. After this DNA capture step beads were pelleted on a magnetic stand and 
washed in ice cold Buffers C and D. Beads were re-suspended in Elution buffer and 
incubated at room temperature with rotation for 15 mins. After addition of Neutralisation 
buffer, beads were pelleted enabling enriched DNA to be separated for use in 
















Figure 2:5 Sonication of genomic DNA for 5-hmC-DNA immunoprecipitation-
sequencing/PCR. Genomic DNA was pooled from triplicate samples from day-3 
differentiated mESCs exposed to atmospheric and 1% O2 (lanes 1 and 2) and 
prepared for 5-hmC-DNA immunoprecipitation-sequencing/PCR by sonication into 
approximately 300-1000 bp fragments. 
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Sequencing libraries were prepared from day 3-differentiated mESCs, cultured under 
atmospheric O2, using NEBNext Ultra II DNA Library Prep Kit for Illumina (New 
England Biolabs) following the manufacturer’s protocol. Briefly, DNA fragments were 
end-repaired and dA tailed at the 3’ end. Adaptors with a T overhang were ligated to the 
dA tail fragment. Fragments of 200 bp inserts were size selected using Agencourt 
Ampure XP Beads (Beckman Coulter), eluted in 10 mM Tris-HCl, indexed and the library 
PCR amplified for 12 cycles. Libraries were quantified by QPCR using NEBNext 
Library Quant kit for Illumina (New England Biolabs) and pooled at 4 nM concentration. 
The library pool was sequenced on the MiSeq (Illumina) single read for 50 cycles.  
 
PCR amplification of the Tet3 promoter from atmospheric O2 and 1% O2 hMeDIP 
samples was performed using Q5 high fidelity DNA polymerase (New England 
Biolabs). PCR reaction mixes contained 2 μl of 5-hmC enriched DNA in 10 μl Q5 buffer, 
10 μl Q5 GC Enhancer buffer, 1 μl 10 mM dNTPs, 5 μl 10 μM primers (forward and 
reverse), 1 μl polymerase and made with RNase/DNase-free water to give a total 
reaction volume of 50 μl. Primers used were as follows (given 5’-3’): forward 
GAGAGGGCATAGCGGACTTG and reverse GCAGACTGCAGATGAGTGGA. PCR 
was conducted under the following cycling conditions, according to the manufacturer’s 
protocol: Initial denaturation (98 °C, 30 secs) and 30 cycles of denaturation (98 °C, 10 
secs), annealing (64 °C, 20 secs) and extension (72 °C, 30 secs) with a final extension 
phase (72 °C, 2 mins). PCR products were visualised by agarose gel electrophoresis. 
 
 TrueMethyl® genome analysis (bisulfite and oxidative-bisulfite 
sequencing)  
 
The TrueMethyl® genome analysis kit (Cambridge Epigenetix) was utilised to investigate 
the methylation status of specific CpGs at the single nucleotide level within the Tet3 
promoter region. This assay is based on bisulfite conversion of DNA, which functions to 
deaminate unmethylated cytosines (C) to produce uracil (U) leaving modified 5-mC and 
5-hmC bases intact. To distinguish between 5-mC and 5-hmC marks this assay kit 
employs the use of oxidative bisulfite chemistry. Here, the oxidative step converts C to 
U, 5-hmC to 5-fC and has no effect on 5-mC. After subsequent bisulfite treatment and 
PCR amplification, 5-mC is read as C, whereas C and 5-hmC are read as thymine (T), 
depicted schematically in Figure 4:21. 
 
Genomic DNA was prepared from undifferentiated, day 3-differentiated, day 3-
differentiated Tet1 KD, and day 3-differentiated 1% O2 mESCs, as described in section 
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2.8.1. The size of DNA after mechanical shearing was verified by gel electrophoresis to 
be in the range of 300-1000 bps, see Figure 2:6. DNA was quantified using a Qubit® 
dsDNA HS assay kit (Thermo Scientific) and a total of 400 ng total DNA/sample was split 
equally between bisulfite and oxidative bisulfite conversion steps. The assay was 














Samples were prepared for PCR amplification in a reaction mix containing: 12.5 µl KAPA 
HiFi HotStart Uracil+ ReadyMix PCR kit (2X) (KAPA Biosystems), 1 µl oxidative and 
bisulfite treated DNA (diluted 1:10), 1.5 µl 10 µM primer and 10 µl RNase/DNase-free 
water. Amplification was conducted under the following cycling conditions: initial 
denaturation (98 °C, 45 secs), followed by 35 cycles of denaturation (98 °C, 45 secs), 
annealing (60 °C, 30 secs), extension (72 °C, 30 secs) and a final extension (72 °C, 1 
min). Amplification products were visualised by agarose gel electrophoresis. DNA bands 
were excised and purified using a QIAquick gel extraction kit (Qiagen) according to 
manufacturer’s instructions and sequenced by Sanger Sequencing (Source BioScience) 
with PCR amplification primers.  
 
Primers for oxidative and bisulfite amplification were designed using EpiDesigner primer 
design tool (www.epidesigner.com) with the following restrictions: amplicon size, 140 bp 
– 210 bp with an optimal size of 160 bp. In addition, the minimum amount of CpGs to 
include in the amplicon was changed from 4 to 2. Primers used were as follows (given 





Figure 2:6 Sonication of genomic DNA for TrueMethyl genome analysis. 
Genomic DNA (lanes 1-9) was prepared for TrueMethyl genome analysis by 
sonication into approximately 300-1000 bp fragments. 
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 Chromatin Immunoprecipitation-PCR 
 
Chromatin immunoprecipitation (ChIP) is a technique used to investigate the interactions 
of proteins, including histone modifications, with a region of genomic DNA. Proteins are 
cross-linked to DNA, fragmented and immunoprecipitated with an antibody against the 
protein target. The DNA fragments isolated in this complex were identified by a targeted-
PCR approach.  
 
ChIP was performed using EZ-Magna ChIP™ A/G (Millipore) in accordance with 
manufacturer’s instructions. Briefly, undifferentiated and day 3-differentiated mESCs 
were fixed by the addition of formaldehyde to cell culture medium at a final concentration 
of 1% for 10 mins at room temperature. For differentiating cells, EBs were transferred to 
a falcon tube and fixed under agitation. Unreacted formaldehyde was quenched with 
10X glycine for 5 mins, before cells were washed twice in ice cold PBS. Cells were 
scraped in ice cold PBS containing protease inhibitor cocktail, collected and pelleted. 
Pellets were firstly lysed in cell lysis buffer for 15 mins on ice, pelleted and re-suspended 
in nuclear lysis buffer. DNA was sonicated to a size between 200-1000 bps, as described 
in section 2.8.1. For each IP reaction chromatin was mixed with immunoprecipitating 
antibody (see Table 2) and protein A/G magnetic beads before incubation with rotation 
overnight at 4 °C. An aliquot of chromatin was kept as input for PCR and a negative IgG 
control was included for each immunoprecipitating antibody.  
 
Protein A/G magnetic beads were pelleted with a magnetic separator and washed in low 
salt buffer, high salt buffer, and LiCl wash buffer with a 5 min incubation with rotation 
between steps. Protein/DNA complexes were eluted, and DNA isolated by resuspension 
of beads in ChIP Elution Buffer with proteinase K, followed by a heat step for 2 hrs at 62 
°C under agitation. Following a final heat step of 95 °C for 10 mins, DNA was purified on 
spin columns and eluted in 50 μl of Elution buffer C.  
 
PCR amplification of the Tet3 promoter region was performed with Q5 high fidelity DNA 
polymerase. A reaction mix containing 2 μl of purified DNA template, 5 μl Q5 buffer, 5 μl 
Q5 GC Enhancer buffer, 0.5 μl 10 mM dNTPs, 2.5 μl 10 μM primers (forward and 
reverse), 0.5 μl polymerase was made up to a total reaction volume of 25 μl with 
RNase/DNase-free water. Primers used were as follows (given 5’-3’): forward 
GGGTCATCTGGTGGATCTTC and reverse GACACCGCTAGAACACAGCA. 
Thermocycler conditions were as follows: initial denaturation (98 °C, 30 secs) and cycles 
of denaturation (98 °C, 10 secs), annealing (66 °C, 20 secs) and extension (72 °C, 30 
secs) with a final extension phase (72 °C, 2 mins). ChIPs for H3K27me2, H3K27me3 
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and H3K4me3 were amplified for 28 cycles and Tet1 for 30 cycles. Amplification products 
were visualised by agarose gel electrophoresis. 
 
 Microarray analysis  
 
To assess the influence of Tet enzymes upon early cellular differentiation, a microarray 
was performed enabling simultaneous wide-spread gene expression analysis. 
GeneChip technology fundamentally works by incorporating a fluorescent dye into 
copies of the sample and hybridising these to selected probes on an array chip, which is 
then scanned to produce an image file that can be analysed.  
 
A microarray was performed from RNA isolated from day 2-differentiated P19 cells 
overexpressing Tet1, Tet2 and Tet3 (pcDNA™ 3.1 control was also included). The 
Affymetrix Mouse Transcriptome Array (MTA) 2.0 was performed and analysed by 
AROS Applied Biotechnology from pooled triplicate samples. Quality control analysis 
was performed on RNA samples prior to proceeding with the array.  
 
 5’Rapid Amplification of cDNA ends  
 
To identify the transcriptional start sites of the Tet3 gene, 5’Rapid Amplification of cDNA 
ends (5’RACE) was performed using SMARTer RACE 5’/3’ kit (ClonTech) according 
to manufacturer’s instructions.  
 
In brief, 5’RACE ready cDNA was prepared from 1 g of mRNA from day 7-differentiated 
mESCs. Here, first strand cDNA synthesis was primed with an oligo dt18 primer using 
SMARTScribe Reverse Transcriptase, once the 5’end of the RNA is reached, an 
additional few nucleotides are added to the 3’end of the first strand cDNA. This extended 
cDNA tag serves as a template for the SMARTer II A oligonucleotide to anneal and be 
reverse transcribed. This generates a cDNA copy of the original RNA with an additional 
tagging sequence at the end. Next, 5’RACE ready cDNA was PCR amplified using a 
universal primer mix (provided in the 5’RACE kit) and a gene-specific primer against 
mouse Tet3 (5’-3’: TCTCTAGCACCATTGACCGGCGCCCCTG). A second PCR 
reaction using the universal short primer (provided in the 5’RACE kit)) and nested 
primers targeted against the potential Tet3 variants were performed (Tet3 downstream 
(5’-3’: TGGCCCTGAGTCCATCTGAC) and Tet3 upstream (5’-3’: 
CGCCAAGGGCACCTGAAACTGGC)). PCR products were visualised by gel 
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electrophoresis and extracted using the QIAquick gel extraction kit (Qiagen) according 
to manufacturer’s instructions.  
 
PCR products were ligated into a pGEM-T easy vector system (Promega). This 
linearised vector has a single terminal T overhang at both ends enabling efficient ligation 
to PCR products with a terminal A overhang. TA ligations were performed in a reaction 
mix containing 3 l of insert, 1 l of pGEM-T vector, 5 l of 2X rapid ligation buffer and 
1 l of T4 DNA ligase. Ligations were incubated overnight and transformed as described 
in section 2.17.1 below. Bacteria was spread onto ampicillin (100 g/ml) agar plates 
containing 100 l of X-gal (Thermo Scientific) and incubated overnight at 37 C. 
Successfully ligated products have a disrupted non-functional -galactosidase gene that 
can be readily detected by white colonies in the presence of X-gal. If no insert is present, 
the -galactosidase gene is active and can cleave X-gal to form blue colonies. A 
minimum of 6 positive clones were picked and cultured overnight at 37 C under 
agitation. Plasmid DNA was purified using a QIAPrep Spin Miniprep kit (Qiagen) 
according to manufacturer’s instructions and bi-directionally Sanger sequenced (Source 
BioScience) using M13 forward (GTTTTCCCAGTCACGAC) and reverse sequencing 
primers (CAGGAAACAGCTATGAC).   
 
 Luciferase reporter constructs  
 
Luciferase reporter systems enable the instantaneous activity of cloned putative 
promoter sequences to be measured, thereby providing a measure of transcriptional 
activity. The regulatory region of a gene is cloned upstream of the luciferase gene driving 
its expression, thus when introduced into cells the amount of luciferase available is 
directly proportional to promoter activity. Once cells are lysed in the presence of luciferin 
substrate, the luciferase enzyme coverts luciferin into oxyluciferin and the light emitted 
is detected.  
 
2.17.1 Tet3 putative promoter cloning  
 
DNA Amplification  
 
Tet3 putative promoter regions were amplified from 200 ng of mouse genomic DNA or 
from 100 ng of a Tet3 bacterial artificial chromosome (BAC) clone (RP23-331I23). Note, 
for the deletion series, sequences were amplified from 100 ng of the previously cloned 
longer constructs. Primer sequences and amplification conditions for each putative 
promoter fragment are shown in Table 4 and Table 5. PCR products were visualised by 
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gel electrophoresis, cut out and purified using the QIAquick gel extraction kit according 
to manufacturer’s instructions. PCR products were eluted in 30 l of RNase/DNase-free 
water.  
 
Digestion and Ligation  
 
PCR products and the pGL4.2 luciferase reporter construct (Promega) were double 
digested using BglII (New England Biolabs) and XhoI (New England Biolabs) in NEBuffer 
3.1 (New England Biolabs) (restriction enzymes were selected for use in molecular 
cloning based upon their capacity to function in the same reaction buffer). Typically, 25 
l of the purified PCR product and 1 g of vector DNA was digested with 1 l of BglII, 1 
l of XhoI and 5 l of 10X reaction buffer, made up to a total reaction volume of 50 l 
with RNase/DNase-free water. Digestion reaction were incubated for a minimum of 1 hr 
at 37 C. To prevent self-ligation of plasmid DNA, luciferase vectors were treated with 3 
l of shrimp alkaline phosphatase (SAP) (Promega) for at least 1 hr at 37 C. Digested 
PCR products and vectors were purified by gel electrophoresis and extracted with the 
QIAquick gel extraction kit.  
 
Ligation reactions were set up for each vector and insert to have a respective molar ratio 
of 1:0, 1:1, 1:3 and 1:5. Each reaction also contained 1 l of 10X T4 DNA ligase buffer 
(Promega) and 1 l of T4 DNA ligase (Promega), made up to a total of 10 l in 
RNase/DNase-free water. Ligation reactions were conducted overnight at room 
temperature.  
 
Transformation and colony PCR  
 
5 l of ligation product was mixed with 50 l of competent JM109 bacteria cells 
(Promega) and incubated on ice for 1 hr. Bacteria was heat shocked (42 C, 60 secs), 
placed back on ice for (5 min) and incubated with 400 l LB under agitation (37 C, 1 hr). 
150 l of LB-containing bacteria was spread on to ampicillin (100 g/ml) agar plates and 
incubated overnight at 37 C. Colonies were picked, and each mixed into 20 l of 
RNase/DNase-free water and 4 ml of LB containing ampicillin (100 g/ml). Bacteria-
containing water samples were heated (100 C, 5 mins), cell debris centrifuged (800 G, 
5 mins) and 5 l of lysate taken as template DNA to confirm the presence of the correct 
insert by PCR analysis. Each PCR reaction was performed for 25 cycles under the same 
optimised conditions used for initial DNA amplification (see Table 5). 
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Potential positive colonies were grown in the 4 ml of LB containing ampicillin (100 g/ml), 
under agitation overnight at 37 C. Plasmid DNA was purified using a QIAPrep Spin 
Miniprep kit according to manufacturer’s instructions. Diagnostic restriction digestions on 
500 ng of plasmid DNA were performed to confirm the presence of an insert (visualised 
by gel electrophoresis) (see Figure 2:7A). To verify whether this is the correct insert, 
plasmid constructs were bi-directionally Sanger sequenced) using a forward primer 
(Reporter vector primer 3 (Promega): CTAGCAAAATAGGCTGTCCC) upstream of the 
multiple cloning site on the pGL4.2 vector and the corresponding reverse cloning primer 
for the amplified insert. 2 ml from the starter culture of positive clones were added to 150 
ml of LB containing ampicillin (100 g/ml) and incubated overnight at 37 C. Glycerol 
stocks were made by mixing the bacteria culture with sterilised glycerol in a 1:1 ratio 
before being stored at -80 C. Plasmid DNA was purified using a HiSpeed plasmid 
maxi purification kit according to manufacturer’s instructions.  
 
TA cloning  
 
In some instances where the above cloning approach was unsuccessful, PCR products 
were firstly ligated into a pGEM-T easy vector system. Note, PCR amplification 
requires the use of a non-proofreading DNA polymerase. Products amplified with the 
proof reading Hercules II Fusion DNA polymerase (Agilent), were subsequently PCR 
amplified with Taq DNA polymerase (New England Biolabs) to produce A overhangs 
(see Table 5 for cycling conditions). TA ligations were performed as described in section 
2.16 and transformed as described above. Bacteria was spread onto X-gal containing 
ampicillin (100 g/ml) agar plates and incubated overnight at 37 C for blue/white 
screening (see Figure 2:7B). 3-5 white colonies were picked, cultured and plasmid DNA 
purified using a QIAPrep Spin Miniprep kit. The process of cloning into the pGL4.2 vector 
followed the steps outline above, beginning with the digestion and purification of inserts 













2.17.2 Transfection of luciferase constructs  
 
Cells were seeded onto 24-well tissue culture plates at a density of 60,000 cells/well for 
P19, SH-SY5Y and mESCs and 50,000 cells/well for H9c2 cells in 1 ml of medium. 24 
hrs post plating cells were transfected with 1 μg of firefly luciferase construct DNA and 
0.25 μg of a Renilla Luciferase construct, driven by the HSV-thymidine kinase reporter 
(pRL-TK) (Promega), as a co-transfected control. P19 cells were transfected with 
Fugene HD, and SH-SY5Y and H9c2 cells with TurboFect™, in ratio of DNA (g) to 
reagent (l) of 1:3 and 1:2 respectively. DNA was mixed with OptiMEM, and then 
transfection reagent added, to give a total volume of 100 μl. Following a 15 min 
incubation, 100 μl of transfection mix was added to each well, culture plates gently 
swirled and incubated at 37 °C in a CO2 incubator. mESCs were transfected with 
Lipofectamine LTX with Plus Reagent (Thermo Scientific), each transfection was 
prepared as follows: 3 l of LTX reagent was prepared in OptiMEM (total volume of 50 
μl) and combined with a pre-prepared mix of DNA and Plus Reagent (in a 1:1 ratio of 
DNA (g) to reagent (μl)) in 50 μl of OptiMEM. After an incubation for 5 mins, DNA-lipid 
complexes were added to cells (100 μl/transfection), culture plates gently swirled and 
incubated at 37 °C in a CO2 incubator. For low O2 investigations cells were exposed to 
1% O2 directly after the transfection mix was added to cells.  
Figure 2:7 Molecular cloning. (A) Diagnostic digestion of the pGL4.2 luciferase 
vector to confirm the presence of the Tet3 upstream extension B insert (lanes 3-7). 
An empty pGL4.2 vector and its double digested linearised form is shown in lane 1 
and 2 respectively. (B) The Tet3 upstream insert was ligated into the pGEM-T easy 
vector system, transformed into JM109 competent cells and spread onto ampicillin 
agar plates containing X-gal. White colonies contain a successfully ligated insert.  
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The activity of luciferase constructs was also investigated in differentiating P19 and 
mESCs. Cells were plated in T25 culture flasks at a density of 0.625 x106 cells/flask and 
1.25 x106 cells/flask for P19 and mESCs respectively. 24 hrs later cells were transfected 
as described above, but for each transfection the amount of DNA was increased to 6 μg 
for the firefly luciferase reporter and to 1.5 μg for the pRL-TK control (transfection 
reagents were scaled accordingly). 24 hrs post-transfection cells were split equally into 
3 100 mm2 non-tissue culture grade dishes to induce differentiation and incubated at 37 
°C in a CO2 incubator, as described in sections 2.2.1 and 2.2.2.  
 
For all assays the pGL4.2 empty vector was included to control for background luciferase 
activity. For each assay a minimum of 4 technical replicates for each tested construct 
was conducted, which for the majority of studies was performed independently a 
minimum of 3 times.  
 
2.17.3 Luciferase assays  
 
Luciferase assays were conducted using the Dual-Glo Luciferase Assay System 
(Promega) according to manufacturer’s instructions. In brief, 24 hrs post transfection cell 
medium was aspirated and 75 μl of PBS and 75 μl of the Dual-Glo Luciferase Reagent 
(warmed to room temperature) was added to each well. For differentiating cells, 
aggregates were gently centrifuged (800 G), medium aspirated and re-suspended in the 
PBS and Dual-Glo substrate mix. Following a 10 min incubation, under agitation, 140 
μl of lysate was transferred to a single well of a 96-well flat bottomed white opaque plate 
(Corning) and firefly luminescence signal read on a Mithras LB 940 luminometer 
(Berthold Technologies). 70 μl of Dual-Glo Stop  Glo Reagent was added to each 
well for 10 mins under agitation and the Renilla luciferase signal read. The activity of the 
firefly luciferase constructs were normalised to the Renilla signal and expressed relative 
to the pGL4.2 empty vector construct.  
 
 Animal Husbandry  
 
Mice were housed in a standard temperature and humidity controlled animal facility with 
a 12 hr light/dark cycle (daylight from 7 am to 7 pm). In accordance with Housing and 
Care of Animals Used in Scientific Procedures Code of Practice, mice were allowed free 
access to water and standard laboratory chow. All experimental mice used were on a 
C57BL/6 background. Animals were killed according to Schedule 1 methods and tissues 
harvested as required.  
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 Data analysis  
 
Each experiment was performed to include at least a minimum of a technical triplicate, 
and where possible was biologically repeated 3 times. Data was statistically analysed 
and made into figures using GraphPad Prism 7 software. Data containing 2 groups was 
analysed by an un-paired student t-test. Data containing more than 2 groups where 
analysed by a one-way ANOVA with post-hoc analysis. A Dunnett’s test was used when 
comparisons were made to a control group, whereas a Tukey test was used to compare 
all sample groups to each other. In some instances where there were 2f changing 
variables a two-way ANOVA was utilised. In these circumstances the Sidak multiple 
comparison test was also used to enable comparisons between selected groups of data. 
Where possible, data was expressed at mean  standard error of the mean (SEM).  
 
Next-generation sequence analysis was performed using BaseSpace software (Illumina) 
and Galaxy software (https://usegalaxy.org) against the mouse mm10 reference 

























30% Acrylamide 2500 5000 680 680 
1.5 M Tris-HCl pH 8.8 
 
2500 2500 - - 
1 M Tris-HCl pH 6.8 
 
- - 500 500 
10% Sodium Dodecyl 
Sulfate (SDS) 
100 100 40 40 
10% Ammonium persulfate 
(APS) 
100 100 40 40 
Tetramethylethylenediamine 
(TEMED) 
10 10 4 4 






5-mC (Actif Motif, 39649) 
DB: 1:1000 in Odyssey® 
blocking buffer (PBS) 
5-hmC (Actif Motif, 39770) 
DB: 1:10000 in 10% milk 
PBS/T 
TET1(Millipore, 09-872) 
WB: 1:1000 in 5% milk 
TBS/T 
ChIP: 1:50 
TET2 (AbCam, ab94580) 
WB: 1:1000 in 5% milk 
TBS/T 
TET3 (AbCam, ab139311) 
WB: 1:500 in 5% milk 
TBS/T 
H3K27me2 (Cell Signalling, 9728) 
WB: 1:1000 in 10% milk 
TBS/T 
H3K27me3 (Actif Motif, 39155) 
WB: 1:1000 in 10% milk 
TBS/T 
ChIP: 1:50 
H3K4me3 (Cell Signalling, 9751) 
WB: 1:1000 in 5% BSA 
TBS/T 
ChIP: 1:50 
HIF (Thermo Scientific, 16511) 
WB: 1:1000 in 10% milk 
PBS/T 
FLAG (Sigma, F3165) 
WB: 1:1000 in 10% milk 
TBS/T 
-ACTIN (Sigma, A5316) 
WB: 1:5000 in 10% milk 
TBS/T 
-TUBILIN (Sigma, T5168) 





Table 1: Western blot gel casting reagents  
 
Table 2: List of primary antibodies. DB: dot-blot, WB: western-blot, ChIP: 
chromatin immunoprecipitation, TBS/T: Tris-buffered salt solution containing 
0.1% tween-20, PBS/T: Phosphate buffered saline containing 0.1% tween-20, 








Gene Forward primer 5’-3’ Reverse primer 5’-3’ 
-III tubulin TTTTCGTCTCTAGCCGCGTG GATGACCTCCCAGAACTTGGC 
Brachyury GTATTCCCAATGGGGGTGGCT CGAGCCTCCAAACTGAGGG 
Canx TTCCAGACCCTGSTGCAGA TCCCATTCTCCGTCCATATC 
Dcx ACGACCAAGACGCAAATGGA CTTCTGCTTCCGCAGACTTC 
Dnmt3b CCCTCCCCCATCCATAGT TCTGCTGTCTCCCTTCATTGT 
Ezh2 CAGGCTGGGGCATCTTTATC ACGAATTTTGTTGCCCTTTC 
Fabp7 AACCAGCATAGATGACAGAAACTG ACTTCTGCACATGAATGAGCTT 
Foxa2 CATCCGACTGGAGCAGCTA TGTGTTCATGCCATTCATCC 
Foxj3 TGAACAGTGTTGGAAGTGTACATAGT CTGCTGCTGCTGAGGTGTT 
Gapdh GGGTTCCTATAAATACGGACTGC CCATTTTGTCTACGGGACGA 
Gata2 CTCCAGCTTCACCCCTAAGC ACCACAGTTGACACACTCCC 
Gata4 GGAAGACACCCCAATCTCG CATGGCCCCACAATTGAC 
Gdf3 GGGTGTTCGTGGGAACCT CCATCTTGGAAAGGTTTCTGT 
Glut1 GGCGGGACACGCATAGTT ACATGAGGCGGCCCGT 
Glut3 GACCCGAGGAACACTTGCTG CGAACACCAGAGATGGGGTC 
Gulo AAGCCGGTATCCTCCTGACT CCACCAACCGTCACATCAGA 
Hand1 CGGAAAAGGGAGTTGCCTCA GGTGCGCCCTTTAATCCTCT 
Hes5 CCCAAGGAGAAAAACCGACT TGCTCTATGCTGCTGTTGATG 
Hnf4a ACACCACCCTGGAGTTTGAA GCCCAGGCTGTTGGATGAAT 
Lefty1 CAGCTCGATCAACCGCCAGT GGCTGGCATGGCTGTGTT 
Map2 TTCCCTCGTTTCTTCGGTCG GCACACAGCACAGCCTGG 
Mesp1 CGCCTGCCTACCCTAGAC TGAAGAGCGGAGATGAGGGA 
Myh7 AGCAGCAGTTGGATGAGCGACT CCAGCTCCTCGATGCGTGCC 
Nanog AAGGATGAAGTGCAAGCGGT GGTGCTGAGCCCTTCTGAAT 
Ncam1 AAGTACAGAGCGCTCGCC AGGGACTTGAGCATGACGTG 
Nestin AGGCGCTGGAACAGAGATTG CACAGCCAGCTGGAACTTTT 
NeuroD CGAGGCTCCAGGGTTATGAG TTGGTCATGTTTCCACTTCCTGT 
Nppa CAACACAGATCTGATGGATTTCA CCTCATCTTCTACCGGCATC 
Oct4 GTTGGAGAAGGTGGAACCAA CTCCTTCTGCAGGGCTTTC 
Snail1 GTCTGCACGACCTGTGGAAA GGTCAGCAAAAGCACGGTTG 
Sox2 GCACATGAACGGCTGGAGCAACG TGCTGCGAGTAGGACATGCTGTAGG 
Sox7 AGATGCTGGGAAAGTCATGG AGAGGGAGCTGAGGAGGAAG 
Svct1 CGGGTGCCTTGCTTTCATAC CTGGCTGACGTCTCACTGTT 
Svct2 GTGCGATCGGCGGGAC ACCAGGGACACTGGAGTCTT 
Tbx5 AGCACTTCTCCGCTCATTTCAC TGAGGTCTGGTGCTGAAACATC 
Tet1 GAGCCTGTTCCTCGATGTGG CAAACCCACCTGAGGCTGTT 
Tet1 h CCGAATCAAGCCGAAGAATA CCTGGAGATGCCTCTTTCAC 
Tet2 TGTTGTTGTCAGGGTGAGAATC TCTTGCTTCTGGCAAACTTACA 
Tet3 CCGGATTGAGAAGGTCATCTAC AAGATAACAATCACGGCGTTCT 
Tet3 down GGCCGATGCAGTAGTTGGAG TTGACAGTCGCCCCTTGT 
Tet3 h CCATTGCAAAGTGGGTGA CGCACCAGGCAGAGTAGC 





































































CCTTCTCGAGGTTAACCCTCCCTACCCACC GCTTCAGATCTCAAAGGGGCAAAGTTTCCCA 1.50 
Tet3 upstream 
deletion A 
CCTTCTCGAGGTTAACCCTCCCTACCCACC GCTTCAGATCTTTCCTGCCACTCCCTGCGAG 0.92 
Tet3 upstream 
extension A 
CCTTCTCGAGGTTAACCCTCCCTACCCACC GCTTCAGATCTATGATGGAGAAGGCTACGCT 2.36 
Tet3 upstream 
extension B 
CCTTCTCGAGGACTGTTGATATTTCCATAC GCTTCAGATCTCAAAGGGGCAAAGTTTCCCA 2.95 
Tet3 upstream 
deletion 1A 
CCTTCTCGAGGTTAACCCTCCCTACCCACC GCTTCAGATCTCCTCAGAGGGAGGTACATAG 2.20 
Tet3 upstream 
deletion 2A 
CCTTCTCGAGGTTAACCCTCCCTACCCACC GCTTCAGATCTCTCGCTCATTTGGAGTGGAC 1.97 
Tet3 upstream 
deletion 3A 
CCTTCTCGAGGTTAACCCTCCCTACCCACC GCTTCAGATCTGGGTCGCTGGCTACCCTG 1.65 
Table 4: A list of cloning primers for amplification of the Tet3 putative 
promoter regions. Cloning primers contain a leader sequence, shown in italics, 
a restriction enzyme site, underlined, and a complementary sequence to the 













200 ng mouse genomic DNA, 0.5 l 10 mM 
dNTPs (Promega), 1.25 l 10 M forward primer, 
1.25 l 10 M reverse primer, 10 l 5X Hercules II 
reaction buffer (Agilent), 0.4 l DMSO and 1 l 
Hercules II Fusion DNA polymerase (Agilent), 
made up to a 50 l volume with RNase/DNase-
free water 
Initial denaturation (95 C, 2 mins), followed by 
30 cycles of denaturation (95 C, 20 secs), 
annealing (65 C, 20 secs), extension (72 C, 2.5 





100 ng Tet3 downstream construct, 12.5 l 2X 
REDTaq (Sigma), 1.25 l 10 M forward primer, 
1.25 l 10 M reverse primer, made up to 25 l 
volume with RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 
30 cycles of denaturation (94 C, 20 secs), 
annealing (55 C, 20 secs), extension (72 C, 2 





100 ng Tet3 downstream construct, 12.5 l 2X 
REDTaq, 1.25 l 10 M forward primer, 1.25 l 10 
M reverse primer, made up to 25 l volume with 
RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 
30 cycles of denaturation (94 C, 20 secs), 
annealing (55 C, 20 secs), extension (72 C, 2 





100 ng Tet3 downstream construct, 12.5 l 2X 
REDTaq, 1.25 l 10 M forward primer, 1.25 l 10 
M reverse primer, made up to 25 l volume with 
RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 
30 cycles of denaturation (94 C, 20 secs), 
annealing (55 C, 20 secs), extension (72 C, 2 







200 ng mouse genomic DNA, 0.5 l 10 mM 
dNTPs, 1.25 l 10 M forward primer, 1.25 l 10 
M reverse primer, 10 l 5X Hercules II reaction 
buffer, 0.8 l DMSO and 1 l Hercules II Fusion 
DNA polymerase, made up to a 50 l volume with 
RNase/DNase-free water 
Initial denaturation (95 C, 2 mins), followed by 
30 cycles of denaturation (95 C, 20 secs), 
annealing (48C, 20 secs), extension (72 C, 2 








100 ng Tet3 upstream construct, 12.5 l 2X 
REDTaq, 1.25 l 10 M forward primer, 1.25 l 10 
M reverse primer, made up to 25 l volume with 
RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 
30 cycles of denaturation (94 C, 20 secs), 
annealing (62 C, 20 secs), extension (72 C, 2 
mins), and a final extension phase (72 C, 3 
mins) 
 







200 ng Tet3 BAC clone, 2.5 l 10 mM dNTPs, 2.5 
l 10 M forward primer, 2.5 l 10 M reverse 
primer, 10 l 5X Hercules II reaction buffer, 10 l 
betaine and 1 l Hercules II Fusion DNA 
polymerase, made up to a 50 l volume with 
RNase/DNase-free water 
 
For TA cloning: 4 l of Hercules II amplified PCR 
product, 0.5 l 10 mM dNTPs, 0.5 l 10 M forward 
primer, 0.5 l 10 M reverse primer, 2.5 l of 10X 
standard Taq reaction buffer (New England 
Biolabs), 1 l Taq polymerase (New England 
Biolabs), made up to a 25 l volume with 
RNase/DNase-free water 
Initial denaturation (95 C, 2 mins), followed by 30 
cycles of denaturation (95 C, 20 secs), annealing 
(52C, 20 secs), extension (72 C, 3 mins), and a 
final extension phase (72 C, 3 mins) 
 
For TA cloning: Initial denaturation (95 C, 30 
secs), followed by 10 cycles of denaturation (95 
C, 20 secs), annealing (52C, 30 secs), extension 
(68 C, 3 mins), and a final extension phase (68 





Tet3 upstream  
extension B 
200 ng Tet3 BAC clone, 2.5 l 10 mM dNTPs, 2.5 
l 10 M forward primer, 2.5 l 10 M reverse 
primer, 10 l 5X Hercules II reaction buffer, 10 l 
betaine and 1 l Hercules II Fusion DNA 
polymerase, made up to a 50 l volume with 
RNase/DNase-free water 
 
For TA cloning: 4 l of Hercules II amplified PCR 
product, 0.5 l 10 mM dNTPs, 0.5 l 10 M forward 
primer, 0.5 l 10 M reverse primer, 2.5 l of 10X 
standard Taq reaction buffer, 1 l Taq polymerase, 





Initial denaturation (95 C, 2 mins), followed by 30 
cycles of denaturation (95 C, 20 secs), annealing 
(52C, 20 secs), extension (72 C, 3 mins), and a 
final extension phase (72 C, 3 mins) 
 
For TA cloning: Initial denaturation (95 C, 30 
secs), followed by 10 cycles of denaturation (95 
C, 20 secs), annealing (52C, 30 secs), extension 
(68 C, 3 mins), and a final extension phase (68 





100 ng Tet3 upstream extension A, 2.5 l 10 mM 
dNTPs, 2.5 l 10 M forward primer, 2.5 l 10 M 
reverse primer, 10 l 5X Hercules II reaction buffer, 
10 l betaine and 1 l Hercules II Fusion DNA 
polymerase, made up to a 50 l volume with 
RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 30 
cycles of denaturation (95 C, 20 secs), annealing 
(52C, 20 secs), extension (72 C, 3 mins), and a 




100 ng Tet3 upstream extension A, 2.5 l 10 mM 
dNTPs, 2.5 l 10 M forward primer, 2.5 l 10 M 
reverse primer, 10 l 5X Hercules II reaction buffer, 
10 l betaine and 1 l Hercules II Fusion DNA 
polymerase, made up to a 50 l volume with 
RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 30 
cycles of denaturation (95 C, 20 secs), annealing 
(52C, 20 secs), extension (72 C, 2.5 mins), and 




100 ng Tet3 upstream extension A, 2.5 l 10 mM 
dNTPs, 2.5 l 10 M forward primer, 2.5 l 10 M 
reverse primer, 10 l 5X Hercules II reaction buffer, 
10 l betaine and 1 l Hercules II Fusion DNA 
polymerase, made up to a 50 l volume with 
RNase/DNase-free water 
 
Initial denaturation (95 C, 2 mins), followed by 30 
cycles of denaturation (95 C, 20 secs), annealing 
(52C, 20 secs), extension (72 C, 2 mins), and a 












Table 5: PCR reaction and amplification conditions for Tet3 promoter 
cloning 
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Chapter 3: Results 1; The Role of O2 and 


















































 Introduction  
 
The differentiation of ESCs in vitro into 3-dimensional cell aggregates, termed EBs 
recapitulates the early stages of embryonic development. A commonly used and robust 
way to induce EB formation is to plate ESCs in suspension on a non-adherent surface. 
Cells self-assemble themselves together via cell-cell adhesions298,299, proliferate and 
spontaneously differentiate300. The formation of the spheroid structure of EBs in part 
mimics the early embryo and provides a model to study the mechanisms controlling the 
spacio-temporal patterns of gene expression. Specifically, the way in which cells become 
asymmetrically or unequally distributed is poorly understood, but the significance of 
morphogen gradients has long been suggested301. O2 is an important regulator of 
embryogenesis and is considered a developmental morphogen69, yet fundamentally how 
this is sensed to enable developmental patterning remains to be fully elucidated.  
 
3.1.1 Tet activity and O2 
 
Tet enzymes as described in detail previously (see Chapter 1: General Introduction) 
belong to members of the 2-OGDO family. The activity of this group of enzymes is 
absolutely dependent upon its substrates, 2-OG and O2302. Therefore, alterations in the 
available levels of these substrates have the capacity to alter the activity of these 
enzymes and potentially elicit a biological response. Perhaps the most studied example 
of this is the dioxygenase component of HIFs, PHDs, whose hydroxylation activity is 
inhibited in low [O2], resulting in the stabilisation and activation of HIF to enable its 
downstream signalling. Unlike PHDs, the ability of Tets to act as cellular O2 sensors 
remain to be elucidated.  
 
To be an O2 sensor an enzyme must have a high Km (the concentration of substrate 
required for an enzyme to achieve half its maximal response (Vmax)) and thus a low 
affinity for O2, so that its activity can be varied over physiological changes in [O2]. The 
Km of Tet1 and Tet2 has been calculated to approximately 30 M303 (equating to 3% 
O2). This suggests Tet1 and 2 have a high affinity for O2, which in some instances in the 
developing embryo may allow them to be catalytically active, but considering the 
physiological [O2] may be as low as 1% O270,71, these enzymes could demonstrate spatial 
inhibition. However, it should be considered that the calculated Km for PHDs were 
between 230 and 250 M, which exceeds the [O2] in air304 (200 M, calculated in air-
saturated aqueous buffer at 37 C305). These Km values are determined from in vitro 
enzymatic measurements via detection of 14CO2 release from 2-oxo-[1-14C]-glutarate. A 
caveat underpins this methodology in that the enzyme-substrate is most likely to bind 
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O2, thus this order of binding implies the substrate bound to the enzyme could affect the 
Km of O2306,307. This is in agreement with crystallography data on FIH-1, whereby the 
preformed enzyme-Fe2+-2-OG substrate complex was found to bind O2308, thereby 
suggesting Km values should be considered with caution. 
 
A recent study, which to date provides the most in-depth insight into O2 and Tet activity, 
revealed exposure of mESCs to 0.5% O2, compared to atmospheric controls, reduced 5-
hmC levels in mESCs309. Further, 5-hmC loss was also confirmed from hypoxic tumours, 
and was subsequently found to be associated with hypermethylated gene promoters309. 
This study also attempted Km calculations through measuring the conversion of 5-mC to 
5-hmC of recombinant purified Tet1 and Tet2, exposed to decreasing [O2]. Km values of 
0.31% and 0.53% O2 was determined for Tet1 and Tet2 respectively309, which highlights 
a high affinity for O2, which may suggest an unlikelihood of such enzymes to be 
physiological O2 sensors. However, the catalytic activity of all 3 paralogues in response 
to O2, in a cellular model, remain unexplored, and furthermore, the concept of these 
enzymes as O2 sensors in embryogenesis remain to be elucidated.  
 
3.1.2 Cellular metabolites and Tet activity  
 
Cancer studies have revealed mutations in 2 TCA cycle genes, fumarate hydratase (FH) 
and succinate dehydrogenase (SDH)310,311, result in accumulation of fumarate and 
succinate respectively. These substrates have been shown to be competitive inhibitors 
of 2-OGDO enzymes, which include the Tets312 (Schematically shown in Figure 3:1). 
Specifically, these metabolites have been shown to achieve potent IC50 values between 
400-500 M for Tet1 and Tet2303 and have been shown to have a functional affect by 
altering genome-wide DNA methylation profiles312. 
 
Succinate and fumarate also have been shown to inhibit PHDs, by stabilising HIF and 
activating subsequent downstream signalling, thereby acting as a ‘pseudo-hypoxic’ 
response, enhancing angiogenesis and anaerobic metabolism in tumours313,314,315,316. 
The ability of these TCA metabolites to induce a ‘hypoxic response’ may also arise from 
changes in cellular energetics in response to O2. The metabolic state of the cell is 
dependent upon [O2], which is required for ATP production via the OxPhos pathway. To 
sustain cell viability if [O2] decreases, a metabolic switch from OxPhos to anaerobic 
glycolysis occurs, to maintain, albeit inefficiently, ATP generation317,318. This would thus 
result in a decrease in TCA metabolites, reducing levels of the 2-OGDO co-substrate 2-
OG, and therefore potentially reducing enzymatic activity. Furthermore, levels of 
succinate in the mitochondrial matrix has been demonstrated to increase from 0.5 mM 
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to 6 mM under ischemic conditions in vivo319,320. Therefore, a low [O2] may induce indirect 
regulation of Tet activity through altering the metabolic signature of the cell and hence 















Figure 3:1 TCA cycle substrates inhibit 2-OGDOs. Pyruvate, the product of 
glycolysis, is converted to acetyl coA, which enters the TCA cycle and is converted 
to high energy intermediates. This energy is harvested through electron transport by 
the oxidative phosphorylation (OxPhos) pathway where it is converted to ATP. 
Fumarate and succinate are inhibitors of 2-OGDOs and have specifically been 
shown to inhibit PHDs, resulting in the stabilisation of HIF and Tet enzymes, resulting 
in reduced hydroxylation and thus DNA hypermethylation. 
PDH: pyruvate dehydrogenase, CS: citrate synthase, ACH: aconitate hydratase, 
IDH: isocitrate dehydrogenase, OGDH: oxoglutarate dehydrogenase, SCS: 
succinyl-coA synthetase, SDH: succinate dehydrogenase, FH: fumarate hydratase, 






3.1.3 Distinct roles of Tet1, Tet2 and Tet3 in cellular differentiation  
 
Tet proteins are functionally intrinsic to embryogenesis, detailed within Chapter 1: 
General Introduction. However, the precise role of each individual paralogues in cellular 
differentiation remains largely unknown, in part due to the functional redundancy 
between Tet paralogues and the variety of cell culture conditions utilised in cellular 
differentiation models. The general accepted dogma (in part owing to their expression 
profiles) is that Tet1 and Tet2 are involved in the pluripotency and self-renewal 
processes, whereas Tet3 is implicated in differentiation events252,321,322. 
 
The limited studies that have been reported have attempted to delineate between the 
functional roles of each paralogue. For example, in mESCs Tet1 and Tet2 have been 
shown to regulate 5-hmC at different genomic locations, Tet1 is responsible for 5-hmC 
production at promoter regions, whereas Tet2 regulates 5-hmC deposition at gene 
bodies323. This may potentially account for the functional differences determined from 
the loss-of-function studies in mESCs of Tet1 and Tet2, whereby differential skewing 
towards the endoderm/mesoderm/trophoblast lineage and towards the neuroectoderm 
respectively, was reported252. In agreement with this, it was independently shown that 
Tet1 depleted mESCs also skewed differentiation towards the trophectoderm251 and 
Tet2 silenced hESCs altered differential patterning towards the neuroectodermal 
lineage324.  
 
Tet3 has been implicated in cellular specification, and specifically induction of 
neurogenesis325, a topic that is covered in Chapter 5: Results 3. However, it is important 
to highlight here that the silencing of Tet3 in mESC and in neural progenitor cells (NPCs), 
resulted in impairment of neuronal differentiation and the formation of terminal 
differentiated neurones respectively321. More recently, it has also been shown that when 
induced to differentiate along a neural lineage, Tet3-deficient mESCs could skew 
differentiation away from the neuroectoderm and towards the mesodermal lineage322. In 
addition to neural specification, Tet3 is also linked to differentiation events including 
erythroid differentiation326 and eye formation327. Thus, it can be inferred Tet3 has specific 











To investigate the effects of low [O2] upon cellular differentiation and determine whether 
any identified gene expression changes may in part be regulated by Tet enzymes. To 
evaluate this, the aim is to determine the ability of Tet enzymes to function as O2 sensors, 
and consider their potential to differentially regulate developmental genes during cellular 







































 Results  
 
3.3.1 P19 cells form all three germ layers when induced to differentiated into 
embryoid body-like cell aggregates  
 
Murine P19 embryonal carcinoma cells, derived from teratocarcinoma-induced mice, are 
pluripotent cells that can differentiate into cell types of all 3 germ layers and thus 
resemble early embryonic cells328,329. These cells are easily expanded and maintained 
in an undifferentiated state, but can also be efficiently induced to differentiate, thereby 
providing a model to begin to elucidate the effect of O2-dependent signalling upon 
cellular differentiation.  
 
To characterise the patterns of lineage marker expression, P19 cells were induced to 
differentiate unbiasedly into EB-like aggregates and were harvested at days 3,7 and 11 
for QPCR analysis. Firstly, the expression of key pluripotent genes, Oct4330,331 and 
Nanog332–334 were confirmed in undifferentiated P19 cells (Figure 3:2). As might be 
expected, expression of Oct4 was decreased significantly at days 7 and 11, compared 
to undifferentiated cells. However, no significant change in Nanog expression was 
observed, although expression appeared to be decreased in a time-dependent manner 
from days 3 to 11.  
 
The expression of key germ layer markers were also assessed over the defined 
differentiation time course (Figure 3:3). Endodermal markers, Foxa2335 and Sox7336,337, 
displayed distinct expression profiles. Foxa2 was significantly elevated at day 3 to 
approximately 6-fold, relative to undifferentiated cells, and then decreased back to 
comparable expression levels of the undifferentiated state by day 11. In comparison 
Sox7 showed a burst of expression at day 7. Early mesodermal markers, Brachyury338, 
Hand1339 and Mesp1340 were all significantly elevated at day 3, with Brachyury showing 
the most extensive induction of around 90-fold. Expression was subsequently reduced 
to levels comparative of undifferentiated cells at day 7 for Brachyury and Mesp1 and day 
11 for Hand1. The expression of cardiac progenitor markers Tbx5341 and Gata4342 were 
significantly elevated at later time points, day 11 and 7 respectively. Ectodermal markers, 
specifically -III tubulin343 and Ncam1344 (despite not reaching significance) were also 
elevated at later time points (days 11 and 7 respectively). Other ectodermal markers, 
Nestin345, Foxj3346 and Map2347, showed little change over the entirety of the 
differentiation time course, and only Foxj3 displayed significantly reduced expression at 




Figure 3:2 Pluripotency marker mRNA expression during a time course of P19 
cell differentiation. P19 cells were differentiated over an 11 day time course and 
mRNA expression of Oct4 and Nanog assessed by QPCR analysis. Data are 
expressed as the mean  SEM and analysed by a one-way ANOVA with Dunnett’s 




Figure 3:3 mRNA expression of genes representative of all three germ layers 
during a time course of P19 cell differentiation. P19 cells were differentiated over 
an 11 day time course and mRNA expression of key lineage markers were assessed 
by QPCR. Data are expressed as the mean  SEM and for each gene analysed by 
a one-way ANOVA with Dunnett’s post-hoc analysis.  * p<0.05, ** p<0.01, *** 
p<0.001, **** p<0.0001 
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3.3.2 Chemically-mimicked hypoxia modulates gene expression of pluripotent 
and lineage markers in differentiating multipotent P19 cells  
 
To investigate the effects of O2-dependent signalling pathways upon cellular 
differentiation, P19 cells were induced to differentiate into EB-like cell aggregates in the 
presence of the non-specific 2-OGDO inhibitor DMOG348. Activation of low [O2] mediated 























In separate studies, cells were either differentiated for 4 days in the presence of DMOG 
or pre-treated with DMOG for 4 days and differentiated further till days 7 and 11. Cells 
were harvested for QPCR analysis and gene expression of pluripotent and lineage 
markers was assessed. These studies aimed to inform whether a constant mimicked 
hypoxic environment can alter the differentiation profile and/or whether an early hypoxic 
stimulus can affect cell specification at later time points.  
 
 
To identify whether DMOG induces or inhibits differentiation of P19 cells, expression of 
pluripotency markers was assessed (Figure 3:5). DMOG treatment significantly 
decreased Oct4, while trended to increase Nanog expression after 4 days. However, 
pre-treatment with DMOG augmented expression of both genes at day 7, but this was 
not significantly maintained by day 11. This suggests that an initial ‘hypoxic’ environment 
for 4 days with DMOG acted to maintain pluripotency until day 7 and therefore delayed 
the onset of differentiation. The expression of the endodermal markers (Figure 3:6), 
Figure 3:4 HIF-1 protein is induced by 1 mM Dimethyloxalylglycine treatment. 
Undifferentiated P19 cells were treated with 0.5 and 1 mM DMOG for 16 hrs, 
harvested and probed for HIF-1.   
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Sox7 and Foxa2 were respectively found to be decreased and unaffected after DMOG 
treatment at day 4. This effect was sustained for Sox7 at day 7 after pre-treatment of 
DMOG. In comparison, Foxa2 expression was lost at days 7 and 11 after DMOG pre-
treatment. Mesodermal markers displayed a more inconsistent profile (Figure 3:7), 
Hand1 was induced by 14-fold while Brachyury (despite failing to reach significance) 
trended to increase after 4 days of DMOG treatment. However, the expression of Gata4 
and Mesp1 was ablated at this time point. Pre-treatment with DMOG maintained this 
effect upon Brachyury and Gata4 expression till days 7 and 11 respectively, although it 
had an opposing effect on Hand1 expression at day 7. Ectodermal markers (Figure 3:8), 
Ncam1 and Nestin were notably decreased after 4 days of DMOG treatment, an effect 
maintained for Nestin after pre-treatment at days 7 and 11. Similar to Nestin, -III tubulin 
expression was increased in control cells between days 7 and 11, but markedly reduced 
after DMOG pre-treatment. Foxj3 was unaffected by DMOG directly and after pre-
treatment at both tested time points.  
 
Taken together, these data demonstrate the ability of DMOG to skew differentiation away 
from endoderm and ectodermal lineages, and disrupt mesodermal formation. Therefore, 
this is consistent with a role for O2-sensitive cell signalling in the orchestration of 








































Figure 3:5 Chemically-mimicked hypoxia by dimethyloxalylglycine treatment 
and pretreatment alters pluripotency marker expression. In 2 independent 
studies P19 cells were induced to differentiate in the presence of 1 mM DMOG for 4 
days, or were pre-treated with DMOG for 4 days before allowed to differentiate for a 
further 11 days. Pluripotency marker expression was analysed by QPCR. Data are 
expressed as the mean  SEM relative to undifferentiated cells, and analysed by an 













Figure 3:6 Chemically-mimicked hypoxia by dimethyloxalylglycine treatment 
and pretreatment decreases endodermal marker expression. In 2 independent 
studies P19 cells were induced to differentiate in the presence of 1 mM DMOG for 4 
days or were pre-treated with DMOG for 4 days before allowed to differentiate for a 
further 11 days. Endodermal marker expression was analysed by QPCR. Data are 
expressed as the mean  SEM relative to undifferentiated P19 cells, and analysed 
by an unpaired t-test between DMOG treatments at each time point. * p<0.05, ** 











Figure 3:7 Chemically-mimicked hypoxia by dimethyloxalylglycine treatment 
and pretreatment regulates mesodermal marker expression. In 2 independent 
studies P19 cells were induced to differentiate in the presence of 1 mM DMOG for 4 
days or were pre-treated with DMOG for 4 days before allowed to differentiate for a 
further 11 days. Mesodermall marker expression was analysed by QPCR. Data are 
expressed as the mean  SEM relative to undifferentiated P19 cells, and analysed 
by an unpaired t-test between DMOG treatments at each time point. * p<0.05, ** 


























Figure 3:8 Chemically-mimicked hypoxia by dimethyloxalylglycine treatment 
and pretreatment decreases ectodermal marker expression. In 2 independent 
studies P19 cells were induced to differentiate in the presence of 1 mM DMOG for 4 
days or were pre-treated with DMOG for 4 days before allowed to differentiate for a 
further 11 days. Ectodermal marker expression was analysed by QPCR. Data are 
expressed as the mean  SEM relative to undifferentiated cells, and analysed by an 
unpaired t-test between DMOG treatments at each time point. * p<0.05, ** p<0.01, 
*** p<0.001, **** p<0.0001 
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3.3.3 mESCs are induced to differentiate unbiasedly into all three germ layers  
 
To further understand a role of O2 in cell specification, mESCs were used as a more 
physiological model of differentiation (compared to P19 cells). mESCs could be 
maintained undifferentiated, indefinitely, under feeder-free culture in the presence of 2i 
conditions and LIF, as confirmed from visualisation of the rounded and smooth-edge 
morphology, characteristic of pluripotent stem cells (Figure 3:9A). 2i refers to the use of 
2 kinase inhibitors PD0325901 and CHIR99021, targeting MAPK and glycogen synthase 
kinase-3 (GSK3) respectively, which inhibit differentiation signals allowing mESCs to 
self-renew and induce a ground-state of pluripotency with homogeneity349. mESCs were 
unbiasedly induced to differentiate into EBs and subsequently harvested at days 3,7 and 
11 for expression analysis of lineage markers by QPCR (Figure 3:9B).  
 
Pluripotent markers Oct4 and Nanog demonstrated a time-dependent decrease in 
expression, indicative of cells undergoing cellular differentiation. Endodermal markers, 
Sox7 and Foxa2 showed a time-dependent increase in expression, reaching 10 and 
300-fold induction respectively at day 11. Mesodermal markers, Brachyury and Gata4 
were increased by day 3 and reached maximal expression by day 11, while ectodermal 
markers, -III tubulin and Nestin were not increased until later time points (at day 7 and 
11 respectively). These data demonstrated that the differentiation protocol could yield 
cells from all 3 germ layers, thereby demonstrating this cellular model of development is 
































Figure 3:9 mESCs differentiate into embryoid bodies, expressing markers of 
all three germ layers. (A) Representative images of mESCs taken from 
undifferentiated to day 11 of differentiation. Expression of (B) pluripotency, (C) 
endodermal, (D) mesodermal and (E) ectodermal markers over an 11-day time 
course of differentiation. Expression data are displayed as the mean  SEM relative 
to undifferentiated cells. Data are analysed by a one-way ANOVA with Dunnett’s 
post-hoc analysis. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 
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3.3.4 Differentiation of mESCs under 1% O2 skews cellular differentiation   
 
To determine the functional effects of [O2] upon mESC differentiation, an O2-controlled 
chamber capable of exposing cells to a desired set O2 tension (accurate range 0.5-21% 
O2) was utilised (Figure 3:10A). This system was validated by the ability to detect HIF-
1 protein after 4 and 24 hrs of 3% O2 exposure in undifferentiated mESCs (Figure 
3:10B). Compared to atmospheric O2, protein expression was detected at 4 and to a 
lesser extent at 24 hrs, in agreement with HIF-1 showing a transient response to 
hypoxia134,350,351. Cobalt chloride (CoCl2), an iron-chelating agent, which functions to 
inactivate the hydroxylation activity of prolyl hydroxylases, was used as a positive 









The effect of 1% O2, compared to atmospheric O2, upon mESC specification after 7 days 
of differentiation, was analysed by a QPCR array against a plethora of lineage markers. 
The expression of these markers is depicted as a fold change relative to respective 
atmospheric controls (Figure 3:11). Data was normalised to -actin as the most stably 
expressed house-keeping gene available within the array format. Pluripotency markers 
were all consistently elevated in 1% O2 above atmospheric O2 control, suggestive of a 
maintained undifferentiated state and therefore delayed onset of differentiation. 
Endodermal markers remained largely unaffected, with no changes greater than 2-fold. 
A subset of mesodermal markers; Gata2353, Brachyury and Hand1 demonstrated 
increased expression of approximately 7,8,18-fold respectively. However, a large 
proportion of other mesodermal genes failed to demonstrate greater than 2-fold 
changes. Ectodermal markers, and specifically the neuronal progenitor subtypes, all 
Figure 3:10 Culture of mESCs under low O2 tension induces HIF-1 protein 
expression. (A) Low O2 experiments were conducted in a BioSpherix ProOx C21 
regulated C-chamber. (B) HIF-1 protein expression after 3 and 24 hrs of 3% O2 
exposure in mESCs, complete with CoCl2 postive control treatment.  
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demonstrated decreased expression compared to atmospheric controls. Dcx354, a gene 
fundamental to neuronal migration during embryonic development, showed the largest 






















Figure 3:11 1% O2 skews mESC differentiation. A QPCR array from pooled 
triplicate day 7-differentiated mESC samples exposed to 1% O2 showing 
pluripotency , endodermal, mesodermal and ectodermal marker expression. Data 
are expressed as a fold change relative to day 7-differentiated mESCs exposed to  
atmospheric O2, depicted by the dotted line at 1.  
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The expression changes attained from this QPCR screen were validated for a selection 
of genes representative of each lineage, to ensure biological significance. Additional 
markers were included from mesoderm and ectodermal lineages to further verify 
expression trends. Pluripotency markers were confirmed to be increased after 7 days of 
differentiation in 1% O2, compared to atmospheric O2 (Figure 3:12). The relative 
expression levels detected here by QPCR mirrored and validated the QPCR array, such 
that Gdf3355 and Oct4 demonstrated the largest increase and Nanog the smallest 
induction. Endodermal marker expression was also consistent, displaying a significant 
upregulation and downregulation of Sox7 and Hnf4a52 respectively (Figure 3:13). The 
increase in mesodermal expression changes for Gata2 and Hand1 were verified to be 
of similar fold-induction to those observed in the QPCR array, and Nppa356 and Myh7357 
also displayed equivalent trends to those identified in the screen (Figure 3:14). However, 
some additional tested markers, Mesp1 and Tbx5, were significantly decreased, thereby 
highlighting the complexity of the effects of low [O2] in skewing cellular differentiation. 
Comparatively, ectodermal markers were verified to be consistently downregulated in 
1% O2 (Figure 3:15). Supplementary markers Nestin, NeuroD358 and -III tubulin were 
also diminished in 1% O2, compared to atmospheric O2 controls.  
 
These data thus validate the QPCR array findings and again demonstrate the ability of 
[O2] to skew cellular differentiation patterns, which in combination with effects of DMOG 
























































Figure 3:12 Pluripotency markers are elevated in 1% O2 exposed day 7-
differentiated mESCs. Validation of Gdf3, Lefty1, Nanog and Oct4 expression after 
1% O2 exposure, relative to atmospheric O2. Data are expressed as the mean  SEM 

















Figure 3:13 Endodermal markers show less than a 2-fold expression change 
in 1% O2 exposed day 7-differentiated mESCs. Validation of Sox7 and Hnf4a 
expression after 1% O2 exposure, relative to atmospheric O2. Data are expressed 



















Figure 3:14 Early mesodermal markers are elevated in 1% O2 exposed day 7-
differentiated mESCs. Validation of Gata2, Hand1, Nppa and Myh7 expression, 
plus additional markers Mesp1 and Tbx5 after 1% O2 exposure, relative to 
atmospheric O2. Data are expressed as the mean  SEM and analysed by an 







3.3.5 The skewing effects of 1% O2 upon cellular differentiation are largely 
sustained throughout the tested time course  
 
To investigate whether the effects of 1% O2 upon cellular differentiation are evident at 
later time points, expression of a representative example of pluripotency, mesoderm and 
ectodermal markers were determined after 11 days of mESC differentiation in 1% O2. 
The increase in pluripotency marker expression seen at day 7 was lost for Lefty1359, but 
was maintained for Gdf3 and Oct4 at day 11 (Figure 3:16), albeit with a lower fold-
induction.  The effect of 1% O2 upon the mesodermal markers, Hand1 and Tbx5, is 
consistent with that at day 7, however Mesp1 expression is no longer decreased 
compared to atmospheric O2 levels (Figure 3:17). Expression of ectodermal markers 
remain decreased at day 11, relative to atmospheric O2 controls (Figure 3:18), and thus 
are consistent with day 7.  
 
Taken together these data suggest the effects of 1% O2 upon cellular differentiation are 
largely sustained between days 7 and 11, thereby emphasising the fundamental impact 





















Figure 3:15 Ectodermal markers are decreased in 1% O2 exposed day 7-
differentiated mESC. Validation of Fabp7, Hes5, Sox2, Dcx expression, plus 
additional markers Nestin, NeuroD and -III tubulin, after 1% O2 exposure, relative 
to atmospheric O2. Data are expressed as the mean  SEM and analysed by an 

























Figure 3:16 The effects of 1% O2 upon pluripotent marker expression at day 7 
is largely sustained after 11 days of mESC differentiation. Expression of Gdf3, 
Lefty1 and Oct4 after 11 days of mESC differentiation in 1% O2, relative to 
atmospheric O2. Data are expressed as the mean  SEM and analysed by an 











Figure 3:17 The effects of 1% O2 upon mesodermal marker expression at day 
7 is largely sustained after 11 days of mESC differentiation. Expression of 
Hand1, Tbx5 and Mesp1 after 11 days of mESC differentiation in 1% O2, relative to 
atmospheric O2. Data are expressed as the mean  SEM and analysed by an 
































Figure 3:18 The effects of 1% O2 upon ectodermal marker expression at day 7 
is consistent after 11 days of mESC differentiation. Expression of Hes5, Nestin 
and -III tubulin after 11 days of mESC differentiation in 1% O2, relative to 
atmospheric O2. Data are expressed as the mean  SEM and analysed by an 
unpaired t-test. ** p<0.01 *** p<0.001 
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3.3.6 Tet enzymes are differentially regulated by O2 concentration 
 
The requirement of O2 as a co-factor for the enzymatic function of Tet enzymes might 
suggest their potential as O2 sensors within the developing embryo. To investigate these 
enzymes as having a biological significance it was firstly necessary to confirm their 
relative expression in undifferentiated mESCs (Figure 3:19). At the mRNA level, all Tet 
paralogues were detectable, Tet1 was the most abundant paralogue, displaying a 9-fold 































Figure 3:19 Tet1 is the most abundent Tet in undifferentiated mESCs. Relative 
expression of Tet1, Tet2 and Tet3 in undifferentiated mESCs. Data are expressed 
as the mean  SEM and analysed by a one-way ANOVA with Dunnett’s post-hoc 
analysis. **** p<0.0001 
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To investigate whether the change in gene expression patterns, induced by low [O2], 
during mESC differentiation could in part be mediated by Tet enzymes, it was firstly 
necessary to establish whether their activities are sensitive to [O2] over physiological a 
range.  
 
Plasmid constructs expressing Tet1, Tet2 and Tet3 were attained from Addgene (see 
Chapter 2: Material and Methods). To optimise transfection efficiency for Tet expression 
plasmids in mESCs, initial transfection attempts were conducted using a GFP 
expressing plasmid with a variety of transfection reagents (Figure 3:20) and the Amaxa 
4D-Nucleofector (Figure 3:21). Induction of GFP expression 24 hrs post-transfection 
appeared most successful with the ViaFect reagent and with the CA-137 nucleofection 
program. However, cell viability was higher in ViaFect-transfected cells compared to 
the nucleofection attempt. Both transfection methods were employed to express the Tet 
plasmids into mESCs. However, as determined by QPCR and Western blot analysis 
(data not shown), both methods failed to induce any detectable expression of the 
constructs, potentially attributed to the considerably larger size of the Tet plasmids, 
compared to the GFP plasmid, and/or the possibility the mESCs are unable to 

























































































Figure 3:20 Reagent optimisation of mESCs transfections with a GFP plasmid 
revealed ViaFect demonstrated the greatest transfection efficiency. mESCs 
were plated onto 24-well culture plates at 100,000 cells/well 24 hrs prior to 
transfection of 1 g GFP plasmid with either ViaFect, Lipofectamine 2000, 




























































Figure 3:21 Optimisation of Nucleofection protocols for transfection of mESCs 
with a GFP plasmid revealed the CA-137 programme induced the highest 
transfection efficiency. 3x106 mESCs were suspended in P3 Nucleofector 
solution (Lonza) with 2 g of pmaxGFP plasmid and subjected to either CG-104, 
CA-137, CB-150 or CD-118 programmes. Images were acquired 24 hrs post-
transfection. 
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Due to their proven suitability for transient transfection studies, HEK cells were used as 
a proof-of-principle model to test whether the activities of Tet proteins might be regulated 
to changes in [O2]. Tet1, Tet2 and Tet3 constructs were each successfully transiently 
expressed into HEK cells, as confirmed by Western blot analysis by probing against the 
FLAG-tag epitope of the constructs (Figure 3:22A). The result of Tet-overexpression 
upon 5-hmC levels was determined by dot-blot analysis. The specificity of antibodies to 
5-mC and 5-hmC were firstly verified against DNA standards for unmethylated, 
methylated and hydroxymethylated DNA (Figure 3:22B). It was evident there was clearly 
no overlap in antibody selectivity, and hence these antibodies were deemed suitable for 
ongoing studies.  
 
Tet-overexpressed cells were harvested for DNA 48 hrs post-transfection, and probed 
for 5-hmC (Figure 3:22C). Significant inductions in 5-hmC levels above those in pcDNA-
transfected control cells was evident for each construct. Tet2 overexpression 


































Figure 3:22 Overexpression of Tet proteins in HEK cells increased 5-hmC 
above pcDNA control transfected cells. (A) The ability to overexpress each Tet 
protein in HEK cells was assessed by Western blot analysis, probing against the 
FLAG-tag epitope of the constructs. (B) The specificty of antibodies against 5-mC 
and 5-hmC were asessed against known DNA standards (unmethylated DNA, 5-mC 
DNA and 5-hmC DNA) by dot-blot analysis. (C) The functionality of Tet 
overexpression constructs was determined by 5-hmC detection by dot-blot analysis, 
and levels quantified and expressed relative to pcDNA control transfected cells. Data 
are expressed as the mean  SEM and analysed by a one-way ANOVA with 
Dunnett’s post-hoc analysis. * p<0.05, ** p<0.01, *** p<0.001 
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Tet-overexpressing HEK cells were cultured in decreasing O2 concentrations, over a 
range of 5, 3, 1 and 0.5% O2. These O2 concentrations were chosen to represent graded 
levels of O2 that are physiologically relevant in the developing embryo. Levels of 5-hmC 
and 5-mC, detected firstly by dot-blot, were used as a measure of Tet activity. Each dot-
blot (Figure 3:23A) shows 5-hmC and 5-mC levels within HEK cells overexpressing each 
Tet enzyme under atmospheric O2 and the tested [O2]. In addition, 1 mM DMOG (at 
atmospheric O2) was used as a positive control for inhibition. Visual interpretation of 5-
hmC expression clearly demonstrates that Tet1 activity is decreased at 3, 1, and 0.5% 
O2, compared to respective atmospheric O2 controls. Tet2 appeared to be largely 
unaffected at all O2 concentrations, whereas Tet3 at 3% O2 unexpectedly increased 5-
hmC. 5-mC levels appeared largely unaffected by O2 concentrations and were used as 
an internal control for DNA loading to produce a ratio of 5-hmC:5-mC for quantification 
(Figure 3:23B). 5-hmC:5-mC were expressed as percentage of activity compared to 
respective atmospheric O2 controls, represented by the dotted line at 100%. Overall, 
these results demonstrate that Tet1 activity was unaffected at 5% O2, but significantly 
inhibited at 3% O2 and less, to approximately 40% of maximal activity. Tet2 activity was 
only significantly affected at 0.5% O2, to around 70% of maximal activity, equivalent to 
the effect with DMOG treatment. Based on the requirement of Tet enzymes for O2 as a 
co-substrate it would be hypothesised that activity would be decreased in low [O2]. 
However, as stated above intriguingly an approximate 3-fold increase in Tet3 activity at 
3% O2 was observed. Other tested O2 concentrations had no significant effect on Tet3 
activity, and only DMOG treatment resulted in an approximate 50% inhibition.  
 
To verify these findings, mass-spectrometry was used as a more sensitive approach for 
5-hmC and 5-mC detection (Figure 3:24). 3 and 0.5% O2-exposed cells were analysed 
for C, 5-mC and 5-hmC levels. Here, 5-hmC levels were normalised to total C (combined 
C, 5-mC and 5-hmC) and expressed as a percentage of activity, compared to 
corresponding atmospheric O2, depicted by the dotted line at 100%. This analytical 
method decreased the variability between replicates and thus in combination with dot- 
blot findings confirmed that inhibition of Tet1 was the most sensitive to changes in [O2] 
over this tested range, compared to Tet2 and Tet3. It should be noted that mass-
spectrometry analysis did highlight discrepancies, compared to dot-blot analysis, but 
only in the pcDNA-transfected control samples. The increase in 5-hmC at 3% O2 
reported from the mass-spectrometry is likely down to encompassing total C 




































Figure 3:23 Tet proteins displayed differential regulation by O2 concentration. 
(A) pcDNA control or Tet1, Tet2 and Tet3 expressing plasmids were transfected into 
HEK cells and subjected to decreasing O2 concentrations (5,3,1 and 0.5% O2) for 48 
hrs, and harvested for 5-hmC and 5-mC detection by dot-blot analysis. Cells were 
treated with 1 mM DMOG, under atmospheric O2, as a postive inhibitor control. (B) 
Quantifcation of dot blots, displayed as the ratio of 5-hmC:5-mC, expressed as a 
percentage of activity compared to atmospheric control (depicted by the line at 
100%). Data are shown as the mean  SEM and analysed by unpaired t-test 
































Figure 3:24 Mass-spectrometry analysis confirms the differential regulation of 
Tet enzymes by O2 concentration. DNA samples from pcDNA control and Tet1, 
Tet2, and Tet3 expressing HEK cells, subjected to 3 and 0.5% O2 were analysed for 
C, 5-mC and 5-hmC by mass spectrometry. Data is normalised to total C and 
expressed as a percentage of activity compared to corresponding atmospheric O2 
control (depicted by the line at 100%). Data are shown as the mean  SEM and 
analysed by a unpaired t-test between atmospheric O2 and the tested condition. * 
p<0.05, ** p<0.01 
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3.3.7 O2 concentration regulates cellular metabolite levels 
 
In addition to O2, Tet enzymes also require 2-OG as a co-substrate and are known to be 
antagonised by the sterically similar citric acid cycle metabolites, succinate and 
fumarate303. Culture under differing O2 concentrations will affect cellular metabolism and 
hence may therefore influence Tet activity. Thus, to investigate a potential cause for the 
unexpected increase in Tet3 activity seen in response to 3% O2, the metabolic profile of 
HEK cells was determined by 1H-NMR after culture in 3% and 1% O2 (Figure 3:25). 
Lactate levels, indicative of glycolysis activation, were increased at 1% O2, above 
atmospheric O2. Glutamate levels, intrinsic for the formation of the 2-OG citric acid cycle 
intermediate, were significantly reduced in both 3% and 1% O2. These data suggest that 
2-OG levels would likely be reduced and would therefore be predicted to inhibit Tet 
activity. However, succinate levels were also decreased at 3% O2, but not at 1% O2, 
compared to atmospheric O2. Hence, there might be potentially less Tet inhibition by 
succinate at 3% O2 compared to 1% O2, and this may account for the increased activity 
of Tet3. No significant differences were found in fumarate levels between 3% and 1% 
O2.   
 
 
Irrespective of the specific mechanisms underlying the biphasic response of Tet3 activity 
to differing O2 concentrations, the activities of Tet enzymes are demonstrated here to be 
regulated by O2 levels. Notably, Tet1 activity is specifically sensitive to changes in O2 
concentrations that are physiologically relevant within the developing embryo and thus 





















Figure 3:25 Differences in succinate levels between 3 and 1% O2 may in part 
explain the elevated Tet3 activity at 3% O2. HEK cells were subjected to 
atmospheric, 3% and 1% O2 for 24 hrs and cellular metabolite levels determined by 
1H-NMR. Data are expressed as the mean  SEM from 5 repeats and normalised to 
total protein. Data are analysed by a one-way ANOVA with Tukey’s post-hoc 
analysis. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 
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3.3.8 Generation of stable Tet-depleted mESCs   
 
The activities of Tet enzymes appear differentially regulated by [O2], as shown previously 
in section 3.3.6. However, to investigate directly whether Tets are in part responsible for 
mediating mRNA expression changes induced by 1% O2, as presented in section 3.3.4, 
each Tet paralogue was genetically ablated. Genetic ablation of Tet1, Tet2 and Tet3 in 
mESCs was performed by shRNA lentiviral transduction and stable knockdown (KD) cell 
lines were generated following positive selection with puromycin 
 
A dose response for antibiotic selection was firstly conducted by exposing 
undifferentiated mESCs to increasing puromycin concentrations to determine the 
minimal concentration to induce cell death after 72 hrs (Figure 3:26). Complete cell death 













Figure 3:26 A dose response of puromycin treatment revealed 1 g/ml was 
sufficient to induce mESC death after 72 hrs. Undifferentiated mESCs were 
treated with increasing concentrations of puromycin (0.5-4 g/ml) for 72 hrs, 1 g/ml 
was selected as the minimal concentration to induce cell death after this time.  
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2 independent shRNA clones (see Chapter 2: Materials and Methods) against each Tet 
enzyme were assessed to determine their gene silencing ability by QPCR analysis 
(Figure 3:27) (Due to a high level of Tet3 ablation with clone 1, the use of clone 2 was 
not necessary). The greatest level of silencing of Tet1 was achieved with clone 2 (~75%) 
and for Tet2 this was clone 1 (~55%). Tet3 demonstrated the greatest level ablation of 
~95% compared to shRNA control. Clones that produced the greatest level of Tet 


















Figure 3:27 Genetic ablation of Tet1, Tet2 and Tet3 in  undifferentiated mESCs. 
Assessment of genetic silencing capabilities of lenti-viral shRNA clones for Tet1, 
Tet2, Tet3 in mESCs was performed by QPCR analysis. mESCs were firstly infected 
with lenti-viral particles and after 72 hrs postively transduced cells were selected and 
expanded with 1g/ml puromycin containg medium. Data are expressed relative to 
shRNA control infected cells. 
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To determine whether genetic silencing at the mRNA level correlates to protein 
expression, attempts were made to confirm ablation of Tet1, Tet2 and Tet3 by Western 
blot analysis (Figure 3:28). The Tet1 protein band appeared difficult to distinguish, 
however based on the assumption that the protein band seen by probing the Tet 
overexpression construct with FLAG would be of a similar size (see Figure 3:22C) (the 
FLAG tag is small and therefore would not alter the protein size significantly), the 
endogenous Tet1 was depicted by the arrow. Tet1 protein level showed a 20% decrease 
compared to a 75% reduction at the mRNA level. Tet2 ablation resulted in an equivalent 
loss at the protein level, depicted by the arrow, to that at the mRNA level. Virtually no 
protein was detected for Tet3, in agreement with the magnitude of ablation at the gene 
level. However, it should be noted that although Tet3 mRNA is the lowest expressed Tet 
paralogue in undifferentiated mESC it is readily detectable at the protein level. This may 
be due to several possibilities including the mRNA may be degraded after translation, 
translation itself may be upregulated and the protein may have a long half-life due to a 











































Figure 3:28 Genetic silencing of Tets at the mRNA level correlates with the 
loss of protein expression. Positively selected Tet1, Tet2 and Tet3 lenti-viral 
shRNA transduced mESCs were harvested for protein analysis by Western blot. 
Where necessary the correct protein bands are marked with a white arrow. 
Quantification of protein expression is expressed relative to shRNA control. KD: 
knockdown.  
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3.3.9 Genetic ablation of each Tet enzyme has potential compensatory effects 
on other paralogues  
 
To distinguish whether silencing of each Tet enzyme affects expression of the other 
paralogues, mRNA levels were assessed in undifferentiated mESCs (Figure 3:29). 
Successful ablation of each Tet paralogue was again confirmed. However, it was 
apparent that Tet2 expression was elevated in Tet3 KD and Tet3 expression was 
decreased in Tet2 KD. This suggests a potential inter-relationship between the Tet 
enzymes, highlighting potential compensatory effects that should be considered when 











Figure 3:29 Compensatory effects of Tet ablation on other Tet paralogues in 
undifferentiated mESCs. Expression of Tet1, Tet2 and Tet3, relative to shRNA 
control was assessed in Tet1, Tet2 and Tet3 genetically abalted mESCs by QPCR 
analysis in undiffereniated cells. Data are expressed as the mean  SEM and 
analysed by a one-way ANOVA with Tukey’s post-hoc analysis. *p<0.05, **p<0.01,  
**** p<0.0001. KD: knockdown.  
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3.3.10 Tet knockdown inhibits mESC differentiation 
 
The ability of Tet enzymes to in part be responsible for the changes in lineage marker 
expression reported for mESC differentiation under 1% O2 (thereby identifying 
differential roles in cellular specification) was investigated. Tet1-, Tet2- or Tet3-ablated 
mESCs were induced to differentiate for 7 days and a QPCR array against a range of 
lineage markers, as performed in Figure 3:11, was conducted (Figure 3:30). Data is 
expressed as a fold change relative to respective shRNA controls and normalised to the 
-actin house-keeping gene, selected as the most stably-expressed gene within the 
array format. All pluripotency markers were elevated in Tet1-, Tet2-, Tet3-ablated cells, 
with Tet3 silencing inducing the most pronounced effect. These effects were validated, 
which confirmed Tet1 ablation trended to increase expression of all pluripotent markers, 
but only achieved significant induction of Dnmt3b360 and Oct4 (Figure 3:31). Tet2 
silencing resulted in a significant increase in all tested markers, except Dnmt3b (Figure 
3:32). Tet3 ablation, as first seen from the QPCR array, maintained the largest significant 
fold induction of all tested pluripotency genes, compared to Tet1 and Tet2 KD mESCs 
(Figure 3:33). Hence these effects are consistent with the increase in pluripotency 
marker expression established when differentiating cells were cultured in 1% O2 (Figure 
3:11). 
 
Endodermal markers showed little change in expression with either Tet1-, 2- or 3-
ablation, and thus was similar to effects induced by 1% O2 (Figure 3:11). The majority of 
endodermal markers showed the same trend with silencing of either Tet paralogue. 
However, in the case of Foxa1361, Gata1362 and Hnf4a there appeared some minor, yet 
differential effects between ablation of Tet1, 2, 3. Expression of mesodermal markers 
were largely unchanged (less than a 2-fold change), compared to shRNA control. 
Ablation of either Tet enzyme failed to mimic the large induction of the early mesodermal 
markers Gata2, Brachyury, Hand1 and Dcn363 seen with 1% O2 (Figure 3:11). Instead, 
Hand1 expression was in fact substantially and consistently reduced with all Tet silenced 
paralogues. Overall, largely similar effects on expression of each mesodermal marker 
was seen in mESCs ablated of either Tet enzyme. Although some clear differences were 
recorded, such as the increased Gata2 expression in Tet1-silenced cells and reduced 
expression of Ccr5 in both Tet1- and Tet2-, but not Tet3-ablated cells. By contrast to the 
consistent loss of ectodermal marker expression detected in 1% O2 cultured mESCs 
(Figure 3:11), Tet1-, 2- or 3-ablation largely trended to increase expression. Generally 
Tet3 silencing appeared to have a more pronounced effect than that of Tet1 and 2, 
resulting in marked induction of Fabp7364, Dcx, Gbx2365 and Tyr366. However, for genes 
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such as Hes5367, Prom1368, Neurog2369, Galc370 and Gfap371, ablation of either Tet 
induced minimal to no change in expression, compared to shRNA control.  
 
Overall the changes in expression of lineage-specific genes were highly variable, and 
therefore failed show a consistent trend towards (or away from) a specific germ layer. 
Thus, ablation of any one of the Tet enzymes failed to recapitulate the skewed 
differentiation of lineage markers observed in 1% O2, compared to atmospheric O2. 
Despite this, Tet1, Tet2 or Tet3 silencing did mimic the increased pluripotency marker 























Figure 3:30 Tet ablation induces pluripotency marker expression. A QPCR 
array from pooled triplicate samples of day 7-differentiated Tet1, Tet2 and Tet3 
ablated mESCs, showing expression of pluripotency, endodermal, mesodermal and 
ectodermal markers. Data are expressed as a fold change relative to shRNA control 












Figure 3:31 Validation of pluripotency marker expression in Tet1 silenced day 
7-differentiated mESCs. Expression of Dnmt3b, Gdf3, Lefty1, Nanog and Oct4 in 
Tet1 ablated day 7-differentiated mESCs relative to shRNA control cells. Data are 
expressed as the mean  SEM and analysed by an unpaired t-test. * p<0.05. KD: 
knockdown. 
Figure 3:32 Validation of pluripotency marker expression in Tet2 silenced day 7-
differentiated mESCs. Expression of Dnmt3b, Gdf3, Lefty1, Nanog and Oct4 in Tet2 
ablated day 7-differentiated mESCs relative to shRNA control cells. Data are 































Figure 3:33 Validation of pluripotency marker expression in Tet3 silenced day 
7-differentiated mESCs. Expression of Dnmt3b, Gdf3, Lefty1, Nanog and Oct4 in 
Tet3 ablated day 7-differentiated mESCs relative to shRNA control cells. Data are 
expressed as the mean  SEM and analysed by an unpaired t-test. * p<0.05, ** 
p<0.01, **** p<0.0001. KD: knockdown 
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3.3.11 Microarray data revealed differential gene regulation by Tet1, Tet2 and 
Tet3 when overexpressed in P19 cells  
 
To identify further the differential functional role of each Tet paralogue during cellular 
differentiation, Tet1, Tet2, and Tet3 were each overexpressed in P19 cells and induced 
to differentiate unbiasedly into EB-like aggregates for 2 days. Triplicate samples were 
pooled for microarray analysis (conducted by AROS Applied Biotechnology). Firstly, 
successful overexpression of each Tet was confirmed through QPCR (Figure 3:34). Tet1 
showed the greatest induction, over 2000-fold, whereas Tet2 and Tet3 showed similar 




































Figure 3:34 Overexpression of Tet1, Tet2 and Tet3 in undifferentiated P19 
cells. pcDNA control or Tet1-, Tet2- and Tet3- overexpressing plasmids were 
transfected into undifferentiated P19 cells. Succesful overexpression was confirmed 
by QPCR analysis 48 hrs post-transfection, and data is expressed relative to pcDNA.  
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Microarray analysis revealed that Tet1, 2, or 3 overexpression induced differential 
expression changes, compared to pcDNA control transfected cells, with the majority of 
changes identified to be in fact non-coding RNA transcripts. The heat map, complete 
with hierarchical clustering (Figure 3:35A) demonstrates clear differences in expression 
patterns compared to pcDNA control transfected cells (red colours indicating increased 
expression and green decreased expression). This is confirmed by the Venn diagrams 
(Figure 3:35B) depicting the transcripts with a greater than 2-fold increase (shown in red) 
and greater than a 2-fold decrease (shown in green), compared to expression in pcDNA 
control transfected cells. It can be noted that some expression changes are consistent 
among all or 2 of the Tet paralogues. However, it is evident that each Tet regulates 
different transcripts suggesting they have independent functional roles during cellular 
differentiation. Perhaps unexpectedly only a small number of coding genes were 
identified, potentially owing to the short time point after the onset of differentiation at 
which cells were harvested. Despite this, intriguingly, the Tet enzymes did affect 
expression of short non-coding RNAs named miRNAs, which are responsible for post-
transcriptional gene regulation. Table 6 shows the fold change for miRNAs that displayed 
a greater or less than 2-fold change relative to pcDNA transfected control cells. Some of 
these miRNA changes were specific for each Tet paralogue, such as miR-6344 induction 
with Tet3, while other miRNA expression was affected by all Tet paralogues, for example 
miR15b. Interestingly, Tets could also induce different effects upon the same miRNA. 
For instance, miR-378c expression was induced by approximately 9 and 12-fold with 
Tet1 and Tet2 overexpression respectively, but reduced around 3-fold with Tet3 
overexpression.  In light of this data, it may therefore be suggested that Tets contribute 
to gene regulation at the early stages of cellular differentiation indirectly through 























Figure 3:35 Microarray expression analysis revealed differentiated P19 cells 
overexpressing Tet1, Tet2 and Tet3 displayed differential transcript regulation. 
(A) Heat map with hierarchical clustering showing the differential expression of 
transcripts between pcDNA control and Tet1, Tet2, Tet3 overexpressing day 2-
differentiated P19 cells. (B) Venn diagrams showing the number of uniquely and 
commonly expressed transcripts, which displayed a greater or less than 2-fold 
expression change, relative to pcDNA control, between Tet1, Tet2 and Tet3 
overexpressing P19 cells. 
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miRNA Tet1 Tet2 Tet3 
miR-6344   2.10 
miR-669m-1   2.23 
miR-3098   3.73 
miR-15b 2.92 2.97 0.27 
miR-378c 8.79 12.48 0.35 
miR-669a-1 5.14   
miR-669b 0.49 6.91 4.35 
miR-669e 0.43   
miR-669j  2.16  
miR-669k  2.46  
miR-302c   0.44 
miR-302a 2.22  0.32 
miR-367   0.46 
miR-3094 2.54 5.14 0.28 
miR-467e 2.04 3.35  
miR-466l  2.23  
             
  
































Table 6 Differential miRNA expression between Tet1, Tet2 and Tet3 
overexpressing P19 cells. From microarray analysis miRNAs were found to be 
differentially regulated between Tet1, Tet2 and Tet3 overexpressing day 2-
differentiated P19 cells. Here, the miRNAs, complete with their corresponding 
fold change values, relative to pcDNA control cells, are listed. Note only those 
miRNAs that demonstrated a greater or less than a 2-fold change in expression 
are shown.   
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 Discussion  
 
3.4.1 O2 is a regulator of cellular differentiation  
 
To assess the ability of O2 to function as an important signalling molecule in 
differentiation 2 distinct methods were investigated. Firstly, differentiating P19 cells were 
treated with the HIF activator DMOG, the activity of which was confirmed through HIF-
1 protein induction. It should be noted that this chemical mimetic of hypoxia is not a 
specific inducer of HIF, it will inhibit all 2-OGDOs and therefore recapitulate other HIF-
independent O2 signalling pathways. Unbiased differentiation of P19 cells yielded cells 
expressing lineage markers from all 3 germ layers, yet upon DMOG treatment, or pre-
treatment, cellular specification could be skewed. Notably, the most consistent effects 
were seen on ectodermal marker expression, whereby all tested markers showed a 
decrease (or remain unchanged) after DMOG manipulation. Although not directly 
comparable, in a separate study the differentiation of P19 cells towards a neural fate 
demonstrated an increased number of dopaminergic neurons, when exposed to 3% O2 , 
compared to atmospheric controls372. This further highlights the ability of O2 to regulate 
P19 cell differentiation, and is also in agreement with data shown here, suggesting a 
significant affect upon the ectodermal lineage.  
 
The effects of DMOG provide a proof-of-principle concept that activation of O2-sensitive 
signalling can induce changes in cellular specification. However, the use of chemical 
compounds is unlikely to fully recapitulate physiological mechanisms and may have 
additional off target effects. For example, from these studies, exposure of P19 cells to 1 
mM DMOG for greater than 24 hrs, induced cell death. In addition, chemical mimetics 
may in fact resemble anoxia through complete inhibition of 2-OGDOs, whereas 
physiologically (potentially due to distinct Kms) these enzymes likely display different 
sensitivities to [O2]. A study directly comparing chemically-induced hypoxia with 5% O2, 
on the secretion of pro-angiogenic factors from adipocytes, revealed that despite 
similarities, chemically mimicked hypoxia uniquely induced expression of matrix 
metalloproteinases, which was speculated to be caused by activation of different 
intracellular pathways373.   
 
To better mimic the physiological environment of embryogenesis, a ‘hypoxic chamber’ 
was used that could be controlled to a desired [O2]. 1% O2 was selected for differentiation 
studies to be in line with the range of O2 tensions present in the uterus71 and the stem 
cell niche environment81. Additionally, owing to the short diffusion distance of O2, the 
formation of EBs under low [O2] may simulate physiologically relevant O2 gradients, 
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further mimicking early embryogenesis. Also, for future studies mESCs were used as a 
model of cellular differentiation. The cells used were an R1 mESC line, established from 
a 3.5-day blastocyst and therefore provide a more physiological relevant model of 
investigating cellular differentiation than P19 cells, which are isolated from 
teratocarcinomas328,329.  
 
Unbiased differentiation of mESCs, by contrast to P19 cells, resulted in a time-
dependent decrease of both Oct4 and Nanog expression, suggesting the loss of 
pluripotency and thus onset of differentiation. QPCR analysis verified from the 
heterogeneous EB cell population the expression of key germ layer markers. 
Differentiation of mESCs exposed to 1% O2 altered the pattern of differentiation 
significantly. Consistent with the literature69, 1% O2 promoted the undifferentiated state 
by an increase in an array of pluripotent markers. This may be mediated at least in part 
through HIFs, as the expression of Oct4 and Nanog has previously been shown to be 
regulated by HIF-2113,114,115. Furthermore, HIF-1 accumulation under 1% O2 has been 
shown to associate with the Notch intracellular domain, promoting its stability to activate 
Notch downstream targets Hes and Hey374. These can signal to regulate cell fate 
commitment374, and Hes1 specifically has been shown to delay the exit from the 
pluripotent state by activation of Stat3375 (a component of the LIF signalling pathway). 
Moreover, HIF-1 is also implicated in the activation of the Wnt/-catenin signalling 
pathway376,377, well known to promote pluripotency and self-renewal378. Thus overall, 
current evidence suggests that low O2 tensions support the maintenance of a naïve 
pluripotent state at least in part via HIF signalling.  
 
Induction of a selection of mesodermal markers under 1% O2, suggested the 
mesodermal fate could be promoted under low O2 tensions. Previously, expression of 
exogenous HIF-1 in mESCs has been shown to enhance cardiac specification through 
an increase in the beating phenotype of EBs via induction of both early cardiac markers 
Gata4 and Nkx2.5 and later markers -myosin heavy chain 6 (Myh6) and -myosin 
heavy chain 7 (Myh7)119. However, it should be noted that the expression of myosin-
related genes from these studies were unaffected or decreased by 1% O2 at this tested 
time point (Figure 3:11). It has also previously been demonstrated that the timing and 
duration of low O2 tensions can impact upon cardiotypic differentiation. It has been 
demonstrated that exposure of 3% O2 for 24 hrs, followed by normoxic (21% O2) culture 
for a remaining 13 days, abolished the beating phenotype of iPSC derived 
cardiomyocytes376. However, this O2 preconditioning was shown to enhance expression 
of the early mesodermal marker Brachyury376, which was consistent with findings from 
DMOG treated P19 cells (Figure 3:7) and day 7-differentiated mESCs exposed to 1% O2 
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(Figure 3:11). Thus, this supports the notion that [O2] can regulate mesodermal 
differentiation.  
 
mESCs showed consistent reduction of ectodermal marker expression when 
differentiated in 1% O2 (Figure 3:15), similar to the effects of DMOG treatment in 
differentiating P19 cells (Figure 3:8). Specifically, 1% O2 inhibited cells to acquire the 
neuronal lineage, demonstrated through abolishment of Dcx expression, a key gene in 
neurogenesis379. Previous studies have reported low O2 tensions can promote neural 
differentiation380,381,382, however one finding has demonstrated that O2 can have 
differential effects dependent on the time course of neural development383. Specifically, 
it was shown that early neural differentiation of mESCs was inhibited in 5% O2, yet later 
neural differentiation into neurospheres was promoted at this O2 tension383. Thus, overall 
O2 signalling is a critical factor for regulating cellular specification, consistent with its 
potential function as a morphogen during early embryogenesis.  
 
As ESCs differentiate to become specialised cells they acquire distinct cellular identities 
with different phenotypes and functions, which are characterised by unique gene 
expression patterns. The determination of cell fate is dependent upon levels of chromatin 
compaction, which is dynamically adjusted through epigenetic modifications to regulate 
gene expression384. The structure of chromatin is itself liable to changes in O2 
tension272,385, and therefore this led to the hypothesis that Tet enzymes owing to their 2-
OGDO may in part mediate the O2-dependent regulation of mESC function via 
alterations to DNA methylation dynamics.  
 
3.4.2 Tet enzymes are potential O2 sensors 
 
For Tet enzymes to be considered as potential O2 sensors during embryonic 
development they must of course be expressed. mRNA expression data from 
undifferentiated mESCs corroborates with previous data showing Tet1 to be the most 
abundant paralogue, followed by Tet2 and Tet3386,252. The presence of these enzymes, 
and their dependence on O2 for catalytic activity, provides a plausible basis to test their 
ability to act as O2 sensors. Firstly, assessment of the functionality of each Tet under 
atmospheric [O2] revealed that Tet2 showed the greatest induction of 5-hmC, compared 
to Tet1 and Tet3 (Figure 3:22). Western blot analysis confirmed this did not occur 
because of different levels of ectopic expression, suggesting Tet2 has a higher level of 
catalytic activity in baseline atmospheric O2 conditions. The reason for this is not clear 
but this may be due to the lack of the DNA-binding CXXC domain, which is present in 
Tet1 and Tet3173. This potentially may mean that Tet2 has less specificity, reflective of 
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its more promiscuous nature.  
 
Exposure of Tet overexpressing HEK cells to decreasing O2 concentrations, considered 
relevant within the physiological range of mammalian embryogenesis69,81,71, revealed 
Tet1 as the most likely candidate as an O2 sensor, owing to inhibition of its catalytic 
activity at O2 tensions less than 3% (Figure 3:23 and Figure 3:24). However, it should 
also be noted that Tet3 activity was unexpectedly elevated at 3% O2 and therefore may 
also be considered a sensor at this [O2]. Tet2 showed inhibition only at the lowest tested 
[O2], which may be attributed to a high affinity for O2 and thus a low Km. The use of DMOG 
(that may resemble an anoxic state), which is presumed to give maximal inhibition, only 
induced a 30% reduction in activity (compared to 70% inhibition of Tet1 activity), in line 
with effect of 0.5% O2, thereby suggesting Tet2 is also resistant to chemical inhibition. 
Other reports have suggested, through Km calculations, that Tet1 and Tet2 have similar 
sensitivities to O2303,309. However, it can be argued that the recombinant systems used 
in such studies are not as physiological as the cellular model used here.  
 
Analysis of TCA cycle metabolites in 3 and 1% O2 exposed HEK cells revealed that 
differential succinate levels may account for elevated Tet3 activity at 3% O2 (Figure 
3:25). The activation of the anaerobic glycolytic pathway would suggest that TCA 
metabolites would decrease, however as in agreement with the literature the succinate 
levels were found to increase under low O2 tensions319,320, suggesting that O2 induces 
secondary effects that may in part underlie the regulation of Tet-specific functions.   
 
For the first time this data shows the differential regulation of activity of all 3 Tet enzymes 
by O2. Thus, it can be postulated that their spatial distribution within the early embryo 
would enable exposure to O2 gradients, resulting in differential activity, which may in turn 
determine activation of cellular transcriptional pathways regulating cell fate.  
 
3.4.3 Tet proteins are implicated in the pluripotency regulatory network  
 
To investigate whether Tets can have a direct function on cell specification and resemble 
the skewing of mESC differentiation induced by 1% O2, genetically ablated mESCs were 
inducted to differentiate for 7 days and expression of developmental and lineage markers 
assessed (Figure 3:30) (as per for 1% O2 studies).  
 
Ablation of each Tet induced expression of all tested pluripotency markers (Figure 3:31, 
Figure 3:32 and Figure 3:33), consistent with the effects of 1% O2, suggesting that Tet 
enzymes are in part responsible for mediating this response. The implication of Tets in 
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the pluripotency regulatory circuit is well reported, since the enrichment of 5-hmC has 
been noted at binding sites of pluripotency related TFs185, including Oct4 and Nanog387. 
Further analysis has revealed that Tet1 and Tet2 are downstream targets of Oct4252, and 
genome-wide profiling of Tet1 distribution in mESCs correlated with the regulation of 
pluripotency and differentiation-related gene expression388. This may therefore suggest 
that Tets have a functional role in regulating the balance between pluripotency and 
differentiation events.  
 
3 independent groups using ChIP-seq revealed Tet1 preferentially binds at gene 
promoters via CpGs389,183,194, and is associated with 5-hmC390, supporting a 
hypomethylated state. Tet1 binds to actively transcribed pluripotency-associated factors, 
including Nanog390, suggesting a role of Tet-mediated hydroxylation in promoting a 
transcriptionally active state enabling recruitment of TFs and basal transcriptional 
machinery388. To support this notion, Tet1 depletion resulted in a decrease in Nanog 
expression, which correlated with 5-mC on its promoter386. In a separate study, Tet1 and 
Tet2 ablated mESCs resulted in increased promoter methylation and consequently 
decreased expression of the pluripotency-related genes Esrrb, Klf2, Tcl1, Zfp42, Dppa3 
and Ecat1 (albeit Oct4 and Nanog were unaffected)186. A more recent report has 
confirmed the physical association of Tet1 and Tet2 with Nanog, and interestingly were 
shown to be functionally redundant in enhancing the reprogramming and establishment 
of naïve pluripotency391. However, there are discrepancies in Tet silencing studies, Tet1-
depleted cells have been shown to not downregulate Nanog and Oct4 expression252,389. 
Furthermore, Tet1-depeleted mESCs stained positive for alkaline phosphatase (high 
expression of alkaline phosphatase in ESCs provides a measure of pluripotency) and 
retained expression of Oct4 and Nanog251. The authors also took additional steps to 
confirm the pluripotency and differentiation capabilities of Tet1 depleted ESCs by a 
tetraploid complementation assay (a tetraploid embryo will only develop if combined with 
functional diploid ESCs)251. 
 
Inconsistencies in ESC studies are common due to the ESC line used, culture conditions, 
method of Tet silencing and Tet compensatory effects. In addition, transcriptional control 
by Tet1 has added complexity due to an apparent dual function, not only in the activation 
of pluripotency genes as mentioned, but also repression of Polycomb marked 
developmental genes194 (see Chapter 4: Results 2). Perhaps controversially, the data 
collected here appears to demonstrate that Tet proteins are acting to repress 
pluripotency genes, however this expression analysis was performed on day 7-
differentiated samples, not at the undifferentiated level as investigated by many groups. 
It can be noted the induction of pluripotency genes by Tet1 and Tet2 silencing does not 
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fully mimic the extent of increased expression seen with 1% O2, which proposes the 
ability of other O2 sensing pathways, such as HIFs114, to also be implicated.  
 
Intriguingly, despite a lack of literature support, Tet3-silencing here induced pluripotency 
marker expression and to a greater extent than Tet1 and Tet2 ablation. However, a 
potential indication for the involvement of Tet3 in pluripotency regulation can be inferred 
from a study in which Tet1 and Tet2 double knockout mESCs exhibited a 2-fold induction 
of Tet3 mRNA and remained pluripotent248. A further insight was gained from somatic 
cell nuclear transfer experiments, which utilised somatic cells containing an Oct4-EGFP 
transgene392. Compared with embryos derived from wild-type oocytes, Tet3-null oocytes 
displayed reduced EGFP signal, consistent with decreased Oct4 mRNA levels392.  
 
One possible explanation for Tet3 ablation having the most dominant effect on 
pluripotent marker expression in the studies shown here is that during differentiation, 
Tet3 expression increases (while Tet1 and Tet2 decrease)386 (see Figure 4:5). 
Therefore, at the tested day 7-time point Tet3 is likely to have a more intrinsic role in 
cellular differentiation and development. However, silencing of Tet3 for 7 days resulted 
in a compensatory increase in Tet1 expression (data not shown), which may have 
contributed to the increase in pluripotent genes, but also infers a possible regulatory link 
between these 2 Tet paralogues (see Chapter 6: General Discussion). Overall, these 
data suggest Tet proteins may be intrinsic to the balance of pluripotency and lineage 
commitment393.   
 
3.4.4 Tet proteins and miRNAs: a novel gene regulatory mechanism 
 
To gain further insights into the differential role of Tet proteins in cellular differentiation, 
each Tet was overexpressed into P19 cells and induced to differentiate into EBs. 
Microarray analysis surprisingly revealed Tet overexpressing cells induced differential 
expression of miRNAs, rather than lineage-related genes. This unexpected result may 
have occurred because cells were harvested after a short period (2 days) of 
differentiation, which was conducted to ensure the effects of transient Tet 
overexpression were not lost. Intriguingly however, identification of a transcriptional 
regulatory network between Tets and miRNAs may provide further understanding of 
gene regulation at the onset of cellular differentiation.  
 
miRNAs regulate gene expression at the post-transcriptional level via targeting mainly 
the 3’-untranslated regions (3’UTRs) of mRNAs394. In the biogenesis pathway miRNAs 
are transcribed by RNA polymerase II to form long stem-loop containing primary-
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miRNAs (pri-miRNAs)394. Here within the nucleus, a ribonuclease III (RNase III), named 
Drosha and its associated RNA-binding protein, DiGeorge syndrome critical region 8 
(Dgcr8) crops pri-miRNAs into hairpin-shaped precursor-miRNAs (pre-miRNAs) of ~70 
nucleotides in length394. Pre-miRNAs are transported to the cytoplasm via exportin-5 
where Dicer cleavage forms a ~22 nucleotide mature miRNA duplex394. The mature 
miRNA products can be assigned 5p or 3p to represent the arm of the pre-miRNA they 
formed from, in the canonical model one strand of the duplex is biologically active and 
the other (passenger or * strand) is thought to be inactive and degraded395, although this 
concept has been challenged396. The guide strand becomes incorporated into the Ago2 
protein containing RISC, facilitating the stabilisation of miRNA:mRNA interactions. The 
guide strand binds to its target site in the 3’UTR of the mRNA primarily through perfect 
pairing of a 2-7 nucleotide sequence at its 5’ end, known as the seed region395. This 
subsequently results in the repression of gene expression via translational inhibition or 
mRNA degradation. 
 
The regulation of Tets post-transcriptionally by miRNAs has been reported previously in 
the cancer field. For example, Tet2 has been shown to be under extensive miRNA 
regulation (>30 miRNAs) resulting in diminished expression and subsequent 5-hmC 
loss397. However, there is also evidence for such interplay in developmental events. For 
instance miR-26a has been demonstrated to act to decrease mRNA levels of all Tet 
paralogues and is implicated in neuronal398 and pancreatic cell differentiation399. In 
addition, targeting of Tet1 by miR-29400 is implicated in repressing Tet1 expression after 
EB formation and promotion of mesoendodermal lineage formation401.  
 
miRNAs are an integral part of the pluripotent regulatory network. Initial studies in 
mESCs depleted of Dicer, an intrinsic component of miRNA biogenesis, failed to 
differentiate and form teratomas402. Additionally, Dicer mutant embryos have been 
shown to lack Oct4 staining403. Clusters of miRNAs (a set of 2 or more miRNA genes 
that are transcribed from physically adjacent genes404) have been shown as key 
regulators of pluripotency and differentiation events405. Specifically, the promoter region 
of the miR-302 gene, which encodes a cluster of 8 miRNAs (miR-302b*-b-c*-c-a*-a-d-
367), is bound by Oct4, Sox2 and Nanog406,407. miR-302 is highly expressed in 
undifferentiated P19 cells408, so perhaps it was unsurprising that it was detected from 
the microarray shown here after a short period of P19 cell differentiation (Table 6). 
 
The miR-302 family being highly conserved and abundantly expressed in 
undifferentiated ESCs409, has had invested interest in its somatic cell reprogramming 
capabilities to iPSCs410,411,412,413. Interestingly, one proposed mechanism of 
reprogramming is mediated through miR-302 targeting of epigenetic factors to reset 
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global DNA demethylation patterns (in addition to other chromatin modifications)413. For 
example, miR-302 silences MBD2 (important for zygotic demethylation, despite not a 
fully understood mechanisms) as well as Dnmt1, meaning DNA methylation can’t be 
replicated, subsequently leading to global demethylation410,412,414. Furthermore, latest 
mechanistic findings linking miR-302 to pluripotency revealed high endogenous 
expression of miR-302 maintained Oct4 levels via suppression of AKT1, and reversely 
showed, through the use of a miR-302 antagomir the induction of differentiation through 
teratoma formation415.  
 
Besides one study demonstrating Tet2 mRNA is repressed by the miR-302/367 
cluster416, there is limited evidence for this miRNA cluster in Tet regulation. From this 
data (Table 6), miR-302a/c was found to be differentially regulated by Tet1 and Tet3. 
miR-302a was found to be upregulated in Tet1 overexpression, supporting the notion 
that Tet1 is an intrinsic regulator of pluripotency, whereas miR-302a, miR-302c and miR-
367 were down regulated with Tet3 overexpression. Genetic ablation of the miR-302 
cluster in vivo resulted in early developmental defects in the neural tube, residing as 
embryonic lethal, suggesting a role of miR-302 in neurulation events417,418. Thus, the 
Tet3-mediated downregulation of miR-302 demonstrated here may link Tet3 to neural 
development. In support of this neurogenesis role, miR-15b was also shown to be 
downregulated with Tet3 overexpression (Table 6). miR-15b has been shown to promote 
neuronal differentiation, and directly target the 3’ UTR of Tet3 leading to its repression 
and subsequent decreased 5-hmC levels419.  
 
It should be considered that overexpression of Tets are likely to affect many miRNA 
circuits, which may result in changes in miRNA expression that are not in fact direct Tet 
targets. However, investigation into the putative miRNA binding sites within the 3’UTR 
of the Tet proteins, using the miR-walk data base (Available at: http://www.umm.uni-
heidelberg.de/apps/zmf/mirwalk/) revealed that Tet1, Tet2 and Tet3 were predicted to 
be bound by miR-320a/c and miR-15b. The ability of Tet overexpressing P19 cells to 
alter expression of these miRNAs (Table 6) in part confirms the presence of these 
miRNA/Tet regulatory networks. However, these miRNA expression changes need to be 
further validated by QPCR. A final speculative point is that as miRNA expression can be 
regulated by DNA methylation420 and [O2]421, it may thus be plausible to suggest that O2-
dependent regulation of Tet activity may directly impact miRNA expression to 





3.4.5 Conclusion  
 
To conclude, changes in [O2] were shown here to affect the patterning of mESC cellular 
differentiation, consistent with the notion of O2 acting as a morphogen during early 
embryogenesis. A more hypoxic environment (1% O2), compared to atmospheric O2, 
delayed the onset of mESC differentiation through an increase in pluripotency marker 
expression and predominantly skewed differentiation away from the neuroectoderm 
lineage. Tet enzymes were investigated to determine whether at least in part they could 
mediate the skewing effects of low O2 upon cellular differentiation and thus act as O2 
sensors. For their sensor capabilities to be true, the presence of Tet enzymes in ESCs 
was firstly confirmed. Secondly, the activities of the Tet enzymes were shown to display 
differential regulation by physiologically relevant O2 concentrations. Thirdly, functionally, 
genetic ablation of each Tet was shown to induce pluripotency marker expression during 
mESC differentiation (consistent with the effects of 1% O2) and via Tet overexpression 
studies were each shown to differentially regulate miRNA expression. However, it should 
be noted that differentiation of Tet ablated mESCs failed to recapitulate the skewing of 
lineage markers seen by 1% O2, alluding to the involvement of additional O2-dependent 






































4.1.1 Dynamic expression of 5-hmC in differentiating ESCs   
 
Implantation of the blastocyst to the uterine wall results in depletion of ESCs as they 
start to differentiate into more specialised cell types. Attempts to recapitulate early 
embryonic events by the differentiation of ESCs in vitro revealed the loss of 5-hmC, 
compared to undifferentiated cells, after 5 days of EB formation168. Additionally, it was 
independently shown, via a glucosylation assay, that 5-hmC was lost after 4 days of EB 
formation in 2 separate mESC lines, compared to levels in undifferentiated cells422. 
Intriguingly, 5-hmC in differentiating EBs were noted to increase from day 4 to day 8, but 
levels remained over 50% lower than in undifferentiated cells422. Alternatively, by a 
mass-spectrometry approach, it was shown 5-hmC in day 1-differentiated cells was 
elevated, compared to undifferentiated cells, and then subsequently gradually 
decreased to day 7423. 5-hmC levels were then see to increase to levels equivalent to 
undifferentiated cells by day 10423. However, it should be considered the calculation of 
5-hmC levels was performed by normalisation to the combined sum of 5-mC and 5-hmC, 
not total C (C, 5-mC and 5-hmC) and thus will not account for changes in C that may 
arise from proliferation. In comparison, 5-mC levels showed a gradual increase at the 
onset of differentiation, but plateaued by day 3423. These distinct profiles may therefore 
suggest different functional roles of 5-hmC and 5-mC in cell specification. However, the 
exact dynamic profile of 5-hmC during ESC differentiation requires further elucidation 
with a more valid method of quantitation.  
 
4.1.2 Activation of Tet enzymes by Ascorbic acid may control 5-hmC generation 
and distribution during embryogenesis  
 
The importance of a dietary intake of AA, commonly known as vitamin C, was brought 
about through the ability of oranges and lemons to treat scurvy in the early 18th 
century424,425. Scurvy symptoms, such as gum disease and poor wound healing are a 
result of defective collagen production125,426. The synthesis of hydroxyproline, a major 
component of collagen, occurs enzymatically by collagen prolyl-4-hydroxylase427. This 
enzyme belongs to the 2-OGDO family and requires AA as a cofactor for its activity428. It 
is believed that AA maintains 2-OGDOs in an active state, thus enabling continued 
cycling of the enzymes, by the reduction of Fe3+ to Fe2+ 125,427. This is supported by an 
investigation into the effects of AA upon PHD inhibition induced by either O2 deprivation, 
2-OGDO competition, iron chelation or transition metal-induced toxicity429. AA had a 
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profound effect on preventing HIF-1 protein stabilisation specifically in response to iron 
competition429 (the iron chelator desferrioxamine (DFO), Co2+ and Ni2+ all induced HIF-
1 through poisoning of the hydroxylases via removal of enzyme-bound iron125). The 
importance of AA for 2-OGDO activity can also be depicted from Km values, which for 
PHDs range from 140-180 M430, suggesting a high intracellular requirement and 
therefore susceptibility to AA loss125.  
 
The requirement of 2-OGDO’s for AA suggests that Tet-mediated 5-hmC generation may 
be regulated in part through this co-factor. Indeed, it has previously been observed that 
AA can induce DNA demethylation431,432,433 through enhanced Tet activity434.  In mESCs 
it has been reported that the addition of AA induces not only 5-hmC but also the further 
oxidation products 5-fC and 5-caC, suggesting activation of the active DNA 
demethylation pathway434. Furthermore, this study demonstrated that Tet1- and Tet2- 
silenced mESCs failed to induce 5-mC oxidation in the presence of AA, an effect restored 
upon re-expression of Tet2434. This finding was closely mimicked by an additional study, 
which confirmed the effects of AA are Tet-dependent, and further demonstrated that AA 
induced widespread DNA demethylation at the promoters of germ-line genes, resulting 
in their subsequent activation435. Interestingly Tet1 was found to be enriched at 
promoters that gained 5-hmC with AA treatment435, which may suggest Tet1 mediates 
the AA-induced 5-hmC at developmental genes. Additionally Tet1 was found to be 
implicated in somatic cell reprogramming in a AA-dependent fashion436. This finding may 
be due to the necessity of AA to induce hydroxylation and therefore maintain low levels 
of 5-mC, required for naïve pluripotent stem cells437. Overall, this suggests AA may 
function as a switch, dependent on exact concentrations, to determine Tet1 function.  
 
This effect of AA was also found to be applicable to other cell types including MEFs, 
which demonstrated a time-dependent increase in 5-hmC with AA treatment, an effect 
lost by combined siRNA targeting of Tet1, Tet2 and Tet3. Moreover, AA is highly 
concentrated in the brain, especially during embryogenesis, and facilitates the 
differentiation of neural stem cells into dopaminergic neurons438. Mechanistically, 
enhanced transcription of dopaminergic neuronal genes was associated with AA-
mediated induction of 5-hmC by Tet1 within promoter regions439. In addition, AA has also 
been shown to potentiate Tet2 and Tet3, which functionally has been demonstrated to 
increase stability of the Foxp3 TF, required for the development and function of 
regulatory T-cells440.  
 
Finally, it should be considered that unlike HIFs where AA can be substituted for the 
GSH reducing agent430, Tet enzymes have an absolute requirement for AA 
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specifically434,435,441. Therefore, the availability of AA may have implications in health and 
disease through epigenetic control of the genome441.  
 
4.1.3 Tet proteins cross-talk with histone modifications to regulate gene 
transcription 
 
Aside from Tet-mediated DNA demethylation as a means of gene-transcriptional 
regulation (see Chapter 1: General Introduction), Tet proteins co-operate with histone 
marks to control transcription of developmental genes189.  
 
Nucleosomal histones can be post-translationally modified by addition of the 
monosaccharide β-N-acetylglucosamine (GlcNAc) to the hydroxyl group of serine or 
threonine residues to form an O-linked -N-acetylglucosamine (O-GlcNac) residue442,443.  
The process of O-GlcNacylation is mediated by OGT, which was unexpectedly found to 
interact with Tets189. OGT complexes with Tet1 and Tet2 in the nucleus of ESCs, and 
Tet1 specifically has been shown to co-localise with OGT at H3K4me3 positive 
promoters190. Intriguingly, Tet1 and OGT were also found to complex, with Hcf1. Hcf1 is 
a component of the H3K4 methyltransferase SET1/COMPASS complex444 and is 
modified by OGT192 to elevate H3K4me3 to induce transcriptional activation189. 
Furthermore, genetic ablation studies in HEK cells showed the association of Tet2 and 
Tet3 with OGT at H3K4me3 enriched promoters was essential for transcriptional 
activation191. Mechanistically it was shown in this model the Tet-OGT complex targeted 
Hcf1 to control levels of H3K4me3191. Overall, this suggests a functional connection 
between OGT, Tet proteins and the transcriptional activating H3K4me3 mark.  
 
Another prominent mechanism of modifying chromatin is through the Polycomb group of 
proteins (PcG). PcG protein complexes are classified into 2 major families, Polycomb 
repressor complex 1 (Prc1), which has a E3 ubiquitin ligase activity for the 
monoubiquitylation of histone H2A, and Prc2, which has methyltransferase activity for 
the generation of H3K27me2/3445. Prc2 has a core trimeric protein complex containing 
the Ezh1/2 catalytic subunit responsible for depositing H3K27me2/3 marks446,447, 
facilitating the recruitment of additional PcG proteins448 to contribute to the transcriptional 
repressed chromatin state.  
 
Cross-talk between 2 epigenetic silencing mechanisms, DNA methylation and Prc2-
H3K27me2/3 is widely evident since the discovery of an interaction between Dnmts and 
the Ezh2 subunit449. In support of this, it was later demonstrated in DNA hypomethylated 
somatic cells that H3K27me3 and Prc2 was lost from target gene promoters, which 
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subsequently resulted in ectopic expression in some of these genes450. Alternatively it 
has been reported that antagonism exists between 5-mC and H3K27me2/3 at the murine 
imprinted Rasgfr1 locus, whereby either mark prevents placement of the other and are 
thus considered mutually exclusive451. Furthermore, unmethylated CG regions have 
been linked to the recruitment of the Prc2 complex452,453 and perturbation of DNA 
methylation patterns resulted in redistribution H3K27me3454. Finally, in mESCs the loss 
of 5-mC through ablation of Dnmt activity resulted in the induction of H3K27me3 at sites 
of fully methylated regions in wild-type cells455. Therefore, in light of these data the exact 
relationship between 5-mC and Prc2 remains elusive, but further insight may be gained 
into this transcriptional regulatory complex through consideration of the role of DNA 
demethylation and thus the 5-hmC mark.  
 
The current understanding of Tet involvement with PcGs is relatively unexplored, 
however it is documented that in mESCs Tet1 binds to CG rich promoters of Polycomb-
repressed genes194. In a separate study, unique to undifferentiated mESCs, 5-hmC was 
found to co-localise with Prc2 and in fact Prc2 was found to be responsible for 
recruitment of Tet1 to H3K27me3 genomic regions456. However, it should also be noted 
that the reverse effect has been reported, such that Tet1 itself has been shown to 
facilitate Prc2 recruitment194. Functionally, in differentiated cells, it has been shown that 
Prc2 can function to decrease Tet1 expression via H3K27me3 deposition457, which 
therefore may present a mechanism to silence the Tet1-dependent pluripotency network 
upon induction of differentiation. 
 
The active (H3K4me3) and repressive (H3K27me3) histone marks can coexist at 
developmental genes within pluripotent ES cells, a situation referred to as bivalency458. 
This concept of bivalency, having 2 apparent functionally opposing histone marks 
together at a promoter, enables genes to be actively poised for rapid activation193,459. 
The presence of the H3K27me3 mark on lineage specific genes within pluripotent cells 
is necessary to prevent premature expression, as demonstrated by the increase in 
ectoderm differentiation upon disruption of the Prc2 complex460. Therefore, in response 
to developmental signalling cues promoters become resolved into monovalent chromatin 
structures of either H3K4me3 and H3K27me3, resulting in gene activation or silencing 
respectively460. Genome-wide profiling revealed promoters of genes such as 
developmental TFs in ESCs with a high CpG density carry this bivalent signature, but 
this is not always limited to pluripotent cells461. These initial in vitro studies reporting 
bivalency involve the maintenance of pluripotency in a simulated environment, and 
therefore their existence has been linked to the culture conditions462. However, this 
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bivalency phenomenon has been shown to occur in vivo using an adapted ChIP 
methodology in mouse Epi cells of the early post-implantation embryo463 and in PGCs464.  
 
As described above, there is a clear link between Tets/5-hmC and these 2 histone 
methylation marks, but only recently it was made apparent that Tets are involved in the 
de novo establishment and maintenance of the H3K4me3/H3K27me3 bivalent 
domains465. Tet2 overexpression in HEK cells induced loci-specific bivalent domain 
formation at promoters of genes normally found hypermethylated and lacking these 
histone methylation marks465. Furthermore, depletion of Tet1/Tet2 in mESCs led to the 
loss of H3K27me3 and thus bivalency465. No effect upon H3K4me3 was evident likely  
due to binding of this histone mark to CpGs that are unmethylated466. Overall, this 
crosstalk between Tets and histone methylation highlights the ability to fine-tune gene 
transcription. It also may be plausible to speculate that O2 is involved in the regulation 
between these epigenetic marks owing to the 2-OGDO domain, which is not only present 













To determine the profiles of 5-mC and 5-hmC during a time course of mESC 
differentiation exposed to atmospheric and low [O2]. In addition, the aim is to identify the 
Tet enzymes responsible for regulating 5-hmC during cellular differentiation and 

































 Results  
 
4.3.1 A transient burst of 5-hmC was detected during mESC differentiation  
 
To begin to investigate the profile of DNA methylation marks during cellular 
differentiation, the global levels of 5-mC and 5-hmC over an 11-day time course of mESC 
differentiation were determined by dot-blot analysis (Figure 4:1). This revealed that 5-
mC levels increased between days 1 and 3, and continued to be maintained at this 
expression level over the remaining differentiation time course. 5-hmC demonstrated a 
more dynamic profile, showing a significant burst at day 3, which subsequently 
decreased to levels equivalent to those of undifferentiated cells by day 11. This transient 
burst of 5-hmC was also confirmed by analysing the levels of 5-mC in the form of a 5-
hmC:5-mC ratio at each of the tested time points. To verify these findings mass 
spectrometry was used to detect C, 5-mC and 5-hmC, enabling the amount of 5-hmC to 
be normalised to total C within each sample (C, 5-mC and 5-hmC) (Figure 4:2). This 
analytical approach reduced the variability within sample groups, compared to dot-blot 
analysis, and confirmed the expression profile of both methylation marks. Interestingly, 
the significant elevation of 5-hmC at day 1 was not preceded by increased 5-mC levels, 
which may infer that hydroxylation occurred at already existing methylated residues or 





















Figure 4:1 mESCs demonstrate a burst of 5-hmC at day 3 of cellular 
differentiation. mESCs were induced to differentiate over an 11 day time course 
and DNA harvested to assess 5-mC and 5-hmC levels by dot-blot analysis. 
Quantifcation of 5-mC, 5-hmC and the ratio of 5-hmC:5-mC is shown relative to 
undifferentiated mESCs. Data are expressed as the mean  SEM and analysed by 















4.3.2 Compared to atmospheric O2, levels of 5-hmC during mESC differentiation 
are reduced in 1%, but not 3% O2 
 
To establish whether altering [O2] can affect the dynamic 5-hmC profile during 
differentiation, mESCs were induced to differentiate over the same time course as shown 
in section 4.3.1, but in 3% and 1% O2. Dot-blot analysis (Figure 4:3) revealed 3% O2, 
compared to atmospheric O2, had minimal effects on the 5-hmC profile, the only 
significant change being a rather unexpected increase in hydroxylation at day 7. By 
contrast, 1% O2, compared to atmospheric O2, consistently and significantly reduced 5-
hmC levels at all time points, except for days 1 and 11.  
 
Compared to dot-blot analysis, mass-spectrometry (Figure 4:4) reported additional 
significant differences in 5-hmC levels under 3% O2, compared to atmospheric O2. In 
light of these data it may be suggested that 3% O2 acts to delay the burst of 5-hmC at 
day 3, and subsequently prevents its decrease until day 7. Furthermore, under 1% O2 
the blunting of the 5-hmC burst at day 3 was clearly evident, and additionally each 
differentiation time point showed significantly reduced levels of hydroxylation. Finally, it 
can be noted that neither [O2] had a significant effect on levels of 5-hmC in 
undifferentiated mESCs.  
Figure 4:2 Mass-spectrometry analysis confirms a burst of hydroxylation in 
day 3-differentiated mESCs. mESCs were differentiated over an 11 day time 
course and DNA harvested for C, 5-mC and 5-hmC quantitation by mass-
spectrometry analysis. Data are expressed as the mean  SEM relative to 
undifferentiated cells. Data are normalised to total C and analysed by a one-way 





















Figure 4:3 1% O2, but not 3% O2, reduces 5-hmC levels during mESC 
differentiation, compared to atmospheric O2. mESCs were differentiated over an 
11 day time course in atmospheric, 3% and 1% O2 and levels of 5-mC and 5-hmC 
were measured by dot-blot analysis. Data are expressed as the mean  SEM relative 
to undifferentiated mESCs exposed to atmospheric O2, and analysed by a two-way 
































4.3.3 Tet1 is predominately responsible for the burst of 5-hmC in day 3- 
differentiated mESCs  
 
To determine which Tet paralogue may be catalysing the observed O2-dependent burst 
of hydroxylation, the mRNA expression of each Tet enzyme over the time course of 
mESC differentiation was assessed (Figure 4:5). mRNA expression levels of Tet1 and 
Tet2 declined significantly, compared to undifferentiated levels, over the differentiation 
time course. In contrast, Tet3 mRNA expression increased between days 3 and 7 to give 
a 6.5-fold induction above undifferentiated levels, and this increase was maintained at 
day 11. Therefore, Tet1 and Tet2 mRNA decreased concomitant with the burst of 5-hmC 
at day 3, while Tet3 expression remained low until after the time point at which 5-hmC 
levels had peaked. Thus, neither Tet mRNA expression profiles could explain the burst 
of hydroxylation at day 3. Assessment of the relative expression levels of each Tet 
paralogue at day 3 revealed Tet1 was approximately 40-fold and 250-fold more highly 
expressed that Tet2 and Tet3 respectively (Figure 4:6). Hence, Tet1 being the most 
highly expressed suggests it is most likely to be responsible for the burst of hydroxylation 
at this time point.  
 
Figure 4:4 Mass-spectrometry confirms reduced hydroxylation in 1% O2, 
compared to atmospheric O2, during mESC differentiation. mESCs were 
differentiated over an 11 day time course in atmospheric, 3% and 1% O2 and DNA 
harvested for C, 5-mC and 5-hmC quantitation by mass-spectrometry analysis. Data 
are expressed as the mean  SEM relative to undifferentiated mESCs exposed to 
atmospheric O2. Data are normalised to total C and analysed by a two-way ANOVA 










Figure 4:5 Tet1 and Tet2 expression is decreased, whereas Tet3 expression is 
increased during mESC differentiation. The expression of Tet1, Tet2 and Tet3 was 
assessed during an 11 day time course of mESC differentiation by QPCR analysis. 
Data are expressed as the mean  SEM relative to undifferentiated mESCs, and  































To show functionally which Tet enzyme is responsible for mediating the burst of 5-hmC, 
genetically-ablated Tet mESC lines were differentiated for 3 days and levels of 5-hmC 
were detected by both dot-blot (Figure 4:7) and mass-spectrometry (Figure 4:8) analysis. 
Firstly, it was apparent that the induction of 5-hmC in shRNA control samples between 
undifferentiated and day 3 mESCs is consistent with the 5-hmC profile shown in Figure 
4:1 and Figure 4:2. The silencing of each Tet paralogue revealed that Tet1, but not Tet2 
or Tet3, reduced significantly the burst of 5-hmC at day 3, compared to shRNA control 
cells. This result was confirmed through mass-spectrometry, but in addition a small but 
significant drop in 5-hmC levels in Tet2- and Tet3- ablated mESCs compared, to shRNA 
controls was also identified. This was likely due to the highly accurate analytical method, 
resulting in little variability, leading to small errors between samples. However, it 
remained apparent that Tet1 ablation induced the greatest blunting effect of the burst of 
5-hmC. Overall these data confirm that Tet1 is at least in part responsible for this 





Figure 4:6 Tet1 is the most abundent isoform in day 3-differentiated mESCs. 
The relative expression levels of Tet1, Tet2 and Tet3 in day 3-differentiated mESCs 
was assessed by QPCR analysis. Data are expressed as the mean  SEM and 

























































Figure 4:7 Tet1 is predominately responsible for the day 3 burst of 5-hmC in 
differentiating mESCs. 5-hmC levels were detected by dot-blot analysis in 
undifferentiated and day 3-differentiated shRNA control mESCs or mESCs silenced 
for either Tet1, Tet2 or Tet3. Data are expressed as the mean  SEM relative to 
undifferentiated shRNA control cells, and analysed by a two-way ANOVA with 


















































Figure 4:8 Mass-spectrometry analysis confirmed Tet1 is predominantly  
responsible for the hydroxylation in day 3-differentiated mESCs. C, 5-mC and 
5-hmC levels were detected by mass spectrometry in undifferentiated and day 3-
differentiated shRNA control mESCs or mESCs silenced for either Tet1, Tet2 or 
Tet3. Data are expressed as the mean  SEM relative to undifferentiated shRNA 
control cells. Data are normalised to total C and analysed by a two-way ANOVA with 
Dunnett’s post-hoc analysis. **** p<0.001, **** p<0.0001. KD: knockdown. 
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4.3.4 Tet1 ablation or 1% O2 blunts the transient burst of 5-hmC to equivalent                    
levels  
 
As previously shown in section 3.3.6, the activity of ectopically-expressed Tet1 in HEK 
cells was found to be inhibited at O2 concentrations of 3% and less. Thus, to further 
investigate whether Tet1 could be responsible for mediating the O2-dependent burst of 
5-hmC, levels of hydroxylation at day 3 in Tet1 KD and 1% O2 treated mESCs were 
measured (Figure 4:9). These data demonstrated that the transient burst of 5-hmC is 
reduced to equivalent levels by depletion of Tet1 or by 1% O2. However, combination of 
Tet1 ablation and 1% O2 induced a cumulative inhibitory effect, resulting in a reduction 
of 5-hmC to levels to those detected in undifferentiated mESCs. 1% O2 inhibits Tet1 
activity to 50% (Figure 3:23), compared to atmospheric O2, which could explain why 5-
hmC remains elevated at day 3, above undifferentiated levels. Furthermore, Tet1 KD 
failed to result in the complete loss of Tet1 protein (Figure 3:28), therefore a combination 

























Figure 4:9 Tet1 ablation and 1% O2 reduces 5-hmC to equivalent levels in day 
3-differentiated mESCs. 5-hmC levels were quantified by dot-blot analysis for 
shRNA control or Tet1-depleted mESCs in either their undifferentiated state or after 
3 days of differentiation in atmospheric and 1% O2. Data are expressed as the mean 
 SEM relative to shRNA control undifferentiated cells, and analysed by a one-way 
ANOVA with Tukey’s post-hoc analysis. *** p<0.001, ***** p<0.0001. KD: 
knockdown. 
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4.3.5 Ascorbic acid increases 5-hmC in undifferentiated, but not differentiating, 
mESCs  
 
The transient burst of 5-hmC did not correlate explicitly with an increase in mRNA 
expression of any of the Tet paralogues. Hence the activity of the Tet enzyme(s) may be 
increased to generate more 5-hmC at day 3. Aside from O2 and TCA metabolites, the 
activity of Tets can also be upregulated by AA125. To confirm this, undifferentiated 
mESCs were exposed to increasing AA concentrations and 5-hmC levels measured 
(Figure 4:10). AA treatment resulted in a dose-dependent increase in 5-hmC over a 
specific range, reaching a maximal 2-fold induction, compared to untreated cells. 
















Figure 4:10 Ascorbic acid induces a dose-dependent increase in 5-hmC in 
undifferentiated mESCs. Undifferentiated mESCs were treated with increasing 
concentrations of AA (0.01 mM - 5 mM) for 24 hrs. DNA was extracted for  5-hmC 
quantification by dot-blot analysis.  
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To determine whether the transient burst of 5-hmC could be further potentiated by 
exogenous AA, mESCs were differentiated for 3 days in the presence of 1 mM AA 
(Figure 4:11). No significant increase in 5-hmC was detected between untreated and 




























Figure 4:11 Ascorbic acid fails to potentiate the day 3 induction of 5-hmC in 
mESCs. mESCs were differentiated in the absence and presence of 1 mM AA for 3 
days. DNA was extracted and 5-hmC levels quantified by dot-blot analysis. Data are 
expressed as the mean  SEM relative to undifferentiated cells, and analysed by a 
one-way ANOVA with Tukey’s post-hoc analysis. **** p<0.0001 
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4.3.6 Vitamin C transport and synthesis   
 
Vitamin C exists in its reduced form, AA, as well as its oxidised form, DHA467. Transport 
of both forms across the membrane occurs via 2 distinct groups of transporter proteins. 
To establish whether there may be a potential influx in either form of vitamin C during 
differentiation, which might account for the observed transient burst of 5-hmC, the mRNA 
expression of each transporter across the time course of mESC differentiation was 
established. Svct1 and Svct2, responsible for the transport of AA468,469, demonstrated 
distinct expression profiles. Svct1 showed a transient burst at day 7, compared to 
undifferentiated cells, whereas no expression changes for Svct2 were detected over the 
time course tested (Figure 4:12). Overall, it can be concluded that expression of these 
transporters would not account for the increased Tet activity via increased AA transport. 
 
DHA transport is facilitated by the Glut transporters, specifically Glut1,3 and 4470. Glut1 
and 3 showed similar expression profiles (Figure 4:13), with a burst of expression 
detected at day 7. It can be noted Glut1 was significantly increased at all differentiation 
time points, compared to undifferentiated cells. Glut 4 mRNA was barely detectable (data 
not shown). The expression profile of these transporters also does not correlate with the 
burst of 5-hmC at day 3. It should be recognised that in plasma AA is only detectable471, 
therefore Glut transporters are not required for transport of DHA from the maternal 




 Figure 4:12 Svct1 mRNA expression shows a transient burst in day 7-
differentianted mESCs. The expression of AA transporters Svct1 and Svct2 over 
an 11 day time course of mESCs differentiation was detected by QPCR. Data are 
expressed as the mean  SEM relative to undifferentiated cells, and analysed by a 









Endogenous AA synthesis occurs in mice by L-gulonolactone--oxidase (Gulo), which 
converts L-gulonolactone, formed from D-glucose, to L-ascorbic acid472.  Note, this 
enzyme is not present in man or guinea pigs and therefore AA must be acquired from 
the diet473,474. An increase in mRNA expression of Gulo may infer to a greater production 
of AA, which therefore may function to increase Tet activity and account for the transient 
5-hmC burst in day 3-differentiated mESCs. However, Gulo expression was only shown 
to increase significantly from undifferentiated mESCs at day 11 (Figure 4:14), suggesting 






Figure 4:13 Glut1 and Glut3 mRNA expression peaks in day 7-differentiated 
mESCs. The expression of DHA transporters Glut 1 and Glut 3 over an 11 day time 
course of mESCs differentiation was detected by QPCR. Data are expressed as the 
mean  SEM relative to undifferentiated cells, and analysed by a one-way ANOVA 






























4.3.7 Manipulation of 5-hmC levels by a reduction in AA levels induced by 
buthionine sulfoximine and phloretin treatment  
 
To investigate further whether 5-hmC levels might be dependent upon the regulation of 
Tet activity by AA, the effect of inhibition of AA uptake and DHA reduction by phloretin475 
and BSO476 respectively were studied. Phloretin prevents AA uptake through inhibition 
of the sodium-dependent transporters, Svct1 and Svct2476 (and also Glut2477). In 
comparison, BSO inhibits -glutamylcysteine synthetase, which is responsible for GSH 
synthesis478. GSH reduces and recycles DHA to AA479, and thus makes AA available as 
a cofactor for Tet enzymes (and other 2-OG-dependent dioxygenases). 
 
Undifferentiated mESCs were treated with 1 mM BSO or 200 M phloretin and 
separately pre-treated with either BSO or phloretin for 3 hrs before the addition of 1 mM 
AA (Figure 4:15). Cells were harvested 24 hrs after treatments. BSO treatment had no 
significant effect on 5-hmC levels compared to untreated cells and perhaps as expected, 
had no inhibitory effects in combination with exogenous AA treatment. In comparison, 
phloretin also had no significant effect on 5-hmC levels, compared to its DMSO vehicle 
control. However, in combination with AA, phloretin did blunt the increased 5-hmC.  
Figure 4:14 L-gulonolactone--oxidase mRNA expression is induced in day 11-
differentiated mESCs. The mRNA expression of the AA synthesis gene Gulo was 
assessed over an 11-day time course of mESC differentiation by QPCR. Data are 
expressed as the mean  SEM relative to undifferentiated cells, and analysed by a 

























Figure 4:15 Phloretin inhibits uptake of Ascorbic Acid in undifferentiated 
mESCs. Undifferentiated mESCs were treated with 1 mM AA, or left as an untreated 
control, for 3 hrs, prior to the addition of 1 mM BSO or 200 M phloretin. DNA was 
extracted 24 hrs post AA addition and 5-hmC levels quantified by dot-blot analysis. 
Data are expressed as the mean  SEM relative to untreated or DMSO vehicle 
control, for BSO and phloretin treatments respectively. Data are analysed by a one-
way ANOVA with Dunnett’s post-hoc analysis. *** p<0.001, **** p<0.0001 
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To determine the effect of AA upon the transient burst of 5-hmC, mESCs were 
differentiated for 3 days in the presence of BSO or phloretin (Figure 4:16). BSO treatment 
demonstrated a modest dose-dependent inhibitory effect on 5-hmC levels, compared to 
untreated cells. Despite a minimal effect, these data suggest AA may have some 
contribution to the burst of 5-hmC at day 3. Phloretin exerted no repressive effect on 5-
hmC levels, compared to DMSO vehicle control treated cells, thereby suggesting that 
















Figure 4:16 Buthionine sulfoxime modestly reduced 5-hmC levels in day 3-
differentiated mESCs. mESCs were induced to differentiate in the presence of 
increasing concentrations of BSO (100 M-1 mM) or phloretin (100 M-200M) for 
3 days. DNA was extracted and 5-hmC levels quantified by dot-blot analysis. Data 
are expressed as the mean  SEM relative to undifferentiated mESCs. Data are 
analysed by a one-way ANOVA with Dunnett’s post-hoc analysis. * p<0.05, ** 
p<0.01, *** p<0.001, **** p<0.0001 
 171 
4.3.8 Differing AA content of mESC maintenance and differentiating medium had 
no influence upon the burst of 5-hmC in day 3-differentiated cells  
 
mESCs were maintained and differentiated in 2 distinct types of medium (Chapter 2: 
Material and Methods). While the levels of AA in maintenance medium were low (8.6 M 
in Advance DMEMF-12), the amount contained within the KO serum replacement, used 
for differentiation experiments is understood to be considerably higher (Invitrogen pers. 
comm.), although the exact amounts are proprietary480. To ensure that the burst of 5-
hmC in day 3-differentiated mESCs was not due to changes in cell medium and thus 
potentially AA concentration, undifferentiated mESCs were cultured in maintenance 
medium or maintenance medium supplemented with 15% KO serum replacement (as 
used in differentiation studies) instead of EmbryoMax FBS. In addition, cells 
maintained under these 2 serum-differing conditions were induced to differentiate to day 
3, under normal differentiating KO serum conditions. In this way, the effect of switching 
from EmbryoMax FBS to KO serum (and hence changing AA levels) upon 5-hmC 
levels was determined.  
 
KO serum elevated 5-hmC, compared to EmbryoMax, in undifferentiated mESCs, but 
not to the same extent as 1 mM AA treatment (Figure 4:17). At day 3 of mESC 
differentiation the burst of hydroxylation was evident for cells maintained undifferentiated 
in either serum condition, compared to undifferentiated levels (Figure 4:17). Crucially no 
significant difference was observed in the relative 5-hmC levels between these serum 
conditions. Therefore, it can be concluded that differing AA amounts in cell medium has 
no influence upon the burst of 5-hmC at day 3. This is also supported by the data from 

















Figure 4:17 KnockOut serum moderately increases 5-hmC in 
undifferentiated mESCs, but has no influence on the burst of hydroxylation in 
day 3-differentiated mESCs. 5-hmC levels were quantified from undifferentiated 
mESCs cultured in maintenance medium (containing EmbryoMax FBS) or 
maintenance medium supplemented with 15% KO serum instead of EmbryoMax, 
and compared to 1 mM AA treated mESCs (maintained under normal EmbryoMax 
conditions). In addition, 5-hmC levels were determined for mESCs maintained under 
these 2 serum conditions after 3 days of differentiation (under normal KO serum 
differentiating conditions). Dot-blot quantified data was expressed as the mean  
SEM relative to normally maintained (EmbryoMax) undifferentiated cells. Data are 
analysed by a one-way ANOVA with Tukey’s post-hoc analysis. * p<0.05, ** p<0.01 
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4.3.9 The transient day 3 burst of 5-hmC is predominately targeted to a Tet3 
promoter region  
 
To identify the genomic targets of the burst of 5-hmC at day 3 of mESC differentiation, a 
hMeDIP-seq study was conducted (workflow schematically shown in (Figure 4:18)). 610 
gene loci were identified to be enriched greater than 2-fold compared to total genomic 
input DNA (see supplementary data table in Burr, S et al (2017)481). Unexpectedly the 
largest enrichment, which was more than 7-fold higher than other identified loci, was 
mapped to a CG-rich promoter region of the Tet3 gene, which also comprised the 
B230319CO9Rik sequence tag (visualised in Figure 4:19). Functional annotation 
clustering of the gene list using the DAVID Gene Functional Annotation Tool 
(https://david.ncifcrf.gov) revealed the most enriched cluster to contain 55 genes that 
were associated with developmental and differentiation pathways (see screen shot in 
Figure 4:20A). In addition, some clusters highlighted a selection of genes involved in the 
development of specific tissues, including cardiac morphogenesis (see screen shot in 














































Figure 4:18 Workflow for 5-hmC-DNA immunoprecipitation-sequencing. 
Isolated genomic DNA was sonicated into 200-600 bp fragments and 5-hmC DNA 
was captured and purified by antibody immunoprecipitation. Next-generation 
sequencing libraries were prepared from 5-hmC enriched DNA (this involved the 
following steps: dA tailing, adaptor ligation, size selection, barcoding and PCR 
amplification). The library pools were sequenced and analysed to identify the 
genomic locations containg the 5-hmC mark. Adapted from Li, D et al. Methods. 





























Figure 4:19 5-hmC-DNA immunprecipitation-sequencing revealed Tet3 is 
enriched for hydroxylation in day 3-differentiated mESCs. hMeDIP-seq 
conducted on day 3-differentiated mESCs revealed Tet3 and also the non-coding 
B230319C09Rik transcript was a target for hydroxylation. Data are visualised by an 
annotated screen-shot from the Integrative Genomics Viewer.   
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Figure 4:20 Functional annotation clustering of 601 gene loci identified from 
5-hmC-DNA immunprecipitation-sequencing in day 3-differentiated mESCs. 
601 gene loci were identified from hMeDIP-seq that displayed a greater than 2-fold 
enrichment compared to input DNA. Functional annotation clustering of these loci 
using the DAVID Gene Functional Annotation Tool (accessed at 
https://david.ncifcrf.gov) revealed (A) developmental associated genes, comprising 
55 loci, was the most enriched cluster. Other annotated clusters included tissue 
specific genes involved in (B) cardiac and (C) neural development.  
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4.3.10 The CG-rich Tet3 promoter region gains de-novo 5-hmC at the onset of 
differentiation  
 
To establish whether this Tet3 promoter region acquires 5-hmC as a result of 
differentiation, or alternatively is associated with this mark in undifferentiated mESCs, 
genomic DNA from undifferentiated and day 3-differentiated mESCs was subjected to 
bisulfite and oxidative-bisulfite treatment (TrueMethyl Whole Genome kit). A 200 bp 
fragment containing 3 CpGs within the same Tet3 promoter region as that enriched for 
5-hmC, shown in Figure 4:19, was amplified by PCR and the amplicon sequenced to 
assesses the methylation and hydroxymethylation status (Figure 4:21). Bisulfite 
treatment acts to convert all unmethylated C residues to uracil (U), which are 
subsequently converted to thymine (T) in the PCR reaction. Methylated and 
hydroxymethylated residues are protected from conversion to U and thus remain as a C. 
In undifferentiated mESCs all 3 CpG dinucleotides were devoid of methylation (and 
hydroxymethylation). However, in day 3-differentiated samples all CpGs were converted 
to C, depicted by the arrow, indicative of containing the 5-mC or 5-hmC marks. To 
distinguish between these modifications an oxidative bisulfite step was implemented. 
This oxidative step converts C to U and oxidises 5-hmC to 5-fC, but has no effect on 5-
mC. After the PCR reaction 5-fC (and U) is converted to T while 5-mC remains as a C 
residue. 2/3 CpGs within this PCR amplicon were converted to T, indicating the presence 
of the 5-hmC mark. The remaining CpG, as represented by the arrow, persisted as a C 
residue, suggesting the presence of the 5-mC mark. Overall, these data show that no 
methylation is present within this Tet3 promoter region in undifferentiated mESC, but 














































Figure 4:21 Bisulfite and Oxidative Bisulfite treatment revealed enrichment of 
hydroxylation within the Tet3 promoter region from undifferentiated to day 3-
differentiated mESCs. DNA extracted from undifferentiated and day 3-
differentiated mESCs were subjected to bisulfite and oxidative bisulfite treatment 
(TrueMethyl Whole Genome kit). A 200 bp fragment containing 3 CpG 
dinucleotides within a Tet3 promoter region was amplified from these samples and 
its methylation status interrogated by Sanger sequencing. Shown here are screen 
shots from Sanger sequencing chromatograms (4Peaks software), annotated with 
arrows to depict methylated CpGs (5-mC or 5-hmC) in bisulfite treated samples and 
the 5-mC-containing CpG in oxidative-bisulfite samples. CMS=5-
methylenesulfonate. 
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4.3.11 Tet1 is bound to this Tet3 promoter region in undifferentiated and day 3-
differentiated mESCs  
 
Tet1 has previously been shown to mediate, at least in part, the transient burst of 5-hmC 
apparent within day 3-differentiated mESCs (see section 4.3.3). The most significant 
target of this hydroxylation was found to be a CG-rich Tet3 promoter region (see Figure 
4:19), which therefore may suggest potential for an interaction between Tet1 and Tet3. 
To determine whether Tet1 was localised to this Tet3 promoter region a ChIP assay was 
performed on undifferentiated and day 3-differentiated mESCs. It was confirmed that 
Tet1 was bound to this Tet3 promoter region in both undifferentiated and in day 3-
differentiated mESCs by semi-quantitative PCR (Figure 4:22). QPCR analysis further 
revealed that Tet1 was bound with equivalent occupancy to this Tet3 promoter region in 





















Figure 4:22 Tet1 is bound to the Tet3 promoter in undifferentiated and day 3-
differentiated mESCs. Tet1 ChIP was performed on undifferentiated and day 3-
differentiated mESCs samples. A fragment of the Tet3 promoter region was amplifed 
by PCR from input DNA, IgG control and ChIP samples. PCR products were 































   
Figure 4:23 Tet1 is bound to Tet3 with equivalent occupancy in 
undifferentiated and day 3-differentiated mESCs. Assessment of Tet3 mRNA 
expression was determined by QPCR from chromatin isolated from undifferentiated 
and day 3-differentiated mESC samples, which had been immunoprecipitated using  
a Tet1-specific antibody. Data are expressed relative to undifferentiated mESCs.  
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4.3.12 The histone marks H3K4me3 and H3K27me3 share occupancy with 
Tet1 at this Tet3 promoter region  
 
Tet1 is known to be associated with bivalent gene promoters, whereby the chromatin is 
characterised by the presence of both activating (H3K4me3) and repressive 
(H3K27me3) histone marks194,193. Owing to the finding that Tet1 is localised to a CG-rich 
Tet3 promoter region in both undifferentiated and day 3-differentiated mESCs (see 
section 4.3.11), the potential association with histone marks at this locus was also 
assessed by ChIP. It was revealed that this Tet3 promoter region was occupied by both 
these histone marks in undifferentiated and day 3-differentiated mESCs (Figure 4:24). 
At day 3, the H3K4me3 mark persisted at a similar level to that in undifferentiated mESCs 
(demonstrated by the equivalently intense band). However, the repressive H3K27me3 
mark appeared to be decreased at day 3, compared to undifferentiated mESCs. QPCR 
analysis confirmed the decrease in H3K27me3 levels from undifferentiated to day 3-
differentiated mESCs (Figure 4:25). However, in contrast to the results of semi-
quantitative PCR analysis, H3K4me3 levels appeared increased at day 3 when 
assessed by QPCR.  
 
These data identified Tet3 as a bivalent promoter, and hence the decrease in H3K27me3 
(and maintenance/increase of H3K4me3) from undifferentiated to day 3-differentiated 
mESCs correlated with increased 5-hmC (see Figure 4:21) and the induction of Tet3 











Figure 4:24 The H3K4me3 and H3K27me3 histone marks are associated with 
the Tet3 promoter and appear maintained or lost respectively in day 3-
differentiated mESCs. H3K4me3 and H3K27me3 ChIP was performed on 
undifferentiated and day 3-differentiated mESCs. A fragment of the Tet3 promoter 
region was amplifed by PCR from input DNA, IgG control and ChIP samples. PCR 





Figure 4:25 The Tet3 promoter gains H3K4me3 and loses H3K27me3 between 
undifferentiated and day 3-differentiated mESCs. Assessment of Tet3 mRNA 
expression was determined by QPCR from chromatin isolated from undifferentiated 
and day 3-differentiated mESC samples, which had been immunoprecipitated using 




4.3.13 Ablation of Tet1 induced protein expression of H3K4me3 and H3K27me2 
 
Confirmation that Tet1 is associated with activating and repressive histone marks (see 
section 4.3.12) led to further investigation into the potential cross-talk between these 
epigenetic modifications. Global changes in the protein expression of the repressive 
(H3K27me2/3) and activating (H3K4me3) histone marks were assessed in Tet-ablated 
cells in day 3-differentiated mESCs (Figure 4:26). Tet1 silencing specifically induced 
expression of H3K27me2 and H3K4me3. Tet1- and Tet3- ablation both trended to 
increase H3K27me3, but failed to reach significance. Overall this confirms the presence 







Figure 4:26 Tet1 silencing induces H3K27me2 and H3K4me3 protein 
expression in day 3-differentiated mESCs. shRNA control and Tet-silenced 
mESCs were induced to differentiate for 3 days. Protein was extracted and 
H3K27me2/3 and H3K4me3 expression levels were determined by Western blot 
analysis. Data are shown as the mean  SEM from 3 independent experiments, and 
expressed relative to the shRNA control. Data are analysed by a one-way ANOVA 




4.3.14 The 5-hmC mark found to be enriched within the CG-rich Tet3 promoter 
region is lost by differentiating mESCs in 1% O2 
 
Differentiation of mESCs in 1% O2, compared to atmospheric O2, reduced 5-hmC levels 
(see section 4.3.2). To determine whether the hydroxylation enriched at the Tet3 
promoter region (identified in Figure 4:19) is reduced in a low [O2], hMeDIP-PCR analysis 
was conducted on day 3-differentiated mESCs exposed to atmospheric and 1% O2. 
Primers against the Tet3 promoter were designed to amplify close to the regions used 
for PCR amplification in bisulfite/oxidative-bisulfite and ChIP experiments, which 
encompassed the 5-hmC enriched area identified from the hMeDIP-seq study. 
 
In atmospheric O2, 5-hmC was as expected enriched within this Tet3 promoter region. 
However, this enrichment was lost in mESCs cultured in 1% O2 (Figure 4:27). The exact 
implication of this with respect to Tet3 mRNA expression is investigated below (see 
































Figure 4:27 5-hmC enrichment of the Tet3 promoter is lost in 1% O2 . mESCs 
were differentiated for 3 days in atmospheric or 1% O2 and DNA extracted for 5- 
hMeDIP-PCR. A Tet3 promoter fragment, which encompassed the area of 5-hmC 
enrichment identifed from the hMeDIP-seq study was amplifed by PCR. PCR 
products were visualised by agarose-gel electrophoresis.  
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4.3.15 Tet3 mRNA expression is reduced in differentiating mESCs exposed to 
low [O2] 
 
To determine whether the loss of the 5-hmC mark in 1% O2 (Figure 4:22) impacted upon 
Tet3 expression, mESCs were induced to differentiate over 11 days in atmospheric, 3% 
or 1% O2 and Tet3 mRNA levels assessed (Figure 4:28).  
 
In undifferentiated mESCs, culture under low [O2] trended to decrease Tet3 mRNA 
expression. However, by day 3 mRNA levels were increased under low O2 exposed 
conditions. By days 7 and 11 Tet3 expression was significantly decreased in both 3 and 
1% O2, compared to atmospheric O2. Taken together, these data propose that O2-
dependent hydroxylation of the Tet3 promoter, at day 3 of mESC differentiation, may act 
as a ‘mark’ for increased expression at a later stage of cellular differentiation. However, 
[O2] is likely to affect many cellular processes, due to its intrinsic role as a cofactor for 2-
OGDO containing enzymes, and thus may have additional transcriptional regulatory 
roles. For example, it may be hypothesised from the data shown here that at the day 3-
time point [O2] can alter the histone methylation marks (see section 4.3.16) to influence 













































































Figure 4:28 Tet3 mRNA expression is reduced in 3 and 1% O2 at day 7- and 11- 
differentiated mESCs. The mRNA expression of Tet3 was assessed by QPCR in 
mESCs over an 11 day differentiation time course in atmospheric, 3% and 1% O2. 
Data are expressed as the mean  SEM relative to undifferentiated mESCs exposed 
to atmospheric O2. Date are analysed by a two-way ANOVA with Tukey’s post-hoc 
analysis. * p<0.05, ** p<0.01, **** p<0.0001   
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4.3.16 1% O2 induced protein expression of H3K27me2/3 and H3K4me3 in day 
3-differentiated mESCs  
 
Literature evidence describes a correlation of 5-hmC with the H3K27me3482 and 
H3K4me3483 histone marks. Owing to 5-hmC levels being O2-dependent (see section 
4.3.2), and the fact that the JmjC-KDMs also contain a 2-OGDO domain, it was decided 
to examine the effects of low [O2] on the global protein expression of these histone 
marks. Protein samples were harvested from undifferentiated and day 3-differentiated 
mESCs, exposed to atmospheric or 1% O2, and were probed for H3K27me2/3 and 
H3K4me3 (Figure 4:29). Protein expression of the repressive marks (H3K27me2 and 
H3K27me3) were decreased from undifferentiated to day 3-differentiated mESCs in 
atmospheric O2, whereas H3K4me3 was unaffected. Differentiation of mESCs in 1% O2 
prevented this loss of H3K27me2 and H3K27me3 at the onset of differentiation, while 
inducing H3K4me3 expression by approximately 4-fold above levels in undifferentiated 
(and day 3-differentiated) mESCs.  
 
Bivalent promoters silence developmental genes in ES cells while keeping them poised 
for activation459,461. Therefore, the loss of the repressive marks (and maintenance of the 
activating mark) at the onset of cellular differentiation may be a characteristic trait. 
Furthermore, the Prc2 mediated H3K27me3 in mESCs is required for pluripotency484,485. 
Therefore, 1% O2 appears to maintain the undifferentiated pluripotent state, consistent 
with the increase in pluripotent marker expression as shown in Figure 3:11 and Figure 
3:12. The elevation of the activating mark H3K4me3 in 1% O2 may account for increased 
Tet3 expression at day 3, (see Figure 4:28). However, more experiments would be 
needed to confirm the increase of this histone mark at the Tet3 promoter in low [O2]. 
Despite this, it would be assumed this was a temporal effect, as Tet3 expression is 










































Figure 4:29 1% O2 induced protein expression of H3K27me2/3 and H3K4me3 
in day 3-differentiated mESCs. Protein was extracted from undifferentiated and 
day 3-differentiated mESCs exposed to atmospheric or 1% O2. Protein expression of 
H3K27me2/3 and H3K4me3 was determined by Western blot analysis. Data are 
expressed as the mean  SEM from 3 independent experiments, and expressed 
relative to shRNA control. Data are analysed by a one-way ANOVA with Tukey’s 
post-hoc analysis. *p<0.05, *** p<0.001, **** p<0.0001 
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4.3.17 The mRNA expression of methyltransferase subunit of Prc2, Ezh2, is 
consistent with the loss and gain of H3K27me2/3 protein expression 
during differentiation under atmospheric and 1% O2 respectively  
 
The catalytic subunit of Prc2, Ezh2, is a histone methyltransferase that targets lysine-27 
of histone H3486. To determine whether Ezh2 mRNA expression is consistent with the 
protein expression of H3K27me2/3 (Figure 4:29), Ezh2 levels were determined in 
undifferentiated and day 3-differentiated mESCs (exposed to atmospheric and 1% O2) 
(Figure 4:30). Concomitant with the decrease in H3K27me2/3 protein, Ezh2 mRNA was 
decreased between undifferentiated and day 3-differentiated mESCs. Additionally, the 
increase in H3K27me2/3 protein after differentiation in 1% O2 was also mirrored by 
increased Ezh2 expression. Thus, these data likely confirm Ezh2 is probably responsible 
for methylation of these histones in mESCs. Furthermore, the Ezh2 mRNA expression 
profile mimics pluripotent marker mRNA expression at the onset of differentiation (Figure 
3:9) and upon exposure to 1% O2 (Figure 3:11 and Figure 3:12), thereby potentially 












Figure 4:30 mRNA expression of Ezh2 is decreased between undifferentiated 
and day 3-differentiated mESCs, but is increased in differentiating cells when   
exposed to 1% O2. Ezh2 mRNA expression was determined by QPCR in 
undifferentiated and day 3-differentiated mESCs exposed to atmospheric and 1% 
O2. Data are expressed as the mean  SEM relative to undifferentiated and day 3-
differentiated atmospheric O2 exposed mESCs. Data are analysed by an unpaired t-
test. * p<0.05  
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4.3.18 Tet1 ablation in mESCs did not affect mRNA expression of Tet3 and its 
transcript variants during a mESC differentiation time course  
 
It was established that low O2 culture decreases Tet3 expression during mESC 
differentiation at day 7 and 11 time points (see Figure 4:28), which is consistent with a 
loss of 5-hmC from its promoter region. Furthermore, Tet1 was shown in part to be 
responsible for the burst of hydroxylation in day 3-differentiated mESCs, which was 
subsequently found to be predominantly targeted to this Tet3 promoter region. Based on 
this evidence it could be speculated that ablation of Tet1 would result in the loss of 5-
hmC from the Tet3 promoter and would act to subsequently decrease Tet3 mRNA.  
 
This hypothesis was tested by differentiating Tet1-ablated mESCs over a defined time 
course of differentiation, where the expression of Tet3 was previously found to be 
induced (between days 3 and 7) (Figure 4:5). The expression of Tet3 (denoted as Tet3 
pan) and 2 known variants named Tet3 upstream (denoted Tet3 up) and Tet3 
downstream (denoted Tet3 down) (see Chapter 5: Results 3 for further details) was 
determined (Figure 4:31). The expression of Tet3 transcript variants was investigated in 
parallel to confirm whether Tet1 may act to regulate the expression of a specific Tet3 
paralogue. It should be noted here that the putative promoter region of the Tet3 
downstream variant was the target of 5-hmC enrichment, as demonstrated from 
hMeDIP-seq analysis (Figure 4:19). Investigation into the regulation of expression of 
these 2 variants is the focus of Chapter 5: Results 3. Tet1-silencing failed to prevent the 
time-dependent increase in Tet3 pan mRNA expression (encompassing all variants) or 
of either the upstream or downstream variants. However, it was evident that compared 
to the relative expression in undifferentiated cells, Tet3 downstream mRNA showed less 




























Figure 4:31 Tet1 albated mESCs had no affect on the mRNA expression of Tet3 
pan and Tet3 up/downstream transcript variants. mRNA expression of pan Tet3 
and both upstream and downstream variants over a 7 day time course of mESC 
differentiation was assessed by QPCR. Data are expressed as the mean  SEM 
relative to undifferentiated mESCs. Data are analysed by a two-way ANOVA with 
Tukey’s post-hoc analysis. **** p<0.0001. KD: knockdown. 
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4.3.19 Tet1-ablated mESCs failed to reduce 5-hmC within the Tet3 promoter 
region 
 
Tet1 silencing was unable to reduce Tet3 mRNA expression during mESC differentiation 
(Figure 4:31). To determine whether this was a result of having no effect on 5-hmC levels 
within the Tet3 promoter region, hMeDIP-PCR was conducted on Tet1-depleted mESCs, 
which had been differentiated to day 3 (Figure 4:32). It was apparent that Tet3 was 
enriched at day 3 in shRNA control cells, above IgG control and reduced in 1% O2 (as 
also shown in Figure 4:27). However, Tet1-ablated mESCs failed to display reduced 
levels of 5-hmC. This result was also confirmed by bisulfite and oxidative bisulfite 
treatment (data not shown), as performed in Figure 4:21. It may be speculated that this 
surprising lack of effect of Tet1 silencing upon Tet3 expression (and hydroxylation of its 



































Figure 4:32 Tet1-ablated mESCs had no effect on 5-hmC levels within the 
Tet3 promoter region. shRNA control and Tet1-ablated mESCs were 
differentiated for 3 days (shRNA control cells were also differentiated for 3 days in 
1% O2) and genomic DNA isolated for hMeDIP-PCR. A Tet3 promoter fragment 
that encompassed the area of 5-hmC enrichment identifed from the hMeDIP-seq 
study was amplifed by PCR and visualised by agarose-gel electrophoresis. KD: 
knockdown.  
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 Discussion  
 
4.4.1 Assessment of DNA methylation marks during mESC differentiation 
revealed a novel transient burst of 5-hmC in day 3-differentiated cells 
 
Examination of 5-hmC levels during an 11-day time course of mESC differentiation 
revealed a dynamic expression profile with a transient burst of hydroxylation at day 3 
(Figure 4:1 and Figure 4:2). 5-hmC has previously been found to be highly expressed in 
ESCs168,252, but as cells differentiate and become specialised (except within neuronal 
cells) levels decline249. Few studies have measured 5-hmC levels at the onset of 
differentiation, however some groups have recorded initial dynamic changes422,423, which 
are perhaps consistent with the novel hydroxylation burst described here. The validity of 
this result was confirmed by 2 independent analyses; dot-blot and mass-spectrometry, 
which showed a high level of correlation. Additionally, the quantitation by mass-
spectrometry of methylation marks in undifferentiated mESCs demonstrated 5-hmC is 
approximately 0.08% and 5-mC approximately 0.6% of total C, which is largely in 
agreement with a previously published study168.  
 
Surprisingly, the increase in 5-hmC from day 1 of mESC differentiation was not preceded 
by an elevation of 5-mC. Previously it has been reported 5-hmC depends on pre-existing 
5-mC186,488. Therefore, this may suggest hydroxylation occurs at already existing 
methylated residues, or alternatively the methylation of C and the subsequent 
hydroxylation of 5-mC are tightly coupled at this stage of differentiation, so as to ensure 
a high rate of turnover resulting in immediate 5-hmC formation.  
 
De novo generation of 5-mC occurs rapidly after day 1 of mESC differentiation (Figure 
4:2), and plateaus by day 5. This may be consistent with methylation functioning to 
silence pluripotent gene transcription as the onset of differentiation489. Pluripotent genes, 
such as Oct4490, Nanog and Lefty1491 are protected from de novo methylation silencing 
in ESCs and are thus hypomethylated, however in response to differentiation signals 
acquire a repressed chromatin state that is thought to involve gain of 5-mC and loss of 
H3K4me3492. In addition, DNA methylation profiling demonstrated that early induction of 
differentiation from mESCs into 3 germs layers (as conducted in these experiments) 
resulted in gains of promoter methylation at germ cell-associated genes, which also 
correlated with the loss of H3K4me3, and is thus associated with a transcriptionally 
inactive state493. This therefore functions to restrict cell fate towards a somatic lineage493. 
However, DNA methylation has also been linked to the precise temporal and spatial 
control of tissue-specific genes. This was proposed from the genetic ablation of Dnmt 
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enzymes in mESCs, which revealed the upregulation 337 tissue-specific genes494. 
Hence DNA methylation is involved in gene repression and therefore DNA demethylation 
may function to activate tissue-specific gene transcription494. Thus, in combination with 
the strikingly different profiles of 5-mC and 5-hmC observed here during mESC 
differentiation, it is apparent that 5-hmC is not merely a consequence of differing 5-mC 
levels, but may itself have an independent functional role in differentiation events.  
 
4.4.2 Tet1 is predominantly responsible for the O2-dependent hydroxylation burst 
at day 3 of mESC differentiation    
 
Differentiation of mESCs under low O2 tensions revealed 1% O2 had a more profound 
inhibitory effect on 5-hmC levels than 3% O2 (Figure 4:3 and Figure 4:4). Given the 
requirement of 2-OGDO domain containing enzymes for O2 it is perhaps unsurprising 
Tet activity is reduced, resulting in decreased hydroxylation. However, as shown with 
ectopic expression of Tet3 in HEK cells, 5-hmC levels were unexpectedly elevated in 
3% O2, which was alluded to be potentially caused by differential O2-dependent 
regulation of cellular metabolites (Figure 3:25). This elevation of 5-hmC in ‘hypoxia’ is 
evident in the literature282. In neuroblastoma cells, 1% O2 exposure induced 5-hmC by 
approximately 2/3-fold, which was found to be attributed to increased Tet1 expression495. 
Similarly, Tet1 and Tet3 expression was also elevated in 1% O2 exposed primary 
isolated breast cancer cells and in some breast cancer cell lines496. A correlation 
between Tet expression and 5-hmC levels in a plethora of cell lines exposed to 0.5% O2, 
revealed that cells without hypoxic induction of Tet mRNA resulted in reduced 5-hmC, 
whereas cells that showed upregulation of Tet mRNA could function to compensate and 
thus increase 5-hmC309. Intriguingly, within this study, undifferentiated mESCs were 
shown to have reduced 5-hmC levels upon exposure to 0.5% O2309, and therefore the 
Tet inhibitory potential in these cells is in agreement with data shown here. However, it 
can be noted no loss of 5-hmC was observed in the undifferentiated mESCs used here 
at the tested 3% and 1% O2 (Figure 4:3 and Figure 4:4). Collectively, it is therefore 
apparent the relationship between O2 and 5-hmC may be cell-type dependent.  
 
Based on the assessment of Tet activity in HEK cells to differential physiological O2 
concentrations (Figure 3:23 and Figure 3:24), Tet1 was found to be the most likely 
paralogue inhibited by low O2 tensions. Tet1 activity was significantly reduced at 3% O2, 
however 5-hmC levels at this O2 tension over the mESC differentiation time course were 
largely unaffected, compared to 1% O2. This may be explained by the apparent increase 
in ectopically expressed Tet3 activity at 3% O2 in HEK cells, which is also reflected by 
elevated 5-hmC levels in control-transfected cells at this O2 tension (Figure 3:24). Hence, 
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the inhibitory effect of Tet1 activity at 3% O2 may have been masked by increased Tet3 
activity. 
 
For Tet1 to be responsible for regulating the O2-dependent burst in day 3-differentiated 
mESCs it must be expressed. Assessment of Tet1, Tet2, and Tet3 mRNA expression 
revealed that Tet1 (and Tet2) decreased while Tet3 increased over the 11-day time 
course of differentiation (Figure 4:5). This expression pattern, also reported 
previously252, highlights a discrepancy within the data, such that the mRNA profile 
doesn’t match elevated 5-hmC levels at day 3. Upon closer inspection of the relative 
expression levels of the Tets in day 3-differentiated mESCs, Tet1 was found to be the 
most abundant (Figure 4:6) and accordingly speculated to be predominant paralogue 
responsible for the hydroxylation burst. This was confirmed through differentiation of Tet-
ablated mESCs (Figure 4:7 and Figure 4:8). Tet1 silencing did not result in total loss of 
5-hmC, which may be accounted for by only partial knockdown of Tet1 and/or potential 
compensatory effects of Tet2 and Tet3 (see Chapter 6: General Discussion). In addition, 
considering Tet1 silencing and 1% O2 reduced 5-hmC levels in day 3-differentiated 
mESCs to equivalent amounts (Figure 4:9), it could be inferred this burst of hydroxylation 
is mediated via Tet1 in an O2-dependent manner. This Tet1-controlled burst of 
hydroxylation has not been reported previously in early differentiated ESCs. However, 
in vivo Tet1 has uniquely been shown to be responsible for hydroxylation in the Epi and 
thus contribute to the dynamic 5-hmC levels in the early developing mouse embryo497.  
 
4.4.3 Ascorbic Acid is not responsible for the increased catalytic activity of Tet 
enzymes at the onset of mESC differentiation  
 
The discrepancy between Tet mRNA expression and the burst of hydroxylation in day 3-
differentiated mESCs may suggest the catalytic capacity of Tet enzymes becomes 
increased. In addition to TCA cycle metabolites303 and O2 as regulators of Tet activity, 
AA has been shown to increase 5-hmC by reducing Fe3+ to Fe2+ and thereby maintaining 
the catalytic capacity of the enzymes441. During early ESC differentiation, AA levels have 
been shown to increase up to day 4498, which coincides with the induction of 5-hmC at 
the onset of differentiation reported from this study (Figure 4:1 and Figure 4:2). 
Therefore, it could be speculated that AA may play a crucial role in increasing the 
catalytic activity of Tet1 to induce this burst of hydroxylation. Hence the ability of AA to 
promote 5-hmC generation via positive regulation of Tet activity was investigated. 
However, collectively the data attained here did not support a role for AA in hydroxylation 
regulation in differentiating cells. Importantly, it should be additionally noted here that the 
novel burst of hydroxylation was not an artefact of cell culture conditions (owing to the 
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different concentrations of AA contained within EmbryoMax FBS and KO serum 
replacement) (Figure 4:17). This further supports the notion that the day 3 burst of 
hydroxylation is independent of AA. Therefore, the precise molecule mechanism(s) 
which underlie increased Tet activity, as Tet1/2 mRNA expression falls and before Tet3 
expression increases, remains to be elucidated. 
 
4.4.4 The transient O2-dependent burst of hydroxylation in day 3-differentiated 
mESCs is predominantly targeted to the Tet3 promoter region  
 
A surprising finding of this study was that the most significant target of this burst of 
hydroxylation in day 3-differentiated mESCs was a CG-rich Tet3 promoter region (Figure 
4:19). It was further established that 5-hmC enrichment of this promoter occurred de 
novo after mESC were induced to differentiate, and thus is in accordance with the global 
5-hmC induction seen at day 3 (Figure 4:21). Considering Tet1 was predominantly found 
to be responsible for this O2-dependent burst of hydroxylation in day 3-differentiated 
mESCs (Figure 4:7 and Figure 4:8), it is plausible to believe that Tet1 is thus responsible 
for 5-hmC enrichment on the Tet3 promoter (and the B230319CO9Rik non-coding 
transcript). Consistent with this hypothesis, the reduction in global 5-hmC under 1% O2 
(Figure 4:3 and Figure 4:4), which could be attributed to the O2-sensing capabilities of 
Tet1 (Figure 3:23 and Figure 3:24), also resulted in the loss of 5-hmC from the Tet3 
promoter region (Figure 4:27). 
 
Intriguingly, the hydroxylation on the Tet3 promoter at day 3 correlated with induction of 
Tet3 expression (between days 3 and 7) and similarly, the loss of hydroxylation in 1% 
O2 resulted in decreased Tet3 expression (at days 7 and 11) (Figure 4:28). Perhaps 
interestingly Tet3 expression was also reduced at 3% O2, but was found to not correlate 
with the loss of global 5-hmC during mESC differentiation under this O2 tension. Thus, it 
could be deduced that this effect may be Tet1-dependent and site specific, as ectopically 
expressed Tet1 activity in HEK cells demonstrated inhibition at 3% O2 (Figure 3:23 and 
Figure 3:24). Hence Tet1-mediated loss hydroxylation at this Tet3 promoter region in 3% 
O2 may account for the reduced Tet3 mRNA expression. Currently there is no literature 
evidence suggesting a regulatory role for Tet1 in the transcriptional regulation of Tet3, 
except from some RNA-seq data from Tet1-silenced undifferentiated mESCs323. Thus it 
was hypothesised Tet1 silencing would reduce 5-hmC within the Tet3 promoter and 
subsequently blunt its mRNA expression.  
 
Assessment of Tet3 expression, over the time points of induction (days 3-7) (Figure 4:5), 
revealed no difference between Tet1-silenced and shRNA control mESCs (Figure 4:31). 
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Upon closer inspection it was revealed that the 5-hmC enriched region within the Tet3 
locus corresponded to a promoter region containing transcriptional start sites for an 
isoform that does not contain the CXXC DNA binding domain175. Expression analysis of 
this isoform, denoted Tet3 downstream, and the full length CXXC-containing variant, 
Tet3 upstream, was also determined between days 3 and 7, in both Tet1-ablated and 
shRNA control mESCs (Figure 4:31). Tet1-silencing had no effect upon either transcript 
variant, however interestingly the upstream transcript showed a greater mRNA induction 
relative to undifferentiated cells, than the downstream. Hence, it might be inferred that 
enrichment of 5-hmC could be functioning as a transcriptional repressor, which appears 
to contradict the belief 5-hmC is associated with euchromatin and increased 
transcription186. However, 5-hmC-mediated transcriptional regulation may be more 
complex, and in fact dependent on its genomic positioning, for example it has been 
suggested that promoter and gene body hydroxylation may contribute to gene repression 
and activation respectively390.   
 
Furthermore, from the hMeDIP-PCR study (Figure 4:32), Tet1-ablated mESCs showed 
no reduction in 5-hmC from the Tet3 promoter, which potentially may explain why no 
change in Tet3 mRNA expression was noted. This may be due to Tet1 being only 
partially silenced, meaning there may be sufficient levels to sustain hydroxylation (a 
small induction of 5-hmC above undifferentiated cells in day 3 is evident in Tet1 KD cells) 
(Figure 4:7 and Figure 4:8). Alternatively, there may have been functional compensation 
or functional redundancy effects with Tet2 at this time point (see Chapter 6: General 
discussion for more details on this phenomenon). Nonetheless, the data presented here 
supports the enrichment of hydroxylation on the downstream Tet3 promoter via O2-
dependent regulation of Tet1.  
 
4.4.5 Tet3 is a bivalent promoter in association with Tet1 
 
ChIP analysis confirmed Tet1 was bound to this Tet3 promoter region in both 
undifferentiated and day 3-differentiated mESCs (Figure 4:22). Tet1 exhibits a strong 
binding preference for unmethylated CG rich regions (or CpG islands) within the 
genome, which often overlaps with transcriptional start sites and therefore gene 
promoters183,499. Hence, due to the high CG content of the Tet3 downstream promoter, 
it is valid to reason that the binding of Tet1 via its N-terminal CXXC domain500 can occur 
at this locus.   
 
In the undifferentiated state Tet1 appears inactive, as 5-hmC is not detectable within this 
Tet3 promoter region (Figure 4:21). This may be a reflection of the low 5-mC levels 
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present in undifferentiated cells, as a result of the 2i culture conditions. 2i conditions 
have been shown to reduce DNA methylation, driven by a decrease in Dnmt enzyme 
expression, to a similar epigenetic pattern seen in the Epi of the pre-implantation 
embryo501,502,503. However, it should be noted that a level of methylation in these 
undifferentiated cells does exist, as treatment with AA induced 5-mC-hydroxylation 
(Figure 4:10). Furthermore, in agreement with the literature, the constitutively methylated 
CpG-poor promoter region of Orm1216 was also found in the undifferentiated mESCs 
used in this study (via bisulfite and oxidative bisulfite treatment) to contain the 5-mC 
mark (but not the 5-hmC) (Data not shown). Importantly it should be noted that the 
induction of a naïve pluripotent state by culture of mESCs under 2i conditions does not 
alter their differentiation potential compared to serum (and LIF) maintained mESCs462. 
Overall, at the onset of differentiation, in the absence of 2i conditions, 5-mC levels rise, 
enabling Tet1 to induce hydroxylation at the Tet3 promoter. The presence of Tet1 at this 
Tet3 promoter potentially enables the close coupling of 5-mC to 5-hmC, reflected by 2 
out of 3 tested CpGs at this promoter containing the 5-hmC mark (Figure 4:21).  
 
In addition to Tet1, the Tet3 promoter region is also marked with the repressive 
(H3K27me3) and active (H3K4me3) histone marks, characteristic of a bivalent promoter. 
Bivalent promoters mark developmental genes, keeping them transcriptionally 
repressed in undifferentiated cells, but poised for immediate activation upon 
differentiation459. Consistent with this study, Tet3 is lowly expressed in undifferentiated 
cells, but becomes induced after day 3 of differentiation, correlating with the loss of the 
H3K27me3 mark and maintenance/gain of H3K4me3 (Figure 4:24 and Figure 4:25). To 
support the credibility of this finding, it has been reported that Tet1 and 5-hmC are 
enriched at gene promoters associated with bivalent domains183,389,184. Further, collated 
H3K4me3 and H3K27me3 ChIP-seq data sets from h/mESCs identified Tet1 as being 
highly enriched at bivalent domains504. This therefore potentially demonstrates Tet1 as 
a fundamental regulator of the balance between the maintenance of pluripotency and 
the onset of differentiation, and consequently therefore suggests that Tet3 is involved in 
developmental signalling. Interestingly, these domains are not enriched with 5-mC494, 
which is consistent with the appearance of predominantly 5-hmC within this region in 
day 3-differentiated cells (Figure 4:21). This also highlights a distinct role between 5-mC 





4.4.6 Tet1 and 1% O2 regulates the protein expression of repressive and active 
histone methylation marks  
 
To gain a further mechanistic insight between Tets and histone modifications, the global 
protein expression of repressive and active histone marks was assessed in day 3-
differentiated mESCs ablated of Tet1, Tet2 and Tet3 (Figure 4:26). The protein 
expression of H3K27me2 was also examined due to a recent study suggesting that the 
ratio between di- and tri- methylated forms of H3K27 can influence the differentiation 
ability of ESCs505. Ablation of Tet1, but not Tet2 or Tet3, induced protein expression of 
H3K27me2 and H3K4me3, which signifies the potential non-redundant functions of Tet 
proteins in early differentiating mESCs. The functional significance of this result is 
currently unclear, but further supports crosstalk specifically between Tet1 with histone 
methylation marks. Perhaps given the literature evidence it is not surprising that Tet1 
interacts with histone marks456,390,506, but considering depletion of Tet1 has previously 
been shown to disrupt Ezh2/Prc2 recruitment194, it was perhaps surprising to see an 
induction of H3K27me2. However, this discrepancy may have occurred since protein 
expression data presented here was obtained from differentiated cells, whereas findings 
in the published study were from undifferentiated cells.  
 
Assessment of the global protein expression of these histone methylation marks at the 
onset of differentiation demonstrated decreased expression of H3K27me2/3, while the 
levels H3K4me3 remained unchanged, compared to undifferentiated mESCs (Figure 
4:29). This is consistent with the loss of a repressive signal, indicative of developmental 
gene activation. To determine whether [O2] can also be a regulator of the histone 
methylation marks, protein expression was assessed after 3 days of differentiation in 1% 
O2 (Figure 4:29). Low O2 culture significantly elevated levels of both the repressive and 
activating marks, which potentially owing to their regulation of lineage control genes507 
may contribute to the skewed differentiation reported in Figure 3:11. Interestingly, Tet1-
ablation and 1% O2 induced similar inductive effects upon histone marks (except for 
H3K27me3), which may potentially further support a role of Tet1 in [O2]-dependent 
signalling. The differential effect of Tet1-silencing on H3K27me3 and H3K4me3 is in 
agreement with a previous study highlighting the weak and strong correlations of Tet1 
with these marks respectively183.  
 
Furthermore, the activity of the JmjC-KDMs are also potentially sensitive to changes in 
O2 tensions owing to their 2-OGDO domain267. Previous studies have highlighted that 
histone methylation marks, including H3K4me3 and H3K27me3 are induced in low 
[O2]508,509,510. Specifically, H3K4me3 induction has been described to be more sensitive 
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to low O2 tensions, compared to H3K27me3511. However, from the data displayed here 
(Figure 4:29), both marks show a similar fold induction at day 3 in 1% O2, compared to 
atmospheric O2. The increase in methylation marks has been described to be attributed 
to inhibition of JmjC-KDMs in low [O2] conditions, however given most KDMs can target 
several histone residues (KDM5A-D targets H3K4me2/3 and KDM6A/B targets 
H3K27me2/3), the sensitivity of specific enzymes to O2 require elucidation511. Despite 
this, it has been shown directly that inhibition of KDM5A in 1% O2 can lead to an increase 
in global H3K4me3509. Additionally, it should also be considered that O2 can regulate 
JmjC-KDMs (including the KDM5 and KDM6 families) transcriptionally511. Further to this, 
it has been identified that KDM5C and KDM6B have been demonstrated to be direct 
targets of HIF-1512,270. Thus, similarly to as reported for the Tet enzymes, the action of 
O2 to inhibit activity or increase transcription of JmjC-KDMs may be cell-type 
dependent309. Collectively, these data demonstrate cross-talk between O2 and 2 
independent epigenetic mechanisms, however how these may function to orchestrate 
transcriptional regulation requires further experimentation.  
 
4.4.7 Conclusion  
 
To summarise, the data shown here demonstrates that 5-hmC is dynamically expressed 
during mESC differentiation. This expression profile exhibits an early burst of O2-
dependent hydroxylation mediated via the catalytic activity of Tet1, which targets a 
promoter region spanning the transcriptional start site of a Tet3 isoform lacking a CXXC 
binding domain. This promoter region displays histone methylation marks, characteristic 
of a bivalent promoter and thus highlights Tet3 as a developmental and/or lineage-
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5.1.1 Cellular specificity of Tet3 
 
Tet3 mRNA expression was found to be induced during mESC differentiation (Figure 
4:5), in agreement with the literature386, suggesting Tet3 is likely to be implicated in 
cellular differentiation. This is supported from in vivo studies whereby the dual loss of 
Tet1 and Tet2 support the development of viable mice (albeit with a large fraction 
exhibiting perinatal lethality)248, yet the combined loss of all 3 Tet enzymes contributed 
poorly to chimeric embryos and restricted developmental potential of EBs254. 
Independently, homozygous mutations of Tet3 has also been shown to result in 
lethality392. Specifically, the loss of Tet3 from ESCs, as mentioned in section 3.1.3, 
impairs neuronal differentiation in vitro321. A neurogenesis role of Tet3 has also been 
demonstrated through overexpression studies in fibroblasts cells, whereby Tet3 was 
shown to contribute to their reprogramming into functioning neurons513. This involvement 
of Tet3 in neurogenesis may be supported from expression data in the brain, whereby 
elevated Tet3 mRNA, compared to Tet2 and Tet1 was recorded in the cerebellum, cortex 
and hippocampus422. In addition, levels of 5-hmC have been recorded to be highest in 
the brain and CNS, compared to, for example the kidney, heart, lung and liver (whereas 
5-mC showed little variation between such tissues)260,514. However, it is worth noting Tet1 
and Tet2 have to some extent also been implicated in neuronal differentiation261, 
potentially suggesting these enzymes function co-operatively to orchestrate 
neurogenesis (see Chapter 6: General Discussion).  
 
Despite the involvement of Tet3 in neurogenesis and its prevalent expression in the 
brain, little is known about how Tet3 is transcriptionally regulated. Evidence from Chapter 
4: Results 2 has suggested that Tet3 may be under epigenetic control via Tet1 activity, 
however mechanisms governing this apparent cellular specificity remains to be 
elucidated. A recent study functionally demonstrated Tet3 controls ectodermal and 
mesodermal cell fate decisions322. Ablation of Tet3 skewed mESC differentiation away 
from the neuroectoderm and towards the cardiac mesoderm lineage, whereas the 
reverse effect was true for ectopic Tet3 expression322. This suggests the precise 
transcriptional control of the Tet3 gene may be an important factor in the regulation of 
both neuronal and cardiac differentiation, however mechanisms that underlie this cellular 
specification remain unknown. Elucidation of such Tet3 regulatory mechanisms could 
enable improvements in neural-directed cellular differentiation, which may aid the 
development of cellular therapies to treat incurable neurodegenerative diseases, such 
as Alzheimer’s, Huntingdon’s, and Parkinson’s. Conversely, inhibition of Tet3 may 
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function to promote cardiac differentiation, which may also aid development of cellular 
therapies to repair damaged myocardium after insult.  
 
5.1.2 Tet3 has two distinct transcript variants  
 
To investigate the regulation of Tet3 it is important to consider alternative protein 
isoforms, which themselves may have independent functions. At present, the Tet3 gene 
has been identified from a murine neural stem cell line to possess 2 major protein-coding 
transcript variants that differ in their N-terminal sequence515. The longer isoform contains 
a DNA-binding CXXC domain, while the other shorter variant does not (a distinct third 
isoform has been identified exclusively in mouse oocytes) (schematically shown in 
Figure 5:1)175. These transcripts originate from distinct promoter regions, suggesting that 
their expression may be regulated independently. Literature evidence has shown that 
both variants were lowly expressed in ESCs, but mRNA was induced once directed to 
undergo neural differentiation515,175. It can be noted that the CXXC-containing variant 
demonstrated a higher fold induction, relative to its shorter form175, although the opposite 
effect was true from an earlier study515. The longer protein isoform may demonstrate 
neural specificity through selective binding to unmethylated CG promoters of neuronal-
related factors, such as Pax6, Ngn2 and Tubb2b via its CXXC domain176. In comparison, 
the shorter variant, which was found to the be most abundant Tet3 isoform in the mouse 
retina, was targeted to DNA through an alternative mechanism516. In this case, the TF 
Rest targeted Tet3 to methylated silenced neuronal genes during retinal maturation to 
subsequently de-methylate and induce transcriptional activation516. The exact neuronal 
functions of both Tet3 isoforms remain controversial515,175,516, however the current data 
do suggest that distinct Tet3 isoforms may have differing functional roles. It can be noted 
that from the data obtained in the unbiased mESC differentiation studies shown in 
Chapter 4: Results 2, 5-hmC was enriched specifically at the Tet3 promoter region that 

























































Figure 5:1 Schematic representation of Tet3 protein isoforms. Tet3 has been 
identified to have 3 distinct protein isoforms, denoted in this figure as Tet3-short 
(Tet3s), Tet3-full-length (Tet3FL) (containing an N-terminal CXXC domain) and a 
mouse oocyte specific variant named Tet3o. These are encoded by transcripts which 
comprise distinct non-coding upstream exons, suggesting they may be differentially 




To further elucidate the tissue specificity of the Tet enzymes and 5-hmC with respect to 
neural and cardiac tissues. Studies then aim to investigate the regulation of Tet3 that 
underlies cell specific function(s). To evaluate this the Tet3 transcript variants in 
unbiased differentiated mESCs will be defined and subsequently their distinct promoter 
































 Results  
 
5.3.1 Brain has higher levels of 5-hmC than heart in both mouse embryos and 
1-week old pups  
 
5-hmC has distinct tissue-specific patterns of expression, and is particularly found with 
high abundance in the brain. To verify the tissue specificity of 5-hmC, genomic DNA was 
isolated from brain and heart in murine E 18.5 embryos and 1-week old pups. 5-hmC 
and 5-mC levels were determined by dot-blot analysis (Figure 5:2 and Figure 5:3). Both 
embryos and 1-week old pups showed an equivalent 2.5-fold elevation in the 5-hmC:5-
mC ratio in brain, compared to heart. Mass-spectrometry was used to validate dot-blot 
data in 1-week old pup samples (Figure 5:4). These data clearly demonstrated increased 



























Figure 5:2 5-hmC levels are higher in mouse embryos brain than heart. 
Genomic DNA was isolated from heart and brain in mouse E 18.5 embryos and 
analysed for 5-hmC and 5-mC levels by dot-blot analysis. Blots were quantified and 
data displayed as the ratio of 5-hmC:5-mC. Data is expressed as the mean  SEM 




































Figure 5:3 5-hmC levels are higher in 1-week old mouse pup brain than heart. 
Genomic DNA was isolated from heart and brain in 1-week old mouse pups and 
analysed for 5-hmC and 5-mC levels by dot-blot analysis. Blots were quantified and 
data displayed as the ratio of 5-hmC:5-mC. Data is expressed as the mean  SEM 










5.3.2 Tet3 mRNA expression accounts for elevated 5-hmC detected in mouse 
brain compared to heart  
 
To investigate which Tet enzyme may be responsible for elevated 5-hmC in brain, 
compared to heart, the mRNA expression of each Tet paralogue was assessed in 
embryonic (E 18.5) (Figure 5:5) and 1-week old pup tissue (Figure 5:6). In the embryo 
no differences in Tet expression between heart and brain were detected. However, Tet3 
trended towards an increased expression in brain, narrowly falling short of significance 
(p=0.055). In 1-week old pups Tet3 mRNA expression was significantly elevated in brain 
compared to heart. Tet1 mRNA was found to be decreased and Tet2 unaffected. Overall 
these data suggest Tet3 as the predominant Tet responsible for elevated 5-hmC levels 
in brain tissue. Note, despite protein detection as a more biological relevant readout 
accurate determination of protein expression was unattainable, attributed to the large 





Figure 5:4 Mass-spectrometry analysis confirmed greater 5-hmC levels in 1-
week old mouse pup brain compared to heart. Genomic DNA was isolated from 
heart and brain in 1-week old mouse pups and analysed for C, 5-mC and 5-hmC 
levels by mass-spectrometry analysis. Data are normalised to total C and displayed 



























Figure 5:5 Tet3 mRNA expression trended to be elevated in mouse embryonic 
brain compared to heart. Tet1, 2 and 3 mRNA expression was determined by 
QPCR analysis from heart and brain in mouse E 18.5 embryos. Data are expressed 

























Figure 5:6 Tet3 mRNA expression is increased in 1-week old mouse pup brain 
compared to heart. Tet1, 2 and 3 mRNA expression was determined by QPCR 
analysis from heart and brain in mouse 1-week old pups. Data are expressed as the 
mean  SEM and analysed by an unpaired t-test. *p<0.05. n=3. 
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5.3.3 Tet expression is induced in neural, compared to cardiac-directed P19 cell 
differentiation  
 
To investigate the cellular specificity of Tet enzymes, P19 cells were directed to 
differentiate towards a neural or cardiac-like lineage in the presence of RA or DMSO 
respectively. To confirm successful induction of a neural and cardiac-like enriched cell 
fate mRNA expression of lineage-specific genes over a 10-day time course of 
differentiation was determined.  
 
Greater induction of ectodermal markers was evident in RA-, compared to DMSO-
treated differentiating P19 cells (Figure 5:7). -III tubulin343 trended towards increased 
expression at all tested time points in RA above DMSO treatment, and reached 
significance at days 4, 6 and 8. Dcx354 expression was significantly induced at all time 
points in the presence of RA, and demonstrated a large induction that peaked at day 6 
to approximately 450-fold above levels in undifferentiated P19 cells. In comparison, 
DMSO treated cells showed equivalent Dcx expression to undifferentiated cells at this 
time point. Ncam1344 expression was induced with RA treatment after day 4 of 
differentiation, compared to undifferentiated P19 cells. Ncam1 mediates cell adhesions 
to modulate, for example, neuronal migration, neurite extension and synapse 
formation517 and thus its expression profile shown here may reflect an involvement in the 
latter stages of neurogenesis. By contrast, mesodermal markers (Figure 5:8), in the 
presence of DMSO, were induced above RA treated cells at early differentiation time 
points. Gata4342, Hand1339 and Brachyury338 were significantly induced above RA treated 











































Figure 5:7 Ectodermal marker mRNA expression is induced with retinoic acid 
above dimethylsulfoxide treated differentiating P19 cells. P19 cells were 
induced to differentiate into embryoid body-like aggregates for 10-days in the 
presence of 1 M RA and 1% DMSO. Ectodermal marker expression was assessed 
by QPCR analysis. Data are expressed as the mean  SEM relative to 
undifferentiated P19 cells, and analysed by multiple t-tests between RA and DMSO 




























Figure 5:8 Mesodermal marker mRNA expression is induced with dimethyl 
sulfoxide above retinoic acid treated differentiating P19 cells. P19 cells were 
induced to differentiate into embryoid body-like aggregates for 10-days in the 
presence of 1 M RA and 1% DMSO. Mesodermal marker expression was assessed 
by QPCR analysis. Data are expressed as the mean  SEM relative to 
undifferentiated P19 cells, and analysed by multiple t-tests between RA and DMSO 
treated cells at each time point. * p<0.05, ** p<0.01, **** p<0.0001 
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Thus RA and DMSO treatment could induce P19 cells to differentiate into cell 
populations characteristic of a neural- and cardiac-like lineage respectively. To 
investigate whether Tet enzymes are differentially associated with these 2 cell 
populations, perhaps consistent with them having an intrinsic role in cell specification, 
mRNA expression of Tet1, Tet2 and Tet3 was determined over the RA- and DMSO-
treated P19 cell differentiation time course (Figure 5:9). Overall, Tet enzymes appear 
more highly expressed in RA, compared to DMSO treated P19 cells. Tet1 mRNA 
appeared to be reduced or unchanged relative to undifferentiated cells (depicted by the 
line at 1) after either RA or DMSO treatment, perhaps consistent with the involvement of 
Tet1 in pluripotency regulation252,506. The expression levels of Tet2 and Tet3 in RA-
treated cells were induced above their relative levels in undifferentiated P19 cells after 2 
days of differentiation, and consistently elevated above their expression levels in DMSO-
treated cells over this time course. Tet2 and Tet3 mRNA peaked at day 6 with RA 
treatment. However, DMSO induced a marked increase in Tet2 expression compared to 
undifferentiated P19 cells, but did not affect Tet3 mRNA expression.  
 
These data suggest Tets may have a greater role in ectodermal, compared to 
mesodermal differentiation. This is in agreement with the elevated 5-hmC levels 
detected in brain, compared to heart tissue (Figure 5:3). However, contrary to the mRNA 
expression in tissue, in addition to induced Tet3 expression, Tet2 (and also to a lesser 
extent Tet1) was also found to be induced in RA- compared to DMSO-treated P19 cells. 
This may thus highlight interplay between the Tet enzymes. However, based upon the 
breadth of literature linking Tet3 function to cellular specificity321,506,518, the focus of future 













































Figure 5:9 Tet enzyme expression is induced with retinoic acid above dimethyl 
sulfoxide treated differentiating P19 cells. P19 cells were induced to differentiate 
into embryoid body-like aggregates for 10 days in the presence of 1 M RA and 1% 
DMSO. Tet1, 2, and 3 expression was assessed by QPCR analysis. Data are 
expressed as the mean  SEM relative to undifferentiated P19 cells, and analysed 
by multiple t-tests between RA and DMSO treated cells at each time point. * p<0.05, 
** p<0.01, *** p<0.001 
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5.3.4 Tet3 has multiple transcriptional starts that encodes two distinct protein 
isoforms in day 7-differentiated mESCs  
 
Elevated 5-hmC levels in brain, compared to heart tissue (see section 5.3.1), was 
predominately attributed to Tet3 mRNA expression (see section 5.3.2). To gain an 
insight into the transcriptional regulation of Tet3 underpinning tissue-specific effects, 
5’RACE was performed to identify transcriptional start sites and hence promoter regions.  
 
5’RACE was performed on mRNA taken from day 7-differentiated mESCs, the time point 
at which Tet3 expression was found to be elevated (Figure 4:5). Sequencing the clones 
of 5’RACE products revealed multiple cap sites that were found to be positioned 
upstream of 2 start codons (ATG), which encode 2 distinct protein isoforms. In 
combination with Tet3 sequence data available from Ensemble 
(https://www.ensembl.org) and NCBI (https://www.ncbi.nlm.nih.gov), multiple cap sites 
within 3 distinct, previously observed, non-coding exons (NCBI accession numbers: 
NM_001347313.1, XM_006505777.3, XM_0065057776.3, XM_006505775.3 and 
XM_017321465.1) and an additional novel non-coding exon (the most 5’ non-coding 
exon) were confirmed to be associated with the upstream start site (Figure 5:10A). In 
addition, multiple cap sites were confirmed in the single non-coding exon at the more 
downstream start site (NCBI accession: NM_183138.2) (Figure 5:10B). These 
transcripts that give rise to 2 distinct protein isoforms are named here as Tet3 upstream 
(NCBI accession numbers: NP_001334242.1, XP_017176954.1, XP_006505840.1, 
XP_006505839.1, XP_006505838.1) and Tet3 downstream (NCBI accession number: 
NP_898961.2), marked in Figure 5:11. The Tet3 upstream transcripts encode a longer 
protein sequence that contains a CXXC DNA binding domain, which is absent in the 
shorter Tet3 downstream encoded protein (previously termed Tet3FL and Tet3s 
respectively by Jin, S et al (2016)175). These distinct proteins may therefore have 
separate functions, and thus the study of their regulation may allude to differential roles 
























































Figure 5:10 Identified cap sites for Tet3 upstream and downstream transcripts. 
5’RACE was performed on day 7-differentiated mESCs to identify cap sites in 2 Tet3 
protein isoforms (A) Tet3 upstream and (B) downstream. Identified cap sites are 
marked by arrows on the non-coding exons in the schematics and underlined in bold 
on the sequences. Light shading represents non-coding exons and darker shading 


















5.3.5 mRNA expression of the Tet3 downstream transcript is induced in 1-week 
old mouse pup brain compared to heart 
 
To quantitate the levels of the Tet3 transcripts that may arise from the 2 distinct promoter 
regions identified from 5’RACE, shown in section 5.3.4, primer pairs were designed for 
use in QPCR, to detect and distinguish between both the Tet3 upstream and Tet3 
downstream variants (Figure 5:12).  
 
Previously, the expression of all Tet3 transcripts (Tet3 pan) was shown to be induced in 
1-week old brains compared to 1-week old hearts (Figure 5:6). The relative contributions 
of Tet3 upstream or downstream variants in mouse brain (and heart) were assessed by 
QPCR analysis (Figure 5:13). Tet3 upstream expression was lower, whereas Tet3 
downstream expression was higher, in brain, compared to heart. Thus collectively, the 
elevated Tet3 pan expression in brain, compared to heart, is predominantly due to the 
downstream variant, suggestive that activation of the downstream promoter may be 






Figure 5:11 Tet3 has 2 distinct protein coding isoforms. 5’RACE, in combination 
with sequencing data available from (https://www.ensembl.org) and NCBI 
(https://www.ncbi.nlm.nih.gov), identified and confirmed multiple cap sites 
positioned upstream of 2 start codons. 4 non-coding exons were associated with the 
more upstream start site, compared to 1 non-coding exon associated with the 
downstream start. These transcripts marked as Tet3 upstream (red) and 
downstream (blue) give rise to 2 protein isoforms that differ by the presence or 




























Figure 5:12 QPCR primer design to detect Tet3 transcript variants. Primers to 
detect specifically the Tet3 upstream and downstream variants were designed for 
QPCR analysis. Tet3 pan primers are also depicted to highlight their ability to detect 




























Figure 5:13 mRNA expression of the Tet3 downstream variant is elevated in 1-
week old mouse pup brain, compared to heart. Relative mRNA expression of 
Tet3 pan, Tet3 upstream and Tet3 downstream in 1-week old mouse pup heart and 
brain was detected by QPCR analysis. Data are expressed as the mean  SEM 
relative to heart expression, and analysed by an unpaired t-test. ** p<0.01, *** 
p<0.001, **** p<0.0001. n=3. 
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5.3.6  Elevated mRNA expression of the Tet3 downstream transcript appears 
partially sustained over a time course of neural-directed P19 cell 
differentiation, compared to the Tet3 upstream variant  
 
To investigate the prospective involvement of the Tet3 downstream variant in neural 
specification, assessment of both upstream and downstream mRNA variants over a time 
course of neural and cardiac-directed P19 cell differentiation was established (Figure 
5:14). Both upstream and downstream variants were induced in RA-, compared to 
DMSO-treated P19 cells. mRNA expression levels of both variants peaked at day 6, 
consistent with Tet3 pan expression (Figure 5:9). However, Tet3 downstream expression 
appeared to be sustained above mRNA levels detected in DMSO treated cells at days 8 
and 10. Therefore, this may suggest the longer upstream protein isoform has a more 




















Figure 5:14 Both the Tet3 upstream and downstream variants are elevated in 
neural, compared to cardiac-directed P19 cell differentiation. P19 cells were 
induced to differentiate into neural and cardiac-like cells in the presence of 1 M RA 
and 1% DMSO respectively. Expression of the Tet3 upstream and downstream 
variants were detected by QPCR. Data are expressed as the mean  SEM relative 
to undifferentiated P19 cells, and analysed by multiple t-tests between RA and 
DMSO treated cells at each time point. * p<0.05 
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5.3.7 Tet3 upstream and Tet3 downstream mRNA are increased during mESC 
differentiation  
 
To examine if either the Tet3 upstream or downstream variants show differential 
expression during mESC differentiation, thereby alluding to potential independent 
functions in cell specification events, their relative contributions to Tet3 pan expression 
were assessed by QPCR (Figure 5:15). Both Tet3 upstream and downstream correlated 
with the induction of Tet3 pan after day 3 of differentiation and seemed to both contribute 
to overall pan expression. The downstream variant appeared to be more highly 
expressed than the upstream in undifferentiated and day 3-differentiated mESCs, but at 
days 7 and 11 appeared equivalent. This therefore demonstrated that the upstream 
variant is induced to a greater extent than the downstream during this early period of 


















































































Figure 5:15 mRNA levels of Tet3 upstream and Tet3 downstream transcripts 
correlates with the induction of Tet3 pan expression after day 3 of mESC 
differentiation. The relative contributions of Tet3 upstream and Tet3 downstream 
to Tet3 pan expression over a time course of mESC differentiation was assessed by 
QPCR analysis. Data is expressed as the mean  SEM relative to Tet3 pan in 
undifferentiated mESCs, and analysed by a two-way ANOVA with Tukey’s post-hoc 
analysis. **** p<0.0001 
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5.3.8 Expression of the Tet3 downstream transcript is less sensitive to 1% O2 
than the Tet3 upstream variant  
 
The loss of Tet3 pan mRNA expression in day 7 and 11-differentiated mESCs exposed 
to 1% O2 (Figure 4:28) is consistent with the loss of neural makers under the same 
conditions (Figure 3:11, Figure 3:15 and Figure 3:18). The ability of the upstream and 
downstream transcripts to demonstrate differential sensitivities to 1% O2 was examined 
by QPCR (Figure 5:16). Similarly to Tet3 pan expression, both transcripts were reduced 
by 1% O2. However, low [O2] appeared to have a less inhibitory effect upon the 
downstream variant. Examining expression differences between atmospheric O2 and 1% 
O2 revealed a 1.7 and 1.3-fold reduction at days 7 and 11 respectively for the 
downstream variant. In comparison, a 3- and 4-fold reduction at days 7 and 11 








































Figure 5:16 mRNA levels of the Tet3 downstream transcript is less sensitive 
to 1% O2 than the Tet3 upstream variant. The sensitivities of Tet3 pan, Tet3 
upstream and Tet3 downstream mRNA expression to 1% O2 was determined in day 
7 and 11-differentiated mESCs. Data are expressed as the mean  SEM relative to 
day 7 atmospheric O2 samples, and analysed by multiple t-tests between 
atmospheric O2 and 1% O2. ** p<0.01, *** p<0.001 
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5.3.9 The cloned Tet3 downstream putative promoter region has higher reporter 
activity, compared to the cloned Tet3 upstream promoter fragment, in both 
undifferentiated and differentiating P19 cells and mESCs  
 
To investigate the transcriptional regulation of the 2 identified Tet3 transcripts, putative 
promoter regions were cloned into luciferase reporter constructs, schematically shown 
in Figure 5:17. The activity of these constructs were assessed in undifferentiated and 
day 2- and 4-differentiated P19 cells (Figure 5:18) and mESCs (Figure 5:19). Both 
putative promoter constructs were deemed functional, shown by induction of activity 
above the pGL4.2 control vector. In both cell types, the fragment of the cloned 
downstream promoter region consistently displayed higher levels of activity, compared 
to the upstream cloned promoter fragment, in both undifferentiated and differentiated 
cells. This may be consistent with the higher level of mRNA expression of the 
downstream, compared to the upstream transcripts in early differentiating mESCs 
(Figure 5:15). The promoter activity at later stages of cellular differentiation, where Tet3 
expression was previously found to be induced (Figure 5:15), could not be investigated 
due to loss of the transient reporter expression after day 4. It can also be noted that the 
luciferase signals in mESCs were lower than those detected in P19 cells, likely owing to 
















Figure 5:17 Schematic representation of the cloned putative promoter regions 
of the Tet3 upstream and downstream transcripts. The putative promoter regions 
of Tet3 upstream and Tet3 downstream transcripts were cloned into luciferase 
reporter constructs, as depicted. Numbers correspond to the number of bps from the 

























Figure 5:18 The Tet3 downstream and Tet3 upstream cloned putative promoter 
fragments showed elevated activity above the pGL4.2 control vector, in 
undifferentiated, day 2- and day 4-differentiated P19 cells. Luciferase reporter 
constructs containing the putative promoter regions of the Tet3 upstream and 
downstream transcripts were transfected into undifferentiated P19 cells. Luciferase 
activity was determined 24 hrs post-transfection or alternatively cells were 
differentiated and activity measured after 2 and 4 days. Data are expressed as the 
mean  SEM relative to the activity of pGL4.2 control vector after normalisation to 
the co-transfected Renilla luciferase control. Data are analysed by a one-way 


























Figure 5:19 The Tet3 downstream and Tet3 upstream cloned putative promoter 
fragments showed elevated activity above the pGL4.2 control vector, in 
undifferentiated, day 2- and day 4-differentiated mESCs. Luciferase reporter 
constructs containing the putative promoter regions of the Tet3 upstream and 
downstream transcripts were transfected into undifferentiated mESCs. Luciferase 
activity was determined 24 hrs post-transfection or alternatively cells were 
differentiated and activity measured after 2 and 4 days. Data are expressed as the 
mean  SEM relative to the activity of pGL4.2 control vector after normalisation to 
the co-transfected Renilla luciferase control. Data are analysed by a one-way 
ANOVA with Tukey’s post-hoc analysis. **** p<0.0001  
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5.3.10 A larger difference in reporter activity is evident between the Tet3 
downstream and Tet3 upstream putative promoter region in neural, 
compared to cardiac cells  
 
The activities of reporter constructs were assessed in more ‘differentiated’ cell types to 
gain further understanding of the mechanisms underlying the cell type specific 
expression patterns of the identified Tet3 variants. Tet3 upstream and downstream 
promoter reporter constructs were transfected into cardiac (H9c2) and neural (SH-SY5Y) 
cells types and luciferase activity determined (Figure 5:20). The downstream was more 
active in both tested cell types, and this was particularly evident in the neural cell type. 
Assessment of the ratio between the activities of the downstream and upstream 
promoter reporters in both cell types was determined from experimental repeats (Figure 
5:20). The downstream promoter demonstrated an approximate 3-fold induction in SH-
SY5Y cells, compared to an approximate 1.5-fold induction in H9c2 cells, above the 
upstream reporter. These data therefore are largely in agreement with elevated Tet3 





































Figure 5:20 The activity of the Tet3 downstream putative promoter is elevated 
above the Tet3 upstream promoter to a greater extent in neural, compared to 
cardiac cells. Luciferase reporter constructs containing the putative promoter 
regions of Tet3 upstream and Tet3 downstream transcripts were transfected into 
H9c2 and SH-SY5Y cells, representative of cardiac and neural-like cells. Luciferase 
activity was determined 24 hrs post-transfection. The ratio of activity from the Tet3 
downstream to the upstream reporter in H9c2 and SH-SY5Y cells, was calculated 
from 3 independent experiments. Data are expressed as the mean  SEM relative 
to the activity of pGL4.2 control vector after normalisation to the co-transfected 
Renilla luciferase control. Data are analysed by an unpaired t-test. *** p<0.001, **** 
p<0.0001 
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5.3.11 The Tet3 downstream putative promoter reporter construct is more active 
in 1% O2, compared to atmospheric O2, in undifferentiated P19 cells  
 
The mRNA levels of both transcript variants of Tet3 were reduced in day 7- and 11-
differentiated mESCs when exposed to 1% O2, however expression of the downstream, 
compared to the upstream variant, appeared less sensitive to changes in [O2] (Figure 
5:16). To begin to assess whether the putative promoter activity of these transcript 
variants is also regulated by low [O2], luciferase constructs were transfected into 
undifferentiated P19 cells and subjected to 1% O2 (Figure 5:21). Perhaps surprisingly 
the Tet3 downstream promoter was shown to be elevated in 1% O2, whereas the Tet3 
upstream promoter appeared unaffected, when compared to atmospheric [O2]. 
Assessment of the ratio between the downstream and upstream reporters in both tested 
O2 tensions was determined from experimental repeats (Figure 5:21). The downstream 
promoter construct displayed an approximate 10-fold induction in 1% O2 compared to 
approximately 6-fold in atmospheric O2, above the upstream promoter. Interestingly, 
analysis of the downstream sequence revealed the presence of 8 core HIF DNA binding 
motifs (A/GCGTG), compared to 3 in the Tet3 upstream sequence. However, it should 
be noted this was conducted in undifferentiated P19 cells, it was not possible to look at 
the effects of [O2] at later differentiated time points due to the loss of luciferase signal 
from the transiently transfected cells.   
 
Attempts were made to investigate whether these effects were consistent in mESCs. 
However, owing to a low transfection efficiency, the pGL4.2 signal in 1% O2 exposed 
cells was almost equivalent to the signal produced in untransfected cells (baseline) and 
















































Figure 5:21 The activity of the Tet3 downstream putative promoter, compared 
to the Tet3 upstream, is induced in 1% O2 compared to atmospheric O2. 
Luciferase reporter constructs containing the putative promoter regions of Tet3 
upstream and downstream transcripts were transfected into P19 cells and exposed 
to atmospheric O2 or 1% O2 for 24 hrs. The ratio of activity from the Tet3 downstream 
to the upstream reporter in atmospheric O2 and 1% O2 was calculated from 3 
independent experiments. Data are expressed as the mean  SEM relative to the 
activity of pGL4.2 control vector after normalisation to the co-transfected Renilla 
luciferase control. Data are analysed by a two-way ANOVA with Tukey’s post-hoc 
analysis and an unpaired t-test. **** p<0.0001 
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5.3.12 A 5’ and 3’ deletion series of the Tet3 downstream putative promoter 
region decreased reporter activity 
 
To identify the specific functional cis-acting promoter sequences that underlies potential 
neural specificity (shown in SH-SY5Y cells, see Figure 5:20) and O2-dependent effects 
(Figure 5:21), a 5’ and 3’ deletion series of the Tet3 downstream reporter construct was 























Figure 5:22 Schematic representation of the Tet3 downstream promoter 
deletion series. A deletion series of the putative Tet3 downstream promoter was 
conducted by sequence deletions from the 5’ and 3’ end. Specific regions were 
identified to have neural and O2-dependent regulation as shown in Figure 5:25 and 
Figure 5:26. Numbers correspond to the number of bps from the most 5’ cap site 
(+1), see Figure 5:10. 
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The effect of the deletion series in undifferentiated and day 2- and 4- differentiated P19 
cells was assessed (Figure 5:23). In undifferentiated cells each deletion induced a 
reduction in promoter activity compared to the downstream construct, suggesting each 
deleted promoter sequence has a positive acting regulatory sequence. This effect was 
consistent in day 2 and day 4 differentiating cells, indicating there was not a distinct 
regulatory sequence required at the onset of differentiation. This is perhaps consistent 
with previous data in mESCs showing Tet3 expression does not increase until after day 
3 of differentiation (Figure 5:15).  
 
 
To confirm whether this deletion series was consistent in mESCs, the activity of the 
deletion constructs was assessed in undifferentiated cells (Figure 5:24). Consistent with 
undifferentiated P19 cells, each deletion had an inhibitory effect on promoter activity, 
compared to the downstream construct. Deletion 3, which is the shortest tested promoter 












































Figure 5:23 5’ and 3’ deletions from the Tet3 downstream promoter results in 
a decrease in reporter activity in undifferentiated and differentiated P19 cells. 
Luciferase reporter constructs containing the Tet3 downstream putative promoter or 
sequence deletions were transfected into undifferentiated P19 cells. Luciferase 
activity was determined 24 hrs post-transfection or alternatively cells were 
differentiated and activity measured after 2 and 4 days. Data are expressed as the 
mean  SEM relative to the activity of pGL4.2 control vector after normalisation to 
the co-transfected Renilla luciferase control. Data are analysed by a one-way 








































5.3.13 A deletion series of the Tet3 downstream putative promoter identified 
potential neural-specific regulatory fragments  
 
The Tet3 downstream putative promoter fragment demonstrated a higher relative 
activity, compared to the upstream promoter region, in neural (SH-SY5Y) cells compared 
to cardiac (H9c2) cells (Figure 5:20). To identify cis acting sequence(s) that might 
potentially promote expression specifically in neural cells, the activity of the Tet3 
downstream promoter deletion reporter constructs were assessed in both SH-SY5Y and 
H9c2 cells (Figure 5:25). All the tested deleted reporter constructs reduced activity in 
SH-SY5Y cells, compared to the undeleted construct, but increased (or maintained) 
activity in H9c2 cells. Specifically, deletion 1 and 2 induced an equivalent 50% reduction 
in activity in SH-SY5Y cells, compared to a significant induction in activity in H9c2 cells. 
Deletion 3, compared to Deletion 2, reduced activity in both cell types, thereby identifying 
Figure 5:24 5’ and 3’ deletions from the Tet3 downstream promoter results in 
a decrease in reporter activity in undifferentiated mESCs. Luciferase reporter 
constructs containing the Tet3 downstream putative promoter or sequence deletions 
were transfected into undifferentiated mESCs. Luciferase activity was determined 
24 hrs post-transfection. Data are expressed as the mean  SEM relative to the 
activity of pGL4.2 control vector after normalisation to the co-transfected Renilla 
luciferase control. Data are analysed by a one-way ANOVA with Tukey’s post-hoc 
analysis. ** p<0.01, *** p<0.001, **** p<0.0001 
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common positive acting sequence(s) within this deleted region. Overall, 2 potential cis-
acting promoter sequences, specific for Tet3 promoter activity in a neural cell type was 


















5.3.14 A deletion series of the Tet3 downstream putative promoter identified an 
O2-dependent regulatory region 
 
The Tet3 downstream putative promoter construct demonstrated an induction in activity 
when subjected to 1% O2 in undifferentiated P19 cells (Figure 5:21). To determine the 
potential O2-senstive fragment(s), the activity of Tet3 downstream deletion reporter 
constructs were assessed in P19 cells exposed to 1% O2 (Figure 5:26). The activity of 
the Tet3 downstream construct was confirmed to be increased in 1% O2, an effect 
maintained in deletion 1, yet lost in deletions 2 and 3. This therefore identified a potential 
O2-dependent regulatory region, depicted on the schematic shown in Figure 5:22. 
 
Figure 5:25 Deletions of the Tet3 downstream putative promoter identified 2 
neural-specific regulatory fragments. Luciferase reporter constructs containing 
the Tet3 downstream putative promoter or sequence deletions were transfected into 
H9c2 and SH-SY5Y cells. Luciferase activity was determined 24 hrs post 
transfection. Data are expressed as the mean  SEM relative to the activity of 
pGL4.2 control vector after normalisation to the co-transfected Renilla luciferase 
control. Data are analysed by a one-way ANOVA with Tukey’s post-hoc analysis. 
Shown are representative figures from 3 independent repeats. ** p<0.01, *** 


























































Figure 5:26 Deletions of the Tet3 downstream putative promoter identified an 
O2 –sensitive regulatory region. Luciferase reporter constructs containing the Tet3 
downstream putative promoter or sequence deletions were transfected into 
undifferentiated P19 cells and exposed to atmospheric O2 or 1% O2 for 24 hrs. Data 
are expressed as the mean  SEM relative to the activity of pGL4.2 control vector 
after normalisation to the co-transfected Renilla luciferase control. Data are analysed 
by multiple t-tests between atmospheric O2 and 1% O2. *** p<0.001 
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5.3.15 A 3’ extension of the Tet3 upstream putative promoter region has a 
positive regulatory function in undifferentiated P19 and mESCs  
 
The Ensembl database (https://www.ensembl.org) indicates a putative promoter region 
that encompasses a large intronic region on the mouse Tet3 upstream variant. Thus, to 
characterise additional potential regulatory sequences, which are not present in the 
existing upstream promoter fragment, 5’ and 3’ sequence extensions, in addition to a 















The activity of these constructs was first assessed in undifferentiated P19 and mESCs 
(Figure 5:28). A 3’ extension of the Tet3 upstream putative promoter sequence, named 
extension A, had a positive regulatory effect in both P19 and mESCs. However, it should 
be noted that in P19 cells the downstream promoter fragment remained more active than 
the upstream extension A fragment. In addition, the positive regulatory effect of the 3’ 
extended sequence, relative to the Tet3 upstream promoter construct, was markedly 
greater in mESCs, compared to P19 cells (9.3-fold compared to 1.7-fold). Deletion A 
reduced promoter activity, compared to the Tet3 upstream promoter, consistently in both 
Figure 5:27 Schematic representation of 5’ and 3’ extensions, and a deletion, 
of the Tet3 upstream putative promoter. Extensions containing potential 
regulatory sequence at the 5’ and 3’ end of the Tet3 upstream putative promoter 
were cloned into luciferase reporters. A deletion construct was also created from 3’ 
end of the Tet3 upstream putative promoter. A specific region identified to have 
neural-specificity, as shown in Figure 5:29, is marked up. Numbers correspond to 
the number of bps from the most 5’ cap site (+1), see Figure 5.10. 
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cell types, suggesting this 3’ end of the putative promoter (encompassing one of the 
identified cap site regions) contains a positive regulatory sequence. Lastly, the 5’ 
extended genomic fragment, extension B, had a marginal inhibitory effect on activity in 
P19 cells and no effect in mESCs, compared to the original Tet3 upstream construct. 
Thus, there are cis-acting sequences downstream of the identified cap sites that act to 



























Figure 5:28  A 3’ end extension of the Tet3 upstream promoter has a positive 
regulatory function in undifferentiated P19 cells and mESCs. Luciferase 
reporter constructs containing the Tet3 upstream putative promoter or the sequence 
extensions/deletion were transfected into undifferentiated P19 cell and mESCs. Note 
the Tet3 downstream promoter was also tested in undifferentiated P19 cells. 
Luciferase activity was determined 24 hrs post-transfection. Data are expressed as 
the mean  SEM relative to the activity of pGL4.2 control vector after normalisation 
to the co-transfected Renilla luciferase control. Data are analysed by a one-way 
ANOVA with Tukey’s (for P19 cells) or Dunnett’s (for mESCs) post-hoc analysis. * 





5.3.16 The 3’ extension of the Tet3 upstream promoter has a neural specific 
regulatory element  
 
The mRNA level of the Tet3 upstream transcript showed increased levels in neural-
directed, compared to cardiac-directed P19 cell differentiation (Figure 5:14). In addition, 
this transcript was shown to be induced during early mESC differentiation to greater 
extent than the downstream transcript (Figure 5:15). To establish whether the Tet3 
upstream promoter reporter construct could function in a cell-type specific manner, the 
activities of the series of upstream reporter constructs was assessed in H9c2 and SH-
SY5Y cells (Figure 5:29). Deletion A and extension B reduced luciferase activity, 
compared to the Tet3 upstream construct, in both cell types, identifying positively and 
negatively acting regulatory regions respectively. However, extension A induced an 
approximate 6-fold induction in activity in SH-SY5Y cells above the upstream construct. 
By contrast, in H9c2 cells extension A showed no difference in promoter activity 
compared to the upstream reporter. Therefore, it can be concluded that the sequence 
comprising this 3’ extension of the Tet3 upstream putative promoter has a neural-specific 















Figure 5:29 A 3’ extension of the Tet3 upstream putative promoter has a 
neural-specific regulatory function. Luciferase reporter constructs containing the 
Tet3 upstream putative promoter or the sequence extensions/deletion were 
transfected into H9c2 and SH-SY5Y cells. Luciferase activity was determined 24 hrs 
post-transfection. Data are expressed as the mean  SEM relative to the activity of 
pGL4.2 control vector after normalisation to the co-transfected Renilla luciferase 
control. Data are analysed by a one-way ANOVA with Dunnett’s post-hoc analysis. 
Shown are representative figures from 3 independent repeats. * p<0.05, **** 
p<0.0001.  
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5.3.17 Deletions from the neural-specific 3’ extension of the Tet3 upstream 
putative promoter identified a 160-base pair regulatory sequence  
 
To identify the precise regulatory sequence responsible for the neural-specific effect of 















The promoter activity of this deletion series was assessed in H9c2 and SH-SY5Y cells 
(Figure 5:31). Deletion 1A reduced promoter activity, compared to extension A, by 
approximately 9-fold in SH-SY5Y cells and 5-fold in H9c2 cells. Deletion 2A increased 
promoter activity in both cell types, compared to deletion 1A (activity remained reduced 
compared to extension A), suggestive that this 230 bp region is inhibitory. A further 
deletion from extension A, deletion 3A, also had an inhibitory effect in both cell types. 
However, compared to deletion 1A, a marginal, but significant elevation in H9c2 cells, 
which was not seen in SH-SY5Y cells, was apparent. Therefore, the major regulatory 
sequence was identified to be found between extension A and deletion 1A. Despite also 
reducing luciferase activity in H9c2 cells, a larger fold reduction was detected in SH-
Figure 5:30 Schematic representation of extension A deletions. Consecutive 
200 bp deletions at the 3’ end of the extension A sequence were cloned into 
luciferase reporter constructs. An identified potential neural specific region is marked 
as shown in Figure 5:31. Numbers correspond to the number of bps from the most 
5’ cap site (+1), see Figure 5.10. 
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SY5Ys with deletion 1A, suggestive that this sequence may have some neural specific 



























Figure 5:31 Deletion 1A reduces luciferase activity to a larger order of 
magnitude in neural cells than cardiac cells, compared to extension A. 
Luciferase reporter constructs containing extension A and its deletions were 
transfected into H9c2 and SH-SY5Y cells. Luciferase activity was determined 24 hrs 
post-transfection. Data are expressed as the mean  SEM relative to the activity of 
pGL4.2 control vector after normalisation to the co-transfected Renilla luciferase 
control. Data are analysed by a one-way ANOVA with Tukey’s post-hoc analysis. 
Shown are representative figures from 3 independent repeats. **** p<0.0001.  
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5.3.18 Sequence homology is found between the identified neural-specific 
regulatory promoter fragments in the mouse compared to human  
 
Similar to the mouse, the human Tet3 gene also encodes variants with a CXXC domain 
(NCBI accession numbers: NM_001287491.1, XM_011532689.2, XM_011532688.2, 
XM_011532686.2, XM_011532685.2, XM_005264187.3, XM_011532684.2, 
XM_011532683.2, XM_017003566.1, XM_011532682.2 and XM_011532690.1) and 
without a CXXC domain (NCBI accession numbers: XM_017003567.1 and 
XM_011532687.2). Sequence comparison of the cloned mouse putative Tet3 promoter 
fragments (Tet3 upstream co-ordinates: -1625 to +2184 and Tet3 downstream co-
ordinates: -493 to +1441) and the homologous human sequences, conducted using the 
Clustal Omega multiple sequence alignment tool 
(https://www.ebi.ac.uk/Tools/msa/clustalo/), revealed an estimated overall similarity of 
70% and 80% for the upstream and downstream promoter regions respectively. 
Alignment of the identified murine neural-regulatory fragments in the Tet3 downstream 
and upstream putative promoters to the human sequence was also conducted (Figure 
5:32 and Figure 5:33). The 2 neural-specific sequences for the downstream promoter, 
highlighted schematically in Figure 5:22, demonstrated the more 3’ promoter fragment 
(Figure 5:32B) has a higher homology to the human sequence. The neural-specific 
sequence identified from deletions of the extension A of the upstream putative promoter 
fragment, schematically depicted in Figure 5:30, also appears to have a high homology 
to the human sequence (Figure 5:33). Therefore, this high level of homology between 
mouse and human sequences may suggest these identified neural-specific fragments 








Figure 5:32 The 3’ neural-specific fragment of Tet3 downstream putative 
promoter has high sequence homology with the human sequence. Alignment 
of the murine Tet3 downstream neural-specific putative promoter fragments with the 
human sequence are shown. (A) The neural region identified at the 5’ end of the 
downstream construct (co-ordinates: -493 to -110). (B) The neural region identified 
at the 3’ end of the downstream construct (co-ordinates: +450 to +1441). The mouse 
sequence is highlighted in bold. * indicates sequence homology. Grey shading and 
underlining highlights putative binding sites for the TF Snal1 and Sox5 respectively, 
see section 5.3.19. Numbers correspond to the number of bps from the most 5’ cap 





































Figure 5:33 The neural specific fragment of the Tet3 upstream putative 
promoter is highly conserved to the human sequence. Alignment of the murine 
Tet3 upstream neural-specific putative promoter fragment (co-ordinates: +2021 to 
+2184) with the human sequence are shown. The mouse sequence is highlighted in 
bold. * indicates sequence homology. Grey shading highlights a putative binding site 
for the Snal1 TF, see section 5.3.19. Numbers correspond to the number of bps from 
the most 5’ cap site (+1), see Figure 5.10. 
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5.3.19 Snal1 was identified as a potential transcription factor responsible for the 
neural-specific effects of the Tet3 downstream and Tet3 upstream putative 
promoter fragments  
 
To begin to elucidate potential TFs that may be responsible for mediating the neural-
specific cis-acting transcriptional regulation, identified in both Tet3 upstream and 
downstream putative promoter fragments, potential TF binding sites were assessed in 
these regulatory sequences using the bioinformatics tool Consite 
(http://consite.genereg.net). The potential neural regulatory sequence at the co-
ordinates -493 to -110 and +450 to +1441 in the Tet3 downstream putative promoter 
(see Figure 5:22 and Figure 5:32) and +2021 to +2184 in the putative Tet3 upstream 
promoter region (see Figure 5:30 and Figure 5:33) was found, among a selection of TFs, 
to have 7, 13 and 1 Snail family transcriptional repressor 1 (Snal1) binding sites 
respectively. Snal1 is key factor involved in embryogenesis and is strongly implicated in 
neural crest formation519,520,521. To begin to investigate the potential regulation of Tet3 by 
Snal1, the mRNA expression of Snal1 was assessed over a time course mESC 
differentiation (Figure 5:34). The expression profile of Snal1 was similar to Tet3 (Figure 
4:5), whereby an induction of mRNA was evident after day 3 of differentiation. This 
suggests the possibility that Snal1 could regulate Tet3 mRNA expression, although 
further experimentation is required to determine this.  
 
It can also be noted TF binding site analysis revealed the ectodermal factor Sox5522 has 
8 putative sites within the neural-regulatory sequence in the Tet3 downstream promoter 






























































Figure 5:34 Snal1 expression is increased over a time course of mESC 
differentiation. The expression of Snal1 was assessed by QPCR over a time course 
of mESC differentiation. Data are expressed as the mean  SEM relative to 
undifferentiated cells, and analysed by a one-way ANOVA with Dunnett’s post-hoc 
analysis. ** p<0.01, **** p<0.0001 
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 Discussion  
 
5.4.1 5-hmC is specifically expressed in mouse brain compared to heart  
 
Differential levels of 5-hmC in brain tissue, compared to heart, at 2 developmental stages 
(E 18.5 embryos and 1-week old pups) was confirmed by 2 analytical methods, dot-blot 
and mass-spectrometry (Figure 5:2, Figure 5:3 and Figure 5:4). Consistent with the 
literature260,259,523, the data shown here demonstrates higher levels of 5-hmC in brain 
tissue, consistent with this base having a functioning role(s) in the mammalian brain524. 
The precise function of 5-hmC in the brain is unknown, however observational studies 
have shown 5-hmC is localised to promoter regions and more abundantly within gene-
bodies, correlating with high transcriptional activity525,182,506. How deposition of 5-hmC 
increases transcription is unknown, however it can be speculated that the DNA 
destabilisation effect of this polar 5-hmC mark facilitates TF binding to promote gene 
expression526,527. 
 
5.4.2 Tet3 is involved in neuronal cell function and differentiation   
 
Tet3 mRNA expression was found to potentially account for the increased 5-hmC in 
brain, compared to heart (Figure 5:5 and Figure 5:6), coinciding with previous studies 
that have reported Tet3 as the predominant paralogue in neuronal tissue422,506,518. 
However, Tet3 expression only trended to increase in embryonic brain above heart, 
suggesting the 2.5–fold induction in the 5-hmC:5-mC ratio may be attributed to a higher 
level of Tet protein expression and/or activity. However, in 1-week old pups Tet3 mRNA 
was significantly elevated in brain, compared to heart tissue, indicating a potential cell-
specific role of Tet3.  
 
Literature evidence suggests Tet3 is involved neurogenesis321,513. To further investigate 
this Tet3 expression was determined in P19 cells directed to differentiate into neural or 
cardiac-like cells in the presence of RA or DMSO respectively528,529. Tet3 mRNA showed 
a dynamic profile in RA-treated cells over the tested 10-day time course (Figure 5:9), 
expression levels showed a time-dependent increase till day 6, which then persisted to 
decrease to levels equivalent to DMSO-treated cells at day 10. This may further provide 
supporting evidence for cell-specific function of Tet3. Consistent with these findings, it 
has previously been shown in mESCs that RA, compared to DMSO treatment, induced 
Tet3 expression (while decreasing Tet1 and Tet2 mRNA levels) to promote 5-hmC 
formation530. In addition, an independent study into neurogenesis revealed Tet3 
expression was found to be low in undifferentiated ESCs and mature neurons, but high 
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in neuronal progenitors and immature neurons, thereby supporting a role of Tet3 in 
neurogenic events531. Intriguingly, from the data shown here (Figure 5:9) Tet2 
expression closely reflected the Tet3 profile, but in fact achieved a higher peak 
expression at day 6 (approximately 8-fold for Tet2, compared to 4.5-fold for Tet3) in RA-
treated cells. Tet2 has also been linked to neural processes, specifically interacting with 
the histone methyltransferase AF9 to facilitate neurodevelopmental gene activation532 
and neuronal-cell survival34. However, Tet2 was also induced in DMSO-treated P19 
cells, above undifferentiated levels after day 6 of differentiation. Hence this infers that 
Tet2 may have a developmental role in more than one cell type.  
 
5.4.3 Tet3 has 2 protein isoforms that potentially may have differential roles in 
neuronal cell differentiation and function  
 
To begin to elucidate the regulation of Tet3, which may underlie lineage-specific 
functions, 5’RACE was performed on day 7-differentiated mESCs samples to identify 
potential transcriptional start sites. Consistent with previous studies515,175, multiple cap 
sites were located upstream of 2 ATG start codons, at 2 distinct regions, encoding a 
longer CXXC-containing variant (Tet3 uptream) and a shorter alternative that lacks this 
domain (Tet3 downstream) (see Figure 5:10). 
 
The exact role of these variants in neuronal cell differentiation and function are 
controversial515,175,516 (see section 5.1.2), and thus attempts were made to decipher the 
potential differential roles of these variants. The Tet3 downstream variant specifically 
demonstrated increased expression in brain, compared to heart, in 1-week old pups 
(Figure 5:13). Despite not being fully mature at this age, mice have undergone a level of 
neurogenesis533.  Further, the Tet3 downstream transcript showed sustained expression, 
compared to the Tet3 upstream, in neural over cardiac-like directed P19 cell 
differentiation (Figure 5:14). However, it should be noted the maturity of neurons derived 
from directed P19 cell differentiation is unknown. In comparison, the Tet3 upstream 
transcript showed a transient induction in mRNA expression in neural-directed P19 cells, 
relative to undifferentiated levels (Figure 5:14). This was found to be consistent with the 
immediate induction of this transcript at the onset of unbiased mESC differentiation 
(Figure 5:15 and Figure 4:31), which correlated with subsequent neuronal maker 
induction (Figure 3:9). In addition, the loss of neuronal progenitor expression in 1% O2-
exposed differentiating mESCs correlated to a greater loss in expression of the 
upstream, compared to the downstream transcript. (Figure 5:16). Therefore, these 
distinct patterns of mRNA expression suggest the 2 protein isoforms may have 
independent roles, and hence it is tempting to speculate from the albeit limited evidence 
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shown here that the downstream transcript may be linked to a neuronal maintenance 
role, whereas the upstream to a more predominant role in early neurogenesis.   
 
5.4.4 Neural-specific regulatory fragments were identified in the both the Tet3 
downstream and Tet3 upstream putative promoters  
 
The putative promoter regions of the 2 distinct protein coding transcripts (Tet3 upstream 
and downstream) were cloned into luciferase reporter constructs as tools to investigate 
the transcriptional regulation that may underlie the potential independent functions of 
these protein isoforms.  
 
Initial assessment of reporter activity in early differentiating P19 cells and mESCs 
demonstrated consistently higher activity in the cloned putative promoter fragment of the 
downstream, compared to the upstream region (Figure 5:18 and Figure 5:19), which may 
thus be reflective of the mRNA expression profiles of these transcripts at the onset of 
mESC differentiation (Figure 5:15). In addition, the cloned downstream fragment 
displayed higher promoter activity, relative to the upstream promoter in SH-SY5Y cells 
(Figure 5:20). Although it should be considered that SH-SY5Y cells are not reminiscent 
of fully mature neurons534,535, 5’ and 3’ deletions of this downstream promoter fragment 
was performed to identify regions of sequence conferring potential neural-specificity 
(Figure 5:22 and Figure 5:25).  
 
Analysis of potential TF binding sites (using the Consite bioinformatics tool) within the 
identified neural-regulatory sequences of the Tet3 downstream promoter fragments 
(Figure 5:32) identified 7 and 13 putative Snal1 binding sites within the co-ordinates -
493 to -110 and +450 to +1411, relative to the number bps from the most 5’ cap site. 
Additional analysis revealed 8 Sox5 binding sites within the co-ordinates +450 to +1411 
(Figure 5:32B), which were more highly conserved with the human sequence than the 
Snal1 sites. Sox5 has previously been reported to be intrinsic to ectodermal formation522, 
involved in oligodendrocyte536 and corticofugal neuron537 development. Therefore, this 
provides a basis for future investigation into a possible role of Sox5 mediated regulation 
of Tet3 mRNA.   
 
Owing to a large defined potential promoter region encompassing the Tet3 upstream 
variant, on the Ensembl database, it was speculated that an additional longer regulatory 
sequence than that originally cloned for the Tet3 upstream putative promoter may exist. 
A 3’ extension of the cloned Tet3 upstream promoter, named extension A, (Figure 5:27) 
was found to contain a positively regulatory sequence (Figure 5:28), which demonstrated 
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neural-specificity (Figure 5:29). Consecutive deletions from extension A identified a 
potentially neural-regulatory sequence of only 163 bps (Figure 5:31). Analysis of putative 
TF binding sites at the co-ordinates +2021 to +2184, relative to the number bps from the 
most 5’ cap site, identified a Snal1 putative binding site (Figure 5:33) that is conserved 
with the human sequence. The Snail family has an intrinsic role in morphogenesis, but 
is specifically linked to promoting cell movements such as in the process of EMT and 
neural crest formation520,538,539. Snail family members are considered as transcriptional 
repressors, functioning to block E-cadherin expression (enabling EMT) and maintain 
germ layer boundaries via repression of ectodermal genes within the mesodermal 
domain540,541. However, there is also evidence for Snail to potentiate 
transcription542,543,544, which supports in vivo data demonstrating a role of Snail as a key 
regulator of neural precursor cells in embryonic and adult mice521. Therefore, considering 
Snal1 and Tet3 have similar gene expression profiles during mESC differentiation 
(Figure 5:34 and Figure 5:15), it can be proposed that Snal1 is a potential candidate for 
regulation of Tet3 expression. Supporting this hypothesis, depletion of Tet3 in xenopus 
resided in a loss of Snal1 expression176, suggesting these factors are intrinsically linked, 
however further investigation is required to determine any functional regulation between 
them.  
 
Overall, the luciferase reporter data shown here goes some way towards identifying 
novel neural-specific regulatory sequences within the Tet3 promoter region, which can 
be used for future investigations to identify TFs that may regulate Tet3 in neurogenic 
events.  
 
5.4.5 Luciferase reporters are unlikely to be under epigenetic control and thus 
data should be interpreted with caution  
 
Perhaps surprisingly, the activity of the Tet3 downstream putative promoter construct 
was elevated in undifferentiated P19 cells (Figure 5:21), whereas the mRNA expression 
of the Tet3 downstream transcript, albeit in differentiated mESCs, was decreased 
(Figure 5:16) in 1% O2. Despite an inability to express luciferase reporters transiently for 
a long enough period to study the effects of [O2] in differentiated cells, evidence from 
Chapter 4: Results 2 demonstrated that the Tet3 downstream promoter region showed 
O2-dependent enrichment of 5-hmC in day 3-differentiated mESCs (Figure 4:27). This 
therefore demonstrated the Tet3 downstream promoter is under epigenetic control. 
However, transient transfections of DNA plasmids are devoid of de novo methylation 
(and thus hydroxymethylation) since they are not replicated. Evidence in the literature 
has only reported such an event in the instance of replication of an artificial chromosome-
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like vector over a larger period of time545. Therefore, data achieved from luciferase 
reporters should be interpreted with caution, as the effect of epigenetic regulation are 
unlikely to be recapitulated in the transiently-transfected plasmids. 
 
5.4.6 Conclusion  
 
In conclusion, the data shown here confirms 5-hmC levels and Tet3 mRNA expression 
are elevated in brain, compared to heart tissue. To understand how Tet3 governs 
potential neural-specificity during development, 2 known Tet3 transcript variants, which 
encode distinct protein isoforms, were firstly confirmed in differentiating mESCs. 
Assessment of mRNA expression and putative promoter activity of these transcript 
variants suggest they are under differential regulation, and therefore may have not only 
cell-type specific functions, but also distinct roles in neurogenesis. Finally, the identified 
highly conserved neural-specific regions in both the Tet3 upstream and downstream 
promoter fragments provide a future basis to confirm whether the potential TFs Snal1 





















































































 Summary and proposed mechanism of O2-dependent regulation of 
cell fate decisions 
 
The data presented here demonstrate for the first time that the Tet enzymes are 
differentially regulated by [O2]. Specifically, Tet1 was identified as the paralogue most 
likely to be differentially inhibited at O2 tensions considered physiologically relevant 
within the developing mammalian embryo, thereby presenting as an O2 sensor. It is 
proposed that Tet1 regulates Tet3 expression in a spatial manner (dependent upon an 
adequate O2 supply) to in part control cell fate decisions, depicted in the schematic 
shown in Figure 6:1. In undifferentiated mESCs, Tet1 is localised to a CG rich region of 
the Tet3 promoter, which is also marked by active (H3K4me3) and repressive 
(H3K27me3) histone marks, characteristic of a bivalent promoter. Global levels of 5-hmC 
(and 5-mC) are low in undifferentiated mESCs, and the Tet3 promoter is devoid of these 
marks when cells are in this pluripotent state. Upon differentiation, it is proposed that 
Tet1 activity is increased in a graded manner, dependent upon O2 availability, to induce 
hydroxylation at a CpG rich region of the Tet3 downstream promoter, which encodes a 
truncated protein isoform, lacking a CXXC DNA binding domain. Concomitant with the 
loss of the H3K27me3 and maintenance of H3K4me3, Tet3 becomes actively 
transcribed to potentially promote neuronal cell specification. Consistent with previous 
reports515,175, transcripts encoding 2 distinct Tet3 protein isoforms with and without a 
CXXC binding domain were identified in differentiated mESCs and tissue samples in 
vivo. These transcripts were shown to be differentially regulated by distinct promoter 
regions that may underlie independent functions in developmental events, but requires 
further elucidation.  
 
Overall, these findings provide a novel mechanistic insight into how the regulation of 
epigenetic modifications via microenvironments of O2 within the developing embryo can 
function to control cell fate decisions. The context and considerations of these findings 






















 O2 signalling in the embryo is likely to encompass a multitude of 
pathways to contribute to developmental gene regulation  
 
The data shown here demonstrated that the morphogenic properties of O2 in early 
cellular differentiation may be attributed at least in part to the differential sensitivities of 
Tet enzymes to O2 tensions, thereby suggesting a possible way to drive asymmetry 
within the early embryo. However, the effect of genetic ablation of Tet enzymes on 
cellular specification produced highly variable results on lineage marker expression, and 
thus failed (with the exception of pluripotency markers) to recapitulate the skewing of 
Figure 6:1 Schematic representation of the proposed O2-dependent regulation 
of Tet3 mRNA expression during cellular differentiation. In undifferentiated 
mESCs Tet1 is bound to a CG rich region of the Tet3 promoter, marked with the 
active (H3K4me3) and repressive (H3K27me3) histone marks. Upon differentiation, 
Tet1 activity increases in an O2-dependent manner to generate 5-hmC within the 
Tet3 promoter region. Concomitantly, H3K27me3 is lost and H3K4me3 is 
maintained, which activates Tet3 transcription to potentially promote neural 
differentiation pathways. Image adapted from Burr, S et al. Nucleic Acids Res. 2017; 
ahead of print481. 
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mESC differentiation upon exposure to 1% O2. This raises 2 possibilities; Tet enzymes 
may show functional compensation and/or redundancy, meaning that the precise 
function of each paralogue is difficult to delineate (discussed in section 6.5) and/or the 
involvement of other O2-dependent signalling pathways. An additional epigenetic 
regulatory mechanism, which controls the methylation status of histones, involve the 2-
OGDO domain containing JmjC-KDMs proteins. The ability of this 7-member 
demethylase family to function as a potential O2 sensor remain to be elucidated, however 
initial Km studies performed on the KDM4 subtype suggest these enzymes are sensitive 
to physiological O2 tensions in the developing mammalian embryo273,274. From studies 
performed here, the global protein expression of the histone marks H3K27me2/3 and 
H3K4me3 were elevated upon exposure of 1% O2 in mESCs, which may be indicative 
of inhibition of KDM6 and KDM5 respectively. Thus, owing to the presence of these 2 
marks at bivalent promoters, it may be speculated that these JmjC-KDMs may function 
similarly to Tet proteins in a spatial manner, based upon O2 availability, to control 
developmental gene expression and thus asymmetry in the embryo.  
 
It should also be considered that O2, in addition to regulating the activity of these 
enzymes, may also affect their transcriptional regulation. For example, data attained 
from these studies demonstrated that exposure of differentiating mESCs to 1% O2 acted 
to elevate Tet3 mRNA expression at day 3, but by days 7 and 11 mRNA levels were 
decreased, compared to atmospheric O2. A recent study using in vitro-produced bovine 
embryos showed elevated Tet1 and Tet3 mRNA expression in 5%, compared to 
atmospheric O2546. Previously, it has been shown that culture of neuroblastoma cells in 
1% O2 induced HIF-1-dependent Tet1 mRNA expression, which was subsequently 
demonstrated to deposit 5-hmC at hypoxia-responsive gene promoters to induce 
transcriptional activation495. Similarly, ablation of HIF-1 in HepG2 cells attenuated the 
1% O2-induced expression of Tet1, Tet2 and Tet3547. The potential for HIF-dependent 
regulation of Tet3 was highlighted from the luciferase reporter data in P19 cells from this 
study, whereby activity of the Tet3 downstream promoter, harbouring 8 core HIF DNA 
binding motifs, was elevated in 1%, compared to atmospheric, O2. However, it should be 
noted, as previously referred to in section 4.4.2, the effects of [O2] upon Tet activity and 
transcriptional regulation is cell-type dependent309. Similarly, KDMs have been reported 
to be under the transcriptional control of HIFs269, and intriguingly demonstrate differential 
specificity, whereby HIF-1 induced KDM3A and KDM4B548 and HIF-2 induced KDM6A 
mRNA expression549.  
 
Overall, the ability of graded levels of O2 to influence the dynamics of DNA and histone 
methylation may provide an insight into mechanisms regulating transcriptional programs 
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in the developing embryo. The fact that HIF signalling appears to be a regulator of these 
epigenetic modifications at the transcriptional level may further indicate its intrinsic role 
as a master regulator of O2 homeostasis550. This may function as either a compensatory 
mechanism for the inhibition of 2-OGDO activity and/or provide an additional mechanism 
to ensure precise control of gene regulation at the epigenetic level. However, it is also 
plausible to imagine that additional O2-dependent mechanisms regulating cell fate 
decisions may exist in what is a highly co-ordinated, complex and relatively unexplored 
field.  
 
 Tet1 was identified as a potential O2 sensor in the developing 
mammalian embryo but also may have non-catalytic functions 
 
From ectopic expression of Tet1, Tet2 and Tet3 in HEK cells, exposed to a graded set 
of low O2 levels, it was concluded that Tet1 activity specifically was inhibited by 
physiologically relevant O2 tensions. Currently, the concept of O2-dependent regulation 
of Tet activity in differentiating mESCs is unexplored in the literature. The only study 
currently that has hinted at the ability of Tet1 to mediate a hypoxic response in mESCs 
arose from the exposure of undifferentiated cells to 0.5% O2, which was shown to have 
a lesser inhibitory effect on 5-hmC levels in Tet1-knockout, compared to wild-type 
cells309. The significance of Tet1 in O2-dependent signalling was demonstrated recently 
from a series of in vivo studies. Tet1-null zebrafish showed lower survival rates upon 5% 
O2 exposure compared to Tet2 and Tet3 silenced fish551. Similarly, it was shown that 
Tet1 ablation in mice showed lower survival rates upon exposure to 10-8% O2, compared 
to wildtype litter mates551. Thus Tet1 ablation appeared to impair hypoxia tolerance, 
perhaps consistent with Tet1 activity being the most sensitive to changes in [O2] as 
demonstrated here. Interestingly, this study reported Tet1 could enhance the 
transcriptional activation of HIF-1 through a stabilising interaction with the C-terminus, 
and of HIF-2, via competing with PHD2 for HIF-2 binding to reduce hydroxylation551. 
This provides a unique insight into Tet1 function, which is independent of its enzymatic 
activity.   
 
An additional non-catalytic role of Tet1 has been highlighted to be responsible for a non-
redundant role at the post-implantation stage of embryogenesis. Tet1 was found to 
repress Epi target genes independent of methylation changes via Jmjd8497. Jmjd8, 
similar to the founding member of the Jmj family Jarid2, lacks essential residues 
necessary for catalytic activity, but functions as a transcriptional repressor497,552. While 
the catalytic domain of Tet1 was found to be dispensable for development, in agreement 
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with previous studies251,553, deletions of the N-terminal fragment downregulated the 
Jmjd8 gene and was associated with gastrulation defects resulting lethality497.  
 
The data from this study found Tet1 to be bound to a CG rich region of the Tet3 promoter, 
encoding the protein isoform lacking the CXXC domain in undifferentiated and day 3-
differentiated mESCs. The function of Tet1 at this site may be twofold. Tet1 has 
previously been shown to be localised to CpG regions at promoters of actively 
transcribed genes and Polycomb-repressed genes. In ESCs, Tet1 can facilitate gene 
repression through a complex with Prc2 and thus association with the H3K27me3 
mark194,456. Furthermore, Tet1 binding at gene promoters was also found to overlap with 
an additional histone mark, H3K4me3, and thus Tet1 is therefore intrinsic to bivalency 
(a chromatin state characterised by the presence of repressive (H3K27me3) and 
activating (H3K4me3) marks)194. An insight into the association of Tet1 with these marks 
was highlighted from assessment of global protein levels, which confirmed that specific 
silencing of Tet1 induced H3K4me3 and for reasons currently unknown the di-methyl 
form H3K27. For the first time, the presence of these histone marks were identified at 
the same Tet3 promoter region as Tet1 in undifferentiated mESCs. Therefore, it was 
concluded that Tet3 is characteristic of a bivalent promoter, and hence can be 
considered a developmental gene poised for activation.  
 
In agreement with the literature554, this bivalent domain was also found to be 
hypomethylated, which may be attributed to the low catalytic activity of Tet1, or as shown 
here, more likely, due to the low levels of 5-mC in undifferentiated ESCs, compared to 
differentiating cells. When induced to differentiate, by day 3, this Tet3 promoter region 
showed a loss of the H3K27me3 mark (H3K4me3 remained) and a gain of hydroxylation, 
correlating with the induction of Tet3 mRNA expression. Although this was not shown 
directly, the data achieved from the studies performed here strongly supports that the 
induction of O2-dependent 5-hmC at this site was primarily mediated by Tet1. Silencing 
of Tet1 failed to reduce 5-hmC at the Tet3 promoter region, potentially attributed to Tet 
compensatory effects (discussed in section 6.5). Consistent with this hypothesis, in 
mESCs it has been reported 5-hmC is preferentially enriched at Tet1-bound gene 
promoters and intragenic regions390. But, upon Tet1 depletion 5-hmC is mainly lost from 
intragenic regions, suggesting potential functional redundancy between Tet1 and Tet2 
at Tet1 bound gene promoters390,506. Therefore, the positioning of Tet1 on the Tet3 
promoter region facilitates the target specificity of 5-hmC, and therefore suggests that 
the pre-requisite formation of 5-mC mark is closely coupled to hydroxylation. In light of 
this, it has been reported that hypermethylation of bivalent promoters is associated with 
transcriptional activation256, consistent with notion that 5-mC impairs recruitment of 
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Prc2454. Thus, with respect to Tet3 regulation specifically, it can be hypothesised that 
initial methylation events may be required to remove the H3K27me3 mark before 
subsequent oxidation by Tet1 to generate 5-hmC. However, the mechanism(s) 
underlying the induction of Tet1 catalytic activity remains to be elucidated, but was 
confirmed not to be a result of AA-dependent modulation of Tet activity.  
 
Collectively, these investigations support the dual functionality of Tet1 at the Tet3 
promoter; a non-catalytic role for the formation of a bivalent domain and the catalytic 
enrichment of 5-hmC.  
 
 Tet1 and Tet3 are implicated in neurogenesis   
 
The investigations performed here reveal a novel mechanism highlighting the potential 
interdependence between Tet1 and Tet3, which may have implications in cell fate 
decisions. Tet3 is the most abundant Tet paralogue in neurons518,506 , and has been 
documented to be fundamental in neural development321,322 as well as the 
transdifferentiation of fibroblasts to functional neurons555. The regulation of neural-
related genes, such as Pax6, Ngn2 and Tubb2b is thought to occur by the co-ordination 
of the CXXC binding domain and the intrinsic hydroxylase activity of Tet3176. Consistent 
with this notion, 5-hmC levels has shown to be increased during neurogenesis, and 
associated with higher transcript levels of genes critical for neuronal differentiation, 
migration and axonal guidance506. Interestingly, in contrast to the negative cross-talk 
reported between 5-mC and H3K27me3 in neural stem cells (loss of 5-mC resulted in 
accumulation of H3K27me3)454, a negative association of 5-hmC with H3K27me3 was 
reported in neuronal differentiation506. This observation is consistent with the data 
reported from day 3-differentiated mESCs at the Tet3 promoter, in which the gain of 
hydroxylation is associated with the loss of H3K27me3.  
 
Hydroxylation at the Tet3 promoter was lost in 1% O2, which correlated with 
transcriptional inhibition in day 7 and 11-differentiated mESCs. Associated with these 
findings was the loss of neuroectodermal marker expression (Figure 3:11 and Figure 
3:15). Therefore, it can be speculated that O2-dependent regulation of Tet3 transcription 
can function to regulate, in part, formation of the ectodermal lineage. The data reported 
here suggests that O2-dependent activity of Tet1 may regulate isoform-specific Tet3 
expression through deposition of the 5-hmC mark. An insight into the possible functional 
co-operation between Tet1 and Tet3 was suggested from expression of both paralogues 
appearing at the 2-cell stage of embryogenesis (Tet3 expression is however rapidly lost 
after the first cleavage events, re-appearing later during cellular differentiation)556. The 
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requirement of both paralogues in early embryonic development were highlighted from 
double deficient mice, whereby no viable embryos were detected past E 10.5, which was 
attributed to poor forebrain formation556. In further support of this, Tet1 has also been 
implicated in brain function557. Specifically, Tet1-ablated mice induced hypermethylation, 
corresponding to decreased expression of neuronal-activity regulated genes, resulting 
in an impairment of extinction learning558. These deleterious effects of Tet1 silencing 
were confirmed independently and additionally were shown to result in decreased adult 
neural progenitor cell proliferation, resulting in impaired neurogenesis553.  
 
The requirement of Tet3 in neuronal differentiation was recently demonstrated through 
loss and ectopic expression of Tet3 in a mESC differentiation model322. This effect was 
not recapitulated in the Tet3 silencing studies performed here (Figure 3:30), likely due 
to differences in the method of cellular differentiation. Li, X et al (2016)322 implemented 
neural-restricted differentiation conditions, compared to the unbiased differentiation 
approach used here. This was reflective of a more pronounced induction of Tet3 mRNA 
expression, recorded to peak at approximately 40-fold322, compared to 7-fold, under 
neural and unbiased differentiation conditions respectively. In addition, discrepancies 
may also be attributed to Tet functional redundancy (see section 6.5) and differences in 
the Tet3 deletion strategy. Li, X et al (2016)322 utilised complete genetic knockout of Tet3, 
whereas an shRNA-mediated gene silencing approach was used here (albeit an efficient 
level of silencing, 90%, was achieved). Aside from the impaired neural specification, 
seen with Tet3 ablation, a skewing of differentiation towards the cardiac mesoderm was 
also reported322. Thus inhibition of Tet3-mediated signalling may also be required to 
mediate mesodermal differentiation, suggestive of Tet3 acting as a switch to control 
lineage specification.  
 
The potential cell specificity of Tet3 was considered in the context of its 2-distinct protein-
coding isoforms, which were confirmed to be present in differentiated mESCs and 
tissues in vivo. Evidence from these investigations suggests Tet1 may regulate isoform 
specific Tet3 through deposition of the 5-hmC mark at the Tet3 downstream promoter 
region, which drives expression of the smaller truncated protein, lacking the CXXC 
domain. However, it should be noted Tet1 silencing failed to decrease the mRNA 
expression of this Tet3 downstream transcript (and/or the Tet3 upstream variant). This 
may be attributed to the inability of Tet1 silenced mESCs to reduce hydroxylation at this 
Tet3 promoter, potentially caused by either Tet functional compensation (see section 
6.5) or a lack of sufficient Tet1 ablation, enabling some functionality to remain. However, 
the exact function of 5-hmC at this region is unknown and will form the basis for future 
investigations. In light of the controversy in the literature surrounding the neuronal 
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involvement of either Tet3 isoform515,175,516, evidence from Chapter 5: Results 3 
demonstrate these protein coding transcript variants confer differential regulation and 
therefore suggests they may have distinct functions in neurogenesis. 
 
 Functional compensation and redundancy between Tet proteins mask 
their independent developmental roles  
 
The precise function of each Tet paralogue in cellular differentiation may be difficult to 
elucidate due to compensatory and functionally redundant effects between the Tet 
enzymes. This was shown to be apparent not only in the undifferentiated stable Tet 
silenced cell lines generated for use in this study, but also widely reported in the 
literature248,251,258,322. For example, recently it was shown that depletion of Tet3 in 
embryos, compared to Tet1/2/3-deficent embryos, demonstrated no overt neuronal 
defects, which was suggested to be caused by functional redundancy from Tet1 and 
Tet2322. In another instance, due to compensatory mechanisms, developmental defects 
in gastrulation required deletion of all 3 Tet paralogues258. A final study important in 
portraying this phenomenon occurred when depletion of Tet1 in mESCs (the most highly 
expression paralogue in these cells) led to only a partial reduction in 5-hmC, leading to 
suggestions other Tet family members could compensate for this loss251. However, 
importantly no change in mRNA levels of either Tet2 and Tet3 was confirmed251, leading 
to speculation that perhaps the catalytic activity of these paralogues can be induced.  
 
 Considerations and Future directions  
 
ESCs are a widely-used tool for studying and modelling cell specification during cellular 
differentiation events. ESCs, derived from the ICM, can be maintained in a ‘ground state’ 
of pluripotency (devoid of methylation) in the presence of 2i and LIF culture conditions349. 
Differentiation of these cells form primed Epi-like cells, mimicking the E 5.5 – E 6.0 pre-
gastrulation Epi (but do not form the TE in culture), and thus are suitable for investigating 
early embryogenesis559. The formation of EBs, as performed in these studies, provide a 
3-dimensional structure that enhances cell-cell interactions, which may be of importance 
to specific developmental programs560. However, EBs typically form different sizes cell 
aggregates and an un-patterned heterogeneous population of cell derivatives. 
Therefore, the spatial organisation of the EB is unlikely to reflect that of the developing 
early embryo, and thus future investigations could encompass advances in 
differentiation strategies aimed at recapitulating developmental patterning561,562,563. In 
addition, the use of iPSCs, specifically derived from human, may provide a more 
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translational approach for the investigation of Tet enzyme function, with the aim of 
understanding their role(s) in cell specification events to facilitate generation of patient 
specific cells for transplantation. Research has already implicated Tet proteins and 5-
hmC in the epigenetic reprogramming required for generation of iPSCs564, and in fact 
Tet1 has been shown to be able to replace the Oct4 in somatic cell reprograming565. 
However, upon assessment of the current literature there is no evidence that Tet proteins 
have been investigated in iPSC directed cellular differentiation.  
 
In light of the current work performed here, demonstrating the potential involvement of 
[O2] and Tet proteins to dictate asymmetry and cell fate decisions in an unbiased model 
of cellular differentiation, it is of potential importance to assess the role of 5-hmC/Tet 
proteins in specific cellular differentiation programmes. Considering it has been 
previously reported that Tet3 may function as regulator of both mesoderm and 
ectodermal differentiation322, the utilisation of well documented methods to direct ESCs 
to cardiac566,567,568 and neural lineage569,570,571 may prove useful to gain a mechanistic 
insight into the exact cell specificity of the Tets. Directed differentiation strategies, in 
combination with the use of CRISPR/cas9, for the generation of a complete Tet knockout 
pluripotent cell line (which could be performed on individual a Tet, or in combination to 
produce double or even triple Tet ablated cells), would provide a valuable tool for 
elucidating the exact functional role of each Tet in a defined cellular specification 
pathway. Furthermore, a CRISPR-based approach could be implemented to target Tet 
enzymes to specific gene loci to induce DNA demethylation572, hence this approach 
could be implemented during ESC differentiation, to control gene expression, and thus 
facilitate derivation of cells for transplantation.  
 
A directed ESC differentiation approach could be additionally implemented to delineate 
between the 2 protein coding isoforms of Tet3 in neuronal specification. One proposition 
may be to generate stable ESC lines expressing the luciferase reporters driven by the 
Tet3 upstream and downstream promoter fragments. This would enable firstly the 
possibility of detecting promoter activity at the time point Tet3 mRNA expression is 
induced during differentiation and provide information into which promoter is more active 
during neurogenesis. The effect of each isoform on neuronal differentiation can then be 
addressed using a genetic ablation strategy and assessing mRNA expression of key 
early (Dcx354, Sox2573) and late (Map2347, NeuN574) neuronal markers. Additional insights 
into the functional roles of these isoforms could be conducted in vivo, whereby staining 
for each isoform in the mouse brain at a variety of developmental stages (embryonic to 
adult) may confirm differential roles in neurogenesis and neuron function. A final follow 
up to this work is to identify TFs that regulate expression of these Tet3 transcript variants. 
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Recently it was identified NeuroD1 could induce Tet3 pan expression575, and in 
combination with the bioinformatics analysis, which identified potential binding sites for 
Snal1 and Sox5 within the Tet3 promoter region, provide candidate TFs to explore. To 
confirm this potential regulation of Tet3, overexpression and genetic ablation of these 
factors in neural and cardiac cell types can be performed to assesses an ability to 
potentiate promoter activity and Tet3 expression. Further verification can be made by 
mutagenesis studies on the proposed TF binding sites on the Tet3 promoter, followed 
by subsequent assessment of promoter activity in neural and cardiac cells.  
 
Building from these studies, future experimentations can be targeted towards an in vivo 
approach. To verify Tet1-dependent regulation of Tet3, which may be of importance in 
neurogenesis, Tet1-knockout mice, or potentially Tet1-conditional knockout mice, under 
control of a neuronal progenitor specific Cre-recombinase such as Nestin576 or Emx1577, 
can be used to assess Tet3 mRNA expression as well as Tet3 staining in the brain. This 
system could also be implemented within an O2 controlled environment, whereby mice 
heterozygous for a deletion in Tet1 can be mated and subsequent pregnant mice 
maintained in mild hypoxia conditions (8% O2) (lowest level of tolerance was determined 
as 5.5% O2), similarly to studies performed by Sparrow, D et al (2012)578. Pregnant mice 
would be sacrificed at varying stages of early embryonic development and the effects 
upon neuronal differentiation assessed. This study would provide information on the 
impact of neuronal development when exposed to low O2 tensions in the absence of the 
in vitro determined Tet1 O2 sensor. Furthermore, as similarly performed from mESC 
differentiation studies, it can be verified whether O2-dependent Tet1-mediated 
hydroxylation on the Tet3 promoter occurs in the mouse brain. The study of Tets and O2 
in embryogenesis may be further examined through whole embryo culture. Utilisation of 
previously documented methods579,580 would enable the exposure of Tet deficient 
embryos to graded levels of low O2 tensions, thereby assessing the O2 sensing 
capabilities of Tets in a more physiological model compared to in vitro cellular 
differentiation. This would further provide insights into the effects of Tet ablation and [O2] 
on developmental patterning and asymmetry. In addition, genomic approaches can be 
implemented here to identify the effects of [O2] on DNA demethylation within the 
developmental genome, and thus provide information on gene regulation, which will 
increase the current understanding of embryogenesis.  
 
In consideration of the studies shown here, some final points should also be mentioned 
that may provide other avenues for future exploration. Firstly, the work performed here 
focused only on the 5-hmC mark, however literature evidence suggests that despite 
being a rare base in the mammalian genome, the 5-fC modification is also stable and 
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has different dynamics to 5-hmC, thereby suggesting this mark may have an 
independent functional role581. Genome-wide mapping data revealed a greater state of 
5-fC enrichment at CpG islands of promoters than 5-hmC, and interestingly found a 
correlation with the H3K4me3, suggestive of a role in transcriptional activation582. 
Therefore, owing to differential substrate specificities of the Tet enzymes198,206, it could 
be hypothesised that changes in [O2] may have less impact upon 5-fC levels and thus 
may have consequential significance upon gene regulation. The complexity of gene 
regulation is further evident from the fact that RNA molecules themselves can become 
methylated to form 5-methylcytidine (5-mrC) and N6-methyladenonsine (m6A), which is 
reported to have influential role on RNA stability, localisation and translation583,584. 
Intriguingly, Tet enzymes can oxidise 5-mrC to form 5-hydroxymethylcytidine, whereas 
the m6A mark can be oxidised to N6-hydroxymethyladenonsine (hm6A) by AlkB family of 
dioxygenases (including fat mass obesity associated isoform)585,586,587. Similarly to the 
Tets, the activity of these enzymes are also dependent upon [O2]586, and is of potential 
interest for prospective investigations to assess the sensitivity of this class of enzyme to 
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